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CRISPR GMOS 
 
Paul Enríquez∗ 
 
ABSTRACT   
A genome editing revolution of unprecedented magnitude—
spearheaded by a scientific breakthrough called CRISPR—is 
underway. This powerful technology has enabled scientists to 
precisely edit genes and is challenging long-held conventions of 
how humans view life. The incipient power to control and alter the 
genetic destiny of living organisms, including plants and animals 
intended for human consumption, raises complex legal issues that 
our legal system will soon be forced to address. Against a 
backdrop of limited natural resources to meet demands for global 
food security and fervid opposition to genetically modified 
organisms (“GMOs”) by many groups worldwide, the future of 
genetically modified (“GM”) crops developed using CRISPR 
technologies is uncertain. 
This Article explores the legal status of genome-edited crops. It 
provides a succinct resource that aims to dissect, demystify, and 
render primary scientific literature on GMOs accessible to law 
and policy makers. The Article also examines the intricacies and 
limitations associated with the current regulatory scheme under 
the Coordinated Framework for the Regulation of Biotechnology, 
and how it discriminates among GM products on the basis of risk 
and process depending on the method through which the products 																																																								
∗ J.D., LL.M., Ph.D. Candidate, Structural and Molecular Biochemistry. I am 
grateful to Anna Stepanova, Fred Gould, Steve Spiker, and John Conley for their 
generous comments on earlier versions of the manuscript, and the Journal’s 
staff, especially Lauren Hunstad and Shannon O’Neil, for their diligent work. In 
memory of John Byrne, who passed well before his time and will be 
remembered dearly by all whose lives he touched. 
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are derived. The Article analyzes the dissonance in the current 
regulatory framework governing GMOs and argues that, in the 
near future, it will likely be increasingly difficult to make 
meaningful and enforceable regulatory distinctions between 
genome-edited and naturally occurring crops. Lastly, the Article 
identifies several obstacles to developing scientific-based public 
policy in the realm of GMOs and proposes a set of policy 
recommendations to facilitate the rational regulation of genome-
edited crops. 
 
TABLE OF CONTENTS 
 
ABSTRACT....................................................................................432	
INTRODUCTION............................................................................435	
I. GENETICALLY MODIFIED ORGANISMS...................................445	
A. From Domestication . . . ................................................447	
B . . . . To Molecular Manipulation ....................................453	
II. MAKING A GMO ....................................................................458	
A. Non-Recombinant DNA Methods .................................459	
1. Interspecific and Intergeneric Hybridization ...........460	
2. Embryo Rescue .........................................................461	
3. Chromosome Engineering ........................................462	
4. Induced Mutagenesis ................................................463	
5. Somaclonal Variation ...............................................464	
B. Genetic Engineering Methods........................................465	
1. Agrobacterium tumefaciens-Based Plant 
Transformation .......................................................465	
2. Particle Bombardment Transformation....................469	
3. Polyethylene Glycol- and Electroporation-Based 
Protoplast Transformation .....................................470	
4. Microinjection ..........................................................471	
5. Other Methods ..........................................................471	
III. HEALTH AND ENVIRONMENTAL GMO SAFETY  
   CONCERNS ..........................................................................472	
A. Human and Animal Health ............................................473	
1. Institutional Authorities and International 
Organizations .........................................................473	
434 N.C. J.L. & TECH. [VOL. 18: 432 
2. Scientific Literature ..................................................476	
3. Dissenting Voices—Opposition to the Scientific 
Consensus ...............................................................481	
B. The Environment ...........................................................487	
1. Crop Yield and Economics .......................................488	
2. Pest Management .....................................................490	
3. Pesticide Use, Acquired Resistance, and  
  Controversies ..........................................................490	
4. Non-Target Species and Biodiversity .......................493	
IV. THE REGULATORY LANDSCAPE—A COORDINATED 
FRAMEWORK......................................................................497	
A. The United States Department of Agriculture ...............500	
B. The Food and Drug Administration ...............................503	
C. The Environmental Protection Agency..........................506	
V. CRISPR GMOS—NEW FOOD OR JUST GMOS 2.0?............508	
A. CRISPR-Based, Targeted Genome Editing—A Brief 
Overview ......................................................................509	
B. CRISPR-Based Genome Editing and the Coordinated 
Framework....................................................................510	
VI. A REGULATORY PATH FOR GENOME-EDITED CROPS IN THE 
TWENTY-FIRST CENTURY .................................................513	
A. Banana vs. Fungus—A Hypothetical ............................516	
B. Applying the Coordinated Framework to Reveal 
Regulatory Gaps ...........................................................519	
C. Regulatory Outlook and Policy Perspectives.................521	
1. The Worlds of Science and Policy ............................522	
2. Promoting Research- and Scientific-Based Policy 
Development ...........................................................525	
 2.1 Facilitate Transparency in the Regulatory 
 Process............................................................525	
 2.2 Disclose Conflicts of Interest............................527	
 2.3 Develop Policies to Promote Dedicated  
 Grants .............................................................529	
 2.4. Incorporate Modern Technologies, When 
 Feasible, and Promote Technology  
 Development ...................................................531	
CONCLUSION ...............................................................................536	
 
MAY 2017] CRISPR GMOs 435 
TABLE OF FIGURES 
FIGURE 1. Crop evolution depicted by juxtaposition of select 
popular crops genetically modified through artificial selection 
and their unmodified wild progenitors..................................452 
FIGURE 2. The molecular basis for insecticide resistance in GM 
crops—A Bt insecticidal Cry protein.....................................494 
FIGURE 3. The molecular basis for herbicide resistance in GM 
crops—A glyphosate-resistant EPSPS (5-enolpyruvylshikimate-
3-phosphate synthase) enzyme...............................................517 
 
INTRODUCTION 
A genome editing1 revolution of unprecedented magnitude—
spearheaded by a scientific breakthrough called “CRISPR” 
(Clustered, Regularly Interspaced, Short Palindromic Repeats)—is 
underway. At its core, this scientific revolution concerns the 
rational and deliberate manipulation of the genetic composition—
genotype2—of myriad living organisms. 																																																								
1 Genome editing is an umbrella term that refers to “scientific technological 
advances that enable rational genetic engineering—at a local (gene) or global 
(genome) level—to facilitate precise insertion, removal, or substitution of 
fragments of Deoxyribonucleic acid (“DNA”) molecules, comprising one or 
more nucleotides . . . into the cell(s) of an organism’s genome.” Paul Enríquez, 
Genome Editing and the Jurisprudence of Scientific Empiricism, 19 VAND. J. 
ENT. & TECH. L. 603, 617 (2017) (internal citations omitted). Genome editing is 
frequently used interchangeably with other terms including, but not limited to, 
gene editing and genetic engineering. Id. at 617 n.53. 
2 The term “genotype” refers broadly to the overall genetic composition of a 
living organism and narrowly to the variant forms of genes—alleles—carried by 
the organism in its cells. See Genotype, SCITABLE, 
https://www.nature.com/scitable/definition/genotype-234 (last visited Mar. 16, 
2016). The discussion of rational manipulation of genetic material frequently 
concerns the alteration of specific DNA sequences known as genes, which 
encode biochemical information to synthesize functional Ribonucleic acid 
(“RNA”) or protein molecules. However, it is important to note that genome 
editing can not only encompass deliberate manipulation of coding regions of 
DNA, but also the alteration of other non-coding DNA regions throughout an 
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Millions of years ago, world history changed course when our 
hominid ancestors concocted the Oldowan toolkit. Now, for the 
first time in the history of civilization, humans have developed 
another set of specialized tools. Only this time, the tools bring the 
previously unimaginable prospect of changing the very essence of 
life—by making intended modifications at specific sites of any 
organism’s genome—within the realm of possibility. The 
discovery of highly precise and programmable enzymes that 
function as macromolecular machines to shear DNA has made that 
feat possible and is democratizing scientists’ access to new tools 
requisite for uncovering future significant medical and scientific 
advances.3 At the same time, the emerging technology in the realm 
of gene editing is challenging long-held conventions of how 
humans view life and the incipient power to control and alter the 
genetic destiny of every living creature. 
More than four decades have passed since the era of 
recombinant DNA gave rise to modern biotechnology.4 During that 
time, humans have innovated ways to address complex challenges 
in fields ranging from synthetic biology to medicine and 
agriculture. The impact of biotechnology on agriculture, for 
example, has been remarkable. Today, agrobiotechnology is 
tackling broad issues such as improving human health and 
nutrition,5 as well as feeding an ever-increasing world population.6 
Feeding the world and achieving food security has become a 
major goal of biotechnology, and with good reason. The United 
Nations estimates that the world population will rise from nearly 																																																																																																																												
organism’s genome, including intergenic (between genes) and intragenic (within 
genes) DNA sequences. 
3 Enríquez, supra note 1, at 614–15, 632. 
4 Id. at 621–22. 
5  E.g., Xudong Ye et al., Engineering the Provitamin A (β-Carotene) 
Biosynthetic Pathway into (Carotenoid-Free) Rice Endosperm, 287 SCIENCE 
303 (2000) (engineering rice enriched in levels of a Vitamin A precursor). 
6 See generally, e.g., NORMAN E. BORLAUG & CHRISTOPHER R. DOWSWELL, 
FEEDING A WORLD OF TEN BILLION PEOPLE: A 21ST CENTURY CHALLENGE, IN 
PROCEEDINGS OF THE INTERNATIONAL CONGRESS IN THE WAKE OF THE DOUBLE 
HELIX: FROM THE GREEN REVOLUTION TO THE GENE REVOLUTION (2003), 
http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.462.3105&rep=rep1&
type=pdf.  
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seven billion to approximately ten billion in the next thirty years.7 
Global crop demand is set to increase more than 100% during that 
same timeframe.8 Limited resources in the form of arable land and 
water available for irrigation will pose great impediments in global 
efforts to foster food security.9 
To confront the challenges of transforming global agriculture 
and improving crop yields, scientists have devised ways of using 
biotechnology to manipulate the genetic material of crop plants to 
engineer pest, chemical, and drought resistance, improve 
nutritional content, optimize yields, and minimize the impact of 
suboptimal environmental conditions.10 
Unfortunately, good intentions and finite scientific knowledge 
often translate into imperfect technologies. Early attempts to 
address modern agricultural problems involved the use of 
traditional breeding coupled with artificial selection11—an often 
tedious and laborious combination of methods—and what is now 
known as transgenesis, a process that refers to the artificial 
																																																								
 7  United Nations Department of Economic and Social Affairs, World 
Population Projected to Reach 9.6 Billion by 2050, UNITED NATIONS (June 13, 
2013), https://www.un.org/development/desa/en/news/population/un-report-
world-population-projected-to-reach-9-6-billion-by-2050.html. 
 8  David Tilman et al., Global Food Demand and the Sustainable 
Intensification of Agriculture, 108 PROC. NAT’L ACAD. SCI. U.S. 20260, 20261 
(2011). 
 9 Elliot M. Berry et al., Food Security and Sustainability: Can One Exist 
Without the Other?, 18 PUBLIC HEALTH NUTRITION 2293, 2300 (2015). 
 10 It bears noting that genetic modification of plants, including crops, has also 
been used for other non-food agricultural purposes beyond the scope of this 
Article, such as bioremediation and the production of biofuels and 
pharmaceutical compounds. See, e.g., Ute Krämer & Agnes N. Chardonnes, The 
Use of Transgenic Plants in the Bioremediation of Soils Contaminated with 
Trace Elements, 55 APPLIED MICROBIOLOGY & BIOTECHNOLOGY 661 (2001) 
(bioremediation); Bryan R. Moser, Camelina (Camelina sativa L.) Oil as a 
Biofuels Feedstock: Golden Opportunity or False Hope?, 22 LIPID 
TECHNOLOGY 270, 273 (2010) (biofuels); Hugh S. Mason et al., Expression of 
Hepatitis B Surface Antigen in Transgenic Plants, 89 PROC. NAT’L ACAD. SCI. 
U.S. 11745 (1992) (pharmaceuticals). 
11 See infra Part I and Section II.A. 
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introduction of genetic material—namely, transgenic 12  DNA—
from one organism into the genome of another unrelated organism. 
Remarkably, scientists proved that the latter approach could be 
used to create pest-resistant, 13  drought-tolerant, 14  herbicide-
resistant,15 and other varieties of plants to ameliorate agricultural 
challenges through biotechnological innovation. 
Notwithstanding the scientific progress, the practice of 
adjoining native and foreign DNAs generated controversy and 
opposition to genetic engineering. A primary objection has been 
that genetic modification of living organisms is “unnatural” and, 
therefore, in some sense, wrong.16 Some opponents of modern 
genetic modification techniques have conjured up parallels to 
Frankenstein; or, the Modern Prometheus,17 the famed fictional 
novel. 18  Despite the lack of logical resemblance, such flawed 
comparisons have permeated social discourse surrounding genetic 
engineering. Public perceptions of genetically modified organisms 
																																																								
12  See, Transgene, SCITABLE, 
http://www.nature.com/scitable/definition/transgene-223 (last visited Dec. 1, 
2016). 
13 See, e.g., Ronald L. Meeusen & Gregory Warren, Insect Control with 
Genetically Engineered Crops, 34 ANN. REV. ENTOMOLOGY 373, 373 (1989). 
14 See, e.g., Jiyul Chang et al., Water Stress Impacts on Transgenic Drought-
Tolerant Corn in the Northern Great Plains, 106 AGRONOMY J. 125 (2013). 
15 See, e.g., Barbara J. Mazur & S. Carl Falco, The Development of Herbicide 
Resistant Crops, 40 ANN. REV. PLANT PHYSIOLOGY & PLANT MOLECULAR 
BIOLOGY 441 (1989). 
16 See, e.g., 10 Scary Facts About GMOs, ONE GREEN PLANET (Mar. 18, 
2013), http://www.onegreenplanet.org/vegan-health/10-scary-facts-about-gmos/. 
17 MARY SHELLEY, FRANKENSTEIN; OR, THE MODERN PROMETHEUS VOL. I 
(1818). The novel’s first edition was published anonymously in 1818, but Mary 
Shelley's name appeared on the second edition, which was published in 1823. 
See Frankenstein, WIKIPEDIA, https://en.wikipedia.org/wiki/Frankenstein (last 
visited May 10, 2017). 
18 See, e.g., Jill Ettinger, Everything You Absolutely Need to Know About 
GMOs, ORGANIC AUTHORITY (Feb. 20, 2012), 
http://www.organicauthority.com/foodie-buzz/what-are-gmos-genetically-
modified-crops-foods.html (“The practice of introducing new DNA and 
chemicals to seeds or animals . . . is similar to how Mary Shelly’s Frankenstein 
created his monster—through piecing together lots of different organisms.”). 
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(“GMOs”)19 have become so distorted that foods derived from 
genetically modified (“GM”) crops are frequently referred to as 
“Frankenfoods.”20 Some opponents of genetic engineering “have 
[even] likened [an] inevitable backlash of GMO technology to the 
destruction and muderous [sic] rampage of Frankenstein’s 
monster.”21 It is no surprise that the use of genetically modified 
organisms in agriculture has become one of the most controversial 
and impassioned topics in modern times. 
While the use of biotechnology for agricultural purposes has 
been the subject of scientific research for decades, CRISPR 
biotechnologies mark a new turning point in the current GMO 
narrative. CRISPR-based genome editing technologies and their 
progeny are poised to raise challenging problems that our legal 
system will be forced to address sooner rather than later. The 
current GM crop regulatory scheme in the United Stated—namely, 
the 1986 Coordinated Framework for the Regulation of 
Biotechnology (“Coordinated Framework”)22—is largely limited in 
scope by older genetic engineering methods that rely on 
recombinant DNA technology. 23  Specifically, the regulatory 
calculus focuses heavily on the introduction of transgenic DNA, 
from foreign organisms—e.g., viruses or bacteria that may be 
considered plant pests under current law—into GM crops by virtue 
of human intervention.24 
At the time the Coordinated Framework went into effect, it 
would have been impossible for scientists—let alone law and 																																																								
 19 See definition infra Part I; see also infra notes 51–59 and accompanying 
text. 
20 See, e.g., Watch Out New Frankenfood Arriving Soon: GMO Potatoes, THE 
ALTERNATIVE DAILY, (http://www.thealternativedaily.com/watch-new-
frankenfood-arriving-soon-gmo-potatoes/ (last visited May 10, 2017); Ettinger, 
supra note 18; Catherine Guthrie, Frankenfood = Genetically Modified Food, 
EXPERIENCE LIFE (June 2013), https://experiencelife.com/article/frankenfood-
genetically-modified-foods/. 
21 Ettinger, supra note 18. 
 22 Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg. 
23,302 (June 26, 1986). 
 23 See infra Section II.B. 
 24 See generally Coordinated Framework for the Regulation of Biotechnology, 
51 Fed. Reg. 23,302. 
440 N.C. J.L. & TECH. [VOL. 18: 432 
policy makers—to predict all of the technologies by which humans 
are now able to alter the genetic composition of whole organisms 
at will. The scientific research and industry communities have, for 
some time, expressed discontent with the status quo, and calls for 
the modernization of the Coordinated Framework are growing 
louder each day. To answer those calls, the Obama Administration 
launched an initiative to modernize the Coordinated Framework.25 
The Executive Branch’s 26  directive to modernize the U.S. 
regulatory system for biotechnology aims to improve transparency, 
efficiency, predictability, and public confidence in the federal 
government’s ability to develop sound health and environmental 
policy.27 
To understand the need for an overhaul of the current 
regulatory scheme, an understanding of how the system 
discriminates between products in terms of risk and process is 
essential. A high degree of dissonance exists between the ways in 
which GM crops derived through recombinant DNA technology 
are regulated relative to those derived through conventional 
hybridization and plant breeding methods.28 
On one hand, GM crops developed through non-recombinant 
DNA techniques—e.g., intergeneric hybridization, induced 
mutagenesis, etc.29—for cross-breeding non-related30 crop species 																																																								
 25  See Memorandum for Heads of Food and Drug Administration, 
Environmental Protection Agency, and Department of Agriculture: Modernizing 
the Regulatory System for Biotechnology Products, (July 2, 2015), 
https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/moderni
zing_the_reg_system_for_biotech_products_memo_final.pdf [hereinafter 
Modernizing the Regulatory System for Biotechnology Products]. 
26 As of the time of this writing, the author is not aware of any reports or 
statements by the Trump Administration that undermine efforts to modernize the 
Coordinated Framework.   
 27 See Modernizing the Regulatory System for Biotechnology Products, supra 
note 25. 
28 See infra Parts IV and V. 
 29 See infra Section II.A (discussing techniques). 
 30 It is important to distinguish cross-breeding of non-related and related plant 
species. Although both types are deemed not to fall under the regulatory 
oversight of the Coordinated Framework, crosses between plants of the same 
species are less likely to lead to unexpected phenotypic or compositional 
changes in crops. 
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or exposing crops to mutagens are largely overlooked under the 
Coordinated Framework. This lack of regulatory oversight exists 
despite the fact that genetic modifications in many non-
recombinant DNA crops are, in theory, more likely to result in 
significant reshuffling of parental genes, 31  which can lead to 
unexpected phenotypic or compositional changes in GM food.32 
On the other hand, GM crops developed with recombinant 
DNA technology, using either non-related or related crop species, 
trigger immediate regulatory scrutiny because, despite being more 
precise than non-recombinant methods, the techniques used to 
introduce DNA could, in theory, also lead to unexpected 
phenotypic or compositional changes in GM food.33 
Three decades of scientific research suggest that present-day 
controversies surrounding GM crops and food are not grounded in 
scientific fact. A scientific consensus has now formed to support 
that proposition.34 From a strict risk-based standpoint, it seems 
logical that some level of deregulation of GM crops should 
proceed. Indeed, many in the scientific community have recently 
argued on behalf of a risk-based approach to replace the current 
process-based approach to biotechnology.35 
The Executive Branch’s directive to modernize the U.S. 
regulatory system for biotechnology coupled with findings in the 
most recent report by the National Academies of Sciences, 
Engineering, and Medicine (“NASEM”) on the status of GM 
crops36 suggest that the future regulatory landscape for GM crops 
will be less restrictive than its current incarnation. However, if the 
new approach to biotechnology is risk-based, how will CRISPR-
mediated genome-edited crops be regulated? In the near future, it 
will likely be increasingly cumbersome to make meaningful and 
enforceable regulatory distinctions between genome-edited and 																																																								
 31 See Irving W. Knobloch, Intergeneric Hybridization in Flowering Plants, 
21 TAXON 97 (1972). 
32 See infra Section II.A. 
33 See infra Section II.B. 
 34 See discussion and studies cited infra Section III.A.2. 
 35 See, e.g., Gregory Conko et al., A Risk-Based Approach to the Regulation of 
Genetically Engineered Organisms, 34 NATURE BIOTECHNOLOGY 493 (2016). 
36 See infra Section III.A.1. 
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naturally occurring crops. Blurring the lines that mark what is 
natural or not is likely to challenge the very essence of what 
constitutes a GMO. And, if that is the effect of technological 
advances in genome editing, should the law regulate CRISPR GM 
crops at all? 
This Article explores the complex issues raised by new genome 
editing technologies—particularly CRISPR genome editing—on 
the legal status of GMOs. 
Part I provides an overview of GMOs and how humans have 
manipulated living organisms to fit their needs since the dawn of 
civilization. It introduces evidence of domestication-induced crop 
genetic modification over the past few millennia to point out that 
arguments that humans ought not to interfere with nature’s course 
have little merit.37 This Part also introduces the reader to key 
scientific discoveries that ushered in the age of evolutionary and 
molecular biology, which together sparked an agricultural 
transformation that led to global commercialization of the first GM 
crops.38 
Part II provides a detailed account of numerous techniques 
used by scientists to make a GMO. It intentionally divides methods 
to produce GMOs in two categories: non-recombinant DNA 
methods,39 which often rely on artificial selection of desirable plant 
traits, and genetic engineering methods, 40  which depend on 
recombinant DNA technologies. Importantly, this Part discusses 
the advantages, limitations, and potential risks associated with the 
techniques, and airs common misperceptions concerning the false 
natural status often ascribed to non-recombinant DNA methods. 
Part III examines the controversies generated by GMOs over 
the past two decades and anchors the discussion under the 
framework of a Jurisprudence of Scientific Empiricism.41 This 
theoretical foundation is critical to properly address rising legal 
and policy questions related to GMOs that are firmly grounded in 																																																								
37 See infra Section I.A. 
38 See infra Section I.B. 
39 See infra Section II.A. 
40 See infra Section II.B. 
41 See Enríquez, supra note 1, at 603, 611–14. 
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reason and scientific facts. This Part provides a comprehensive 
examination of the current state of the primary scientific literature 
related to the potential health 42  and environmental 43  concerns 
surrounding GMO biotechnology. The primary goal is to deliver a 
succinct resource to render dense scientific information accessible 
to law and policy makers.  
In addition, Part III analyzes distinct rationales behind fervid 
opposition to GMOs, which have contributed to making regulation 
of GMO biotechnologies a “global problem.”44 Evidence suggests 
that opposition to GMOs is not exclusively related to technological 
aversion on ethical, health, or environmental grounds, but centers 
on economic, financial, and political concerns instead. 45  As a 
result, many opponents of GMO technologies have been criticized 
as hypocritical.46 For instance, although a majority of European 																																																								
42 See infra Section III.A. 
43 See infra Section III.B. 
44 Paul Enríquez, Deconstructing Transnationalism: Conceptualizing 
Metanationalism as a Putative Model of Evolving Jurisprudence, 43 VAND. J. 
TRANSNAT’L L. 1265, 1269, 1336 (2010). For instance, several European 
countries have banned GMOs in recent years. See infra note 217 and 
accompanying text. The bans raise complex legal issues concerning international 
trade, intellectual property rights, and the future regulation of genome-edited 
crops in the European Union and around the world. 
45  See, e.g., GM Crop Ban, SCOTTISH GOV’T RIAGHALTAS NA H-ALBA 
GOV.SCOT (Aug. 9, 2015), http://news.gov.scot/news/gm-crop-ban (announcing 
Scotland’s recent ban of GMOs in order to “protect and further enhance [its] 
clean, green status.”); Laurence A. Kogan, Trade Protectionism: Ducking the 
Truth About Europe’s GMO Policy, N.Y. TIMES (Nov. 27, 2004), 
http://www.nytimes.com/2004/11/27/opinion/trade-protectionism-ducking-the-
truth-about-europes-gmo-policy.html?_r=0 (arguing that the European 
Commission’s opposition to GMOs in previous years was based on “blatant 
trade protectionism,” and that EU policies have influenced developing countries 
in Africa to oppose GMOs for fear of trade restrictions to EU markets.); Natasha 
Geiling, Scotland Bans Genetically Modified Crops, THINKPROGRESS (Aug. 10, 
2015), https://thinkprogress.org/scotland-bans-genetically-modified-crops-
8d6ac8849259 (citing potential consumer backlash and a desire to preserve an 
image of producing high-quality goods as a driving factor behind Scotland's 
decision to ban GMOs). 
46 See Mark Lynas, With G.M.O. Policies, Europe Turns Against Science, N.Y. 
TIMES (Oct. 24, 2015), 
https://www.nytimes.com/2015/10/25/opinion/sunday/with-gmo-policies-
europe-turns-against-science.html (arguing that European policies on GM crops 
444 N.C. J.L. & TECH. [VOL. 18: 432 
countries currently ban production of GM crops, Europe “imports 
over 30 million tons” of corn and soy-based animal feeds every 
year—mostly derived from GM crops—for its livestock industry 
because they are cheaper than non-GM crops.47  
Part IV examines the jurisdictional power that regulatory 
agencies use to implement the Coordinated Framework. It 
discusses key statutory provisions that give the United States 
Department of Agriculture, the Food and Drug Administration, and 
the Environmental Protection Agency shared power to promulgate 
rules for GM crop oversight.48 This Part also examines how the 
Coordinated Framework, which was intended to enact policies that 
would primarily follow a products-based approach to the 
regulation of biotechnology, has not lived up to that goal. 
 Part V introduces CRISPR-Cas9 and modern genome editing 
technologies. It provides a brief overview of CRISPR-based 
genome editing and the pressure the technology is exerting on the 
Coordinated Framework.49 This Part highlights shortcomings of the 																																																																																																																												
are hypocritical because Europe imports large amounts of GM crops for animal 
feed). 
Along this point, it is interesting to note the geographical dissonance between 
the United States and the European Union (“EU”) when it comes to GM crops 
and global climate change. Although a scientific consensus has formed to 
support the safety of GM crops and the anthropogenic contributions to global 
climate change, the US and the EU have different general approaches to these 
issues. See, e.g., Brian Kennedy & Cary Funk, Many Americans are Skeptical 
About Scientific Research on Climate and GM Foods, PEW RESEARCH CTR. 
(Dec. 5, 2016), http://www.pewresearch.org/fact-tank/2016/12/05/many-
americans-are-skeptical-about-scientific-research-on-climate-and-gm-foods/; 
CINNAMON PIÑON CARLARNE, CLIMATE CHANGE LAW AND POLICY: EU AND US 
APPROACHES 348–49, 359–60 (2010).	
The EU has chosen to embrace scientific evidence and lead the world in 
progressive climate policies, but blatantly ignores scientific evidence vis-à-vis 
GM crops. Id.; Lynas, supra note 46. In contrast, the US takes a progressive 
approach to cultivation and consumption of GM crops, but frequently ignores 
the scientific consensus on the dangers posed by global climate change, and has 
failed to address global climate change at the federal level. PIÑON CARLARNE, 
supra; Lynas, supra note 46. 
47 Lynas, supra note 46.  
48 See infra Part IV. 
49 See infra Part V. 
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methods of plant transformation discussed in Part II, which are 
limited by the inability to control where, and with what frequency, 
insertion of foreign DNA occurs into a target plant species. The 
discussion then compares those limitations to the advantages of 
modern genome editing technologies, which are precise and need 
not rely on the insertion of foreign DNA sequences at all to carry 
out intended genetic manipulations. 
Finally, part VI paves a path for the regulation of genome 
editing technologies in the twenty-first century. It illustrates 
regulatory gaps in the Coordinated Framework vis-à-vis genome 
editing technologies using a hypothetical, identifies several 
obstacles to developing scientific-based public policy in the realm 
of GMOs, and proposes a set of policy recommendations to 
facilitate the rational regulation of genome-edited crops.50 
I. GENETICALLY MODIFIED ORGANISMS 
The term genetically modified organism, colloquially known as 
GMO, refers broadly to any living organism comprising artificially 
altered genetic material, which is intended to produce a desired 
phenotype (trait). 51  On occasion, other terms, such as living 
modified organism (“LMO”)52 or genetically engineered organism 
(“GEO”),53 have been used to refer to the same concept, but none 																																																								
50 See infra Part VI. 
 51  See, e.g., Frequently Asked Questions on Genetically Modified Food, 
WORLD HEALTH ORG., http://www.who.int/foodsafety/areas_work/food-
technology/faq-genetically-modified-food/en/ (last visited Dec. 1, 2016); 
Genetically Modified, OXFORD ONLINE DICTIONARY, 
https://en.oxforddictionaries.com/definition/genetically_modified (last visited 
Dec. 1, 2016); Julia M. Diaz & Judith L. Fridovich-Keil, Genetically Modified 
Organism, ENCYCLOPEDIA BRITANNICA (Nov. 28, 2016), 
https://www.britannica.com/science/genetically-modified-organism.  
 52 See SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY, THE 
CARTAGENA PROTOCOL ON BIOSAFETY TO THE CONVENTION ON BIOLOGICAL 
DIVERSITY, Art. 3(g) (2000) (“‘Living modified organism’ means any living 
organism that possesses a novel combination of genetic material obtained 
through the use of modern biotechnology.”). 
 53 See, e.g., Glossary of Agricultural Biotechnology Terms, U.S.D.A. (Feb. 27, 
2013), 
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have become as pervasive as GMO.54 Although many definitions 
do not specify the type of species encompassed by GMO, the term 
is applicable to microbes, fungi, plants, and animals, but not 
human beings.55 
The striking diversity of microbes, 56  fungi, 57  plants, 58  and 
animals59  amenable to genetic manipulation has facilitated the 
evolution of a wide range of connotations elicited by the term 
GMO in different biotechnological contexts. A common thread, 
however, is the notion that GMOs can be used in the production of 
genetically modified food60 intended for human consumption.61 
Accordingly, it is no surprise that many GMOs have collectively 
																																																																																																																												
https://www.usda.gov/wps/portal/usda/usdahome?contentid=biotech_glossary.ht
ml. 
54 As articulated earlier, in a narrow sense—particularly in the view of some 
opponents of GMOs—the term presumably refers mainly to organisms that have 
been created using recombinant DNA technology to introduce foreign genetic 
material.  
 55 See, e.g., Directive 2001/18/EC of the European Parliament and of the 
Council on the Deliberate Release into the Environment of Genetically Modified 
Organisms and Repealing Council Directive 90/220/EEC, OFFICIAL JOURNAL 
OF THE EUROPEAN UNION, L 106, Art. 2 (2001) (“‘Genetically modified 
organism (GMO)’ means an organism, with the exception of human beings, in 
which the genetic material has been altered in a way that does not occur 
naturally by mating and/or natural recombination.”) (emphasis added). 
 56 E.g., V. V. Mistry, Chymosin in Cheese Making, in FOOD BIOCHEMISTRY 
AND FOOD PROCESSING 223 (Benjamin K. Simpson ed., 2d ed. 2012). 
 57 E.g., Production of Provitamin A Carotenoids in Mushrooms and Uses 
Thereof, U.S. Patent No. 8,907,165 (filed Feb. 11, 2010). 
 58 Robert T. Fraley et al., Expression of Bacterial Genes in Plant Cells, 80 
PROC. NAT’L ACAD. SCI. U.S. 4803 (1983). 
 59 E.g., Bernadette M. Dunham, AquAdvantage Salmon Approval Letter and 
Appendix, FDA (Nov. 19, 2015), 
http://www.fda.gov/AnimalVeterinary/DevelopmentApprovalProcess/GeneticEn
gineering/GeneticallyEngineeredAnimals/ucm466214.htm; Enríquez, supra note 
1, at 661–64. 
 60  GM food sources can encompass a wide array of living organisms 
consumed by humans including edible fungi (e.g., mushrooms), plants, and 
animals (vertebrate or invertebrate). 
 61 Other GMO-derived products exist including, but not limited to, drugs, 
cosmetics, antibodies, and more. See, e.g., infra note 65. 
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made their way into our food supply62 as humans have availed 
themselves of myriad living organisms on Earth for agriculture and 
food processing purposes. 
Thus, in the case of plants, which are the focus of this Article,63 
the manipulation of GM crops through biotechnology seeks to 
introduce genetic material into crop plants to address ongoing 
issues64—pest and chemical resistance, manipulation of nutritional 
content, susceptibility to disease or suboptimal environmental 
conditions, yield optimization, storage tolerance, drought 
resistance, etc.—that affect the improvement of agricultural 
practices worldwide.65 
A. From Domestication . . . 
From times immemorial, humans have utilized domestication 
as a strategy for altering, taming, or influencing wild living 
organisms to suit particular needs. The transition of ancient wolves 
into domestic dogs, for example, is thought to date as far back as 
33,000 years ago.66 Breeding and non-natural selection67 of docile 																																																								
 62 See, e.g., G. Bruening and J. M. Lyons, The Case of the FLAVR SAVR 
Tomato, 54 CAL. AGRIC. 6 (2000); Enríquez, supra note 1, at 656–57; David 
Johnson & Siobhan O’Connor, These Charts Show Every Genetically Modified 
Food People Already Eat in the U.S., TIME MAG. (Apr. 30, 2015), 
http://time.com/3840073/gmo-food-charts/. 
 63 Although this Article specifically covers plant-derived GM foods, food 
from other GM organisms share many similarities with GM crops, including the 
methods with which they are created and, to some extent, how they are 
regulated. For a brief overview of genome editing and other biotechnological 
uses of GM animals in agriculture, see Enríquez, supra note 1, at 662–64. 
 64 Enríquez, supra note 1, at 654–55, 660–61. 
 65 It bears noting that genetic modification of plants, including crops, has also 
been used for other non-food agricultural purposes beyond the scope of this 
Article, such as bioremediation and the production of biofuels and 
pharmaceutical compounds. See, e.g., Krämer & Chardonnes, supra note 10 
(bioremediation); Moser, supra note 10 (biofuels); Mason et al., supra note 10 
(pharmaceuticals). 
 66 Nikolai D. Ovodov et al., A 33,000-Year-Old Incipient Dog from the Altai 
Mountains of Siberia: Evidence of the Earliest Domestication Disrupted by the 
Last Glacial Maximum, 6 PLOS ONE e22821 (2011). 
 67 Guo-dong Wang et al., The Genomics of Selection in Dogs and the Parallel 
Evolution Between Dogs and Humans, 4 NATURE COMM. 1860 (2013). 
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behavior—and other traits—eventually led to striking genetic 
changes,68 critical for domestication,69 that facilitated the evolution 
of wolves into an entirely novel species;70 one which did not 
naturally occur, and would not exist today, but for human 
intervention. 
From an evolutionary standpoint, domestication has proven to 
be remarkable. It can exert substantial pressure to induce rapid 
phenotypic evolution that yields great variation from a limited 
genetic pool.71 What was done with the wolf is not a unique 
historical or anthropological anomaly. Roughly 10,000 years ago, 
domestication of all major crop plants occurred through ancient 
agricultural practices,72 which led to allele73 fixation of desired 
agronomic traits over the span of several hundred years.74 
Among the first crops to undergo artificial, or non-natural, 
selection 75  resulting in genetic alterations was a domesticated 
version of the wild Mexican grass Balsas teosinte, the progenitor 
of modern day maize (corn).76 Molecular evidence demonstrates 
that maize and teosinte are strikingly similar. Indeed, they share 
																																																								
 68 Pontus Skoglund et al., Estimation of Population Divergence Times from 
Non-Overlapping Genomic Sequences: Examples from Dogs and Wolves, 28 
MOLECULAR BIOLOGY & EVOLUTION 1505 (2011). 
 69 Adam H. Freedman et al., Genome Sequencing Highlights the Dynamic 
Early History of Dogs, 10 PLOS GENETICS e1004016 (2014). 
 70 Simon J. M. Davis & François R. Valla, Evidence for Domestication of the 
Dog 12,000 Years Ago in the Natufian of Israel, 276 NATURE 608 (1978). 
 71 Gianni Liti et al., Population Genomics of Domestic and Wild Yeasts, 458 
NATURE 337 (2009). 
 72  Rong-Lin Wang et al., The Limits of Selection During Maize 
Domestication, 398 NATURE 236, 236 (1999) (citation omitted). 
 73  An allele is a variant form of a gene. See Allele, SCITABLE, 
http://www.nature.com/scitable/definition/allele-48 (last visited Dec. 1, 2016 ). 
 74 Wang et al., supra note 72, at 238. 
 75  Artificial selection and non-natural selection are used interchangeably 
throughout this Article to denote human-induced evolution through selective 
breeding of sexually compatible or incompatible organisms to produce desirable 
offspring. 
 76 Id. See also George W. Beadle, Teosinte and the Origin of Maize, 30 J. 
HEREDITY 245 (1939) (first proposing the idea that maize descended from 
teosinte). 
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identical centromere positions and chromosome arm lengths.77 
They also possess equal number of chromosomes, and knobs at the 
same chromosomal positions, which occur at similar frequencies.78 
Furthermore, modern maize varieties can be crossed with teosinte 
to form hybrids that exhibit complete chromosomal pairing and 
fertility.79 
Despite their genetic similitude, maize and teosinte are not only 
drastically different in appearance, but also in terms of utility. For 
instance, the teosinte ear (Figure 1)80 features between five and 
twelve kernels, each sealed tightly in a stony casing that is 
impervious to the digestive tract environment of birds and 
mammals.81 In contrast, the maize ear bears over 500 naked kernels 
that are easily digested by any animal that ingests them.82 These 
and other significant differences between maize and teosinte have 
been empirically linked to a mere five genes.83 Thus, maize is a 
vivid illustration of the principle that few naturally occurring 
mutations, derived through non-natural selection of rare and 
desirable characteristics, can exert combinatorial effects that 
account for a wide array of seemingly complex phenotypes.84 
More importantly, although the transformation of modern crops 
from their ancient progenitors is thought to have occurred within a 
period of several hundreds of years,85 our current understanding of 																																																								
 77 John Doebley, The Genetics of Maize Evolution, 38 ANN. REV. GENETICS 
37, 40–41 (2004). 
 78 Id. 
 79 Id. 
80 See infra note 104. 
 81 Id. at 39. 
 82 Id. 
 83 See Allison Weber et al., Major Regulatory Genes in Maize Contribute to 
Standing Variation in Teosinte (Zea mays ssp. parviglumis), 177 GENETICS 2349 
(2007). 
 84 Id. Genome-wide association studies have also provided important evidence 
of this principle. See, e.g., Edouard Cadieu et al., Coat Variation in the Domestic 
Dog Is Governed by Variants in Three Genes, 326 SCIENCE 150 (2009) 
(providing evidence from a study of more than 1,000 dogs from 80 breeds, 
which revealed that distinct mutations in only three genes account for the 
majority of coat characteristics in purebred dogs in the Unites States). 
 85 See Wang et al., supra note 72. 
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systematic breeding practices followed by artificial selection has 
revealed that such drastic genetic transformations can successfully 
take place within just a few generations.86 
Other crops have experienced similar non-natural selection in 
their path toward domestication. Modern day wheat (Triticum 
aestivum) originates from the hybridization of a wild wheat grass 
(Aegilops tauschii) and an ancient tetraploid 87  wheat hybrid 
(Triticum turgidum), 88 which led to the creation of the vastly 
popular hexaploid wheat species89 that are produced and consumed 
all over the world today. 90  Rice, arguably the world’s most 
important crop to human nutrition and caloric intake, 91  has 
experienced drastic transformations. Wild rice species often 
display long awns and severe shattering, which are important for 
seed dispersal.92 In contrast, domestic rice species have evolved to 
																																																								
 86 For instance, artificial selection in dog breeds (that is, systematic breeding 
practices involving crosses between different breeds, followed by selection of 
specific traits) over the last 200 years is primarily responsible for the dramatic 
diversification of traits—body size, coat color, hair texture, etc.—observed in 
modern canines. See Robert K. Wayne & Bridgett M. vonHoldt, Evolutionary 
Genomics of Dog Domestication, 23 MAMMALIAN GENOME 3 (2012). 
 87 Polyploidy refers to the heritable condition of having more than two 
complete sets of chromosomes. See Margaret Woodhouse et al., Polyploidy, 
SCITABLE (2009), http://www.nature.com/scitable/nated/topicpage/polyploidy-
1552814 (last visited Dec. 1, 2016). Accordingly, a tetraploid organism has four 
sets of chromosomes, and a hexaploid organism has six sets of chromosomes. 
 88 Moshe Feldman & Mordechai E. Kislev, Domestication of Emmer Wheat 
and Evolution of Free-Threshing Tetraploid Wheat, 55 ISRAEL J. PLANT SCI. 207 
(2007). 
 89  Yoshihiro Matsuoka, Evolution of Polyploid Triticum Wheats Under 
Cultivation: The Role of Domestication, Natural Hybridization and 
Allopolyploid Speciation in Their Diversification, 52 PLANT CELL PHYSIOLOGY 
750, 751 (2011). 
 90  Global Crop Production Analysis: Maps, U.S.D.A. (Dec. 9, 2016), 
https://www.pecad.fas.usda.gov/ogamaps/Default.aspx?cmdty=Wheat&attribute
=Production. 
 91 Gurdev S. Khush, Origin, Dispersal, Cultivation and Variation of Rice, 35 
PLANT MOLECULAR BIOLOGY 25 (1997). 
 92  Megan Sweeney & Susan McCouch, The Complex History of the 
Domestication of Rice, 100 ANNALS BOTANY 951 (2007). 
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contain short awns, if any, and reduced shattering, thereby 
resulting in maximum seed count for harvesting.93 
Human-dependent selection has not been limited to grain crops 
throughout history. The wild progenitors of present day tomatoes 
(Figure 1)94 had very small fruit designed for species propagation 
rather than human consumption.95 However, artificial selection of 
large fruit size and shape transformed the wild species, once 
endogenous to the South American Andes, into today’s prized 
tomato cultivars.96 
The modern strawberry (Figure 1)97 was derived from hybrids 
between two octoploid Native American species that were 
subsequently selected for fruit size and firmness. 98  Numerous 
similar fates have been reported for the evolution of other fruits 
and crops (Figure 1),99 including the potato,100 banana,101 broccoli,102 
and a vast list of others,103 all of which have been selected for size, 
taste, shape, nutritional content, and a variety of other desirable 
agronomic traits. 
 
 
 
																																																								
 93 Id. 
94 See infra note 104. 
 95 Yuling Bai & Pim Lindhout, Domestication and Breeding of Tomatoes: 
What Have We Gained and What Can We Gain in the Future?, 100 ANNALS 
BOTANY 1085, 1087 (2007). 
 96 Id. 
97 See infra note 104. 
 98 Jules Janick, The Origins of Fruit, Fruit Growing, and Fruit Breeding, 25 
PLANT BREEDING REVS. 255, 302 (2005). 
99 See infra note 104. 
100 See generally David M. Spooner et al., A Single Domestication for Potato 
Based on Multilocus Amplified Fragment Length Polymorphism Genotyping, 
102 PROC. NAT’L ACAD. SCI. U.S. 14694 (2005). 
101 See Janick, supra note 98, at 298–99. 
102 See, e.g., id. at 258. 
103 See id. at 272–308 (providing related accounts all over the world for the 
evolution of papaya, kiwi, peach, grape, plum, pineapple, apricot, avocado, 
mango, olive, pomegranate, fig, cherry, citrus fruit, and others). 
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FIGURE 1 
 
Crop evolution depicted by juxtaposition of select popular crops 
genetically modified through artificial selection and their 
unmodified wild progenitors. A. Fruit of wild bananas (left) featuring 
large and hard seeds compared to the cultivated Cavendish banana 
(right), the most popular fruit in the world. B. Fruit of domesticated 
tomatoes (left) relative to the fruit of their wild progenitors (right). C. 
Wild strawberry fruit (left) compared to the large, modern, cultivated 
strawberry fruit (right). D. Juxtaposition of fruit from a domestic 
eggplant cultivar (left) and the small, bitter fruit from its wild 
progenitor species (right). E. The evolution of modern-day maize—
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corn—cobs and kernels from teosinte, maize’s wild ancestor. The 
figure contrasts the ears of teosinte (left), domestic maize (right), and a 
teosinte-maize hybrid (middle).104 The	 figure	 appears	 in	 color	 in	 the	
online	version	of	the	Article.105	
	
The evolution—from wild ancestor to domestic progeny—of 
various agriculturally important crops sheds light on the crucial 
role that non-natural selection driven by humans has played in the 
development of agriculture. The overwhelming evidence related to 
domestication-induced genetic modification of crops, which has 
accrued over the past few millennia, provides strong support 
against arguments that humans ought not to interfere with nature’s 
course. Without human intervention, none of these important 
crops, which collectively feed the world, would exist today. 
Indeed, human intervention is vital for the survival of many of 
today’s staple crops, which could not grow and reproduce in the 
wild without human assistance.106 
B . . . . To Molecular Manipulation   
For millennia, genetic modification of organisms via 
domestication constituted the primary method of manipulating the 
genetic composition of crop plants. That all changed with the dawn 																																																								
104 Items are representative (not to scale) of the actual relative size difference 
between each wild progenitor and its corresponding domesticated crop. The 
figure comprises photographs adapted from the following sources: Wild Banana, 
WIKIPEDIA, https://en.wikipedia.org/wiki/Banana#/media/File:Inside_a_wild-
type_banana.jpg; Cavendish Banana, IMPEXOR, http://impexor.com/wp-
content/uploads/2012/12/cavendishbanana.png; Domesticated and Wild 
Tomatoes, IMGUR, https://i.stack.imgur.com/2AZ7a.jpg; Wild Strawberry, 
LESLIELAND, http://leslieland.com/wp-content/uploads/2008/07/strawberry-
sizes-1.jpg; Domesticated Strawberry, WIKIPEDIA, 
https://en.wikipedia.org/wiki/Strawberry#/media/File:PerfectStrawberry.jpg; 
Domesticated and Wild Eggplant, GENETICS, 
http://www.genetics.org/content/genetics/161/4/1713/F1/graphic-1.large.jpg; 
Teosinte, Maize, and Teosinte-Maize Hybrid, UNIVERSITY OF WISCONSIN-
MADISON, https://teosinte.wisc.edu/Images_to_download/Maize-teosinte.jpg. 
105 The online version can be accessed at the Journal’s website, ncjolt.org, by 
clicking on the “Articles” tab, Volume 18, Issue 4. 
 106  See, e.g., Doebley, supra note 77, at 39 (affirming that “maize is 
completely dependent on humans for its survival”). 
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of the age of evolutionary and molecular biology. Alfred Russel 
Wallace and Charles Darwin’s co-discovery 107  of natural 
selection,108 which prompted Darwin to publish his book On the 																																																								
 107 Charles Darwin & Alfred Wallace, On the Tendency of Species to Form 
Varieties; and on the Perpetuation of Varieties and Species by Natural Means of 
Selection, 3 J. PROC. LINNEAN SOC’Y LONDON ZOOLOGY 45 (1858). 
 108  Over the years, controversy has surrounded the Darwin-Wallace co-
discovery of the theory of evolution by natural selection, credit for which has 
been suggested to belong to Wallace alone. See, e.g., ROY DAVIES, THE DARWIN 
CONSPIRACY: ORIGINS OF A SCIENTIFIC CRIME (2008); JOHN LANGDON BROOKS, 
JUST BEFORE THE ORIGIN: ALFRED RUSSEL WALLACE’S THEORY OF EVOLUTION 
(1984). Among the main accusations against Darwin is the allegation that he 
plagiarized ideas found in a paper Wallace sent to him in 1858, which prompted 
Darwin to revise elements of his own theory and rush to publish it in 1859. John 
van Wyhe & Kees Rookmaaker, A New Theory to Explain the Receipt of 
Wallace’s Ternate Essay by Darwin in 1858, 105 BIOLOGICAL J. LINNEAN 
SOC’Y 249 (2012) (arguing against the same theory). 
 Wallace sent Darwin the draft of his unpublished essay titled On The 
Tendency of Varieties to Depart Indefinitely from the Original Type in 
confidence, requesting Darwin to review it and pass it along to Charles Lyell, a 
close friend of Darwin’s, if he found it worthwhile. Id. In his essay, Wallace laid 
out a version of the theory of evolution by natural selection, which Darwin 
understood to be precisely what he intended to propose in his own theory. See 
Letter from C. Darwin to C. Lyell (June 18, 1858), in THE LIFE AND LETTERS OF 
CHARLES DARWIN, INCLUDING AN AUTOBIOGRAPHICAL CHAPTER VOL. II 116 
(Francis Darwin ed., 1887) (publishing Darwin’s personal letter to Lyell upon 
receipt of Wallace’s draft in which he wrote: “I never saw a more striking 
coincidence; if Wallace had my MS. sketch written out in 1842, he could not 
have made a better short abstract! Even his terms now stand as heads of my 
chapters.”). 
 Following Wallace’s letter, Lyell and Joseph Hooker, another one of Darwin’s 
influential close friends in scientific circles, advised Darwin to publish extracts 
from his prior work on evolution alongside Wallace’s essay at a meeting of the 
Linnean Society of London. Van Wyhe & Rookmaaker, supra, at 249. Lyell and 
Hooker subsequently submitted Darwin and Wallace’s work, without Wallace’s 
knowledge, to the Linnean Society explaining that both men had “independently 
and unknown to one another, conceived the same very ingenious theory to 
account for the appearance and perpetuation of varieties and of specific forms on 
our planet . . . .” Darwin and Wallace, supra note 107, at 45. Lyell and Hooker 
made it known that Darwin thought Wallace’s work to be of high value and 
worthy of prompt publication, which they approved of “provided Mr. Darwin 
did not withhold from the public” his own work on the same subject. Id. at 45–
46. Notably, although Lyell and Hooker’s letter to the Linnean Society credited 
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Origin of Species,109 and Gregor Mendel’s discovery of “discrete 
inherited units” 110 —better known today as genes—laid the 
foundation for the genetics-based era of modern plant breeding. 
Farming practices before the 19th century involved cross-
breeding, domestication, and non-natural selection of traits. 
																																																																																																																												
both men, it also highlighted and preserved their dear friend’s (Darwin) 
purported priority. Id. 
 Despite the controversy surrounding who rightfully deserves credit for the 
theory of evolution by natural selection, researchers have not found clear and 
convincing evidence to corroborate theories that Darwin plagiarized Wallace. 
See generally JOHN VAN WYHE, DISPELLING THE DARKNESS: VOYAGE IN THE 
MALAY ARCHIPELAGO AND THE DISCOVERY OF EVOLUTION BY WALLACE AND 
DARWIN (2013); Van Wyhe & Rookmaaker, supra. Indeed, Darwin’s own 
writings reveal he was ethically torn vis-à-vis Wallace’s disclosure and did not 
wish to minimize Wallace’s contribution. See Letter from C. Darwin to C. Lyell  
(June 25, 1858), in THE LIFE AND LETTERS OF CHARLES DARWIN, INCLUDING AN 
AUTOBIOGRAPHICAL CHAPTER VOL. II 117 (Francis Darwin ed., 1887) (“as I had 
not intended to publish any sketch, can I do so honourably [sic], because 
Wallace has sent me an outline of his doctrine? I would far rather burn my 
whole book, than that he or any other man should think that I had behaved in a 
paltry spirit. Do you not think his having sent me this sketch ties my hands?”). 
 Nevertheless, the circumstances surrounding Lyell and Hooker’s decision to 
help their friend Darwin hang on to a slice of glory in world history by making 
Wallace a co-discoverer remain questionable, particularly when Darwin himself 
realized that his priority had been shattered by Wallace’s 1858 essay. See Letter 
from C. Darwin to C. Lyell (June 18, 1858), in THE LIFE AND LETTERS OF 
CHARLES DARWIN, INCLUDING AN AUTOBIOGRAPHICAL CHAPTER VOL. II 116–
17 (Francis Darwin ed., 1887) (documenting Darwin’s mourning of his loss of 
priority when he wrote: “So all my originality, whatever it may amount to, will 
be smashed [by Wallace’s essay], though my book, if it will ever have any 
value, will not be deteriorated; as all the labour [sic] consists in the application 
of the theory.”). Whatever the case may be concerning Darwin and Wallace’s 
contributions, there is no question that Wallace’s essay triggered prompt 
publication of the theory of evolution in 1858 and Darwin’s own book nearly a 
year later in 1859. 
 109 CHARLES DARWIN, ON THE ORIGIN OF SPECIES BY MEANS OF NATURAL 
SELECTION, OR THE PRESERVATION OF FAVOURED RACES IN THE STRUGGLE FOR 
LIFE (1859). 
 110 Gregor Mendel, Versuche über Plflanzenhybriden [Experiments in Plant 
Hybridization], ABHANDLUNGEN 3–47 (1866), Read at Meetings of the Brünn 
Natural History Society (Feb. 8 & Mar. 8, 1865), reprinted in GREGOR MENDEL, 
EXPERIMENTS IN PLANT HYBRIDIZATION 33–41 (1963). 
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Insights from Mendel’s pea plant hybridization experiments,111 
which ultimately led to conceptualization of Mendel’s Laws of 
Inheritance,112 opened the door for subsequent researchers to apply 
the dual principles of heredity and natural selection in plant 
breeding for purposes of increasing genetic diversity. In time, these 
principles had a combined lasting effect on conventional farming, 
transforming it from an agricultural practice into a bona fide 
agricultural science. 
Scientific discoveries throughout the 20th century involving 
DNA and the molecular mechanisms of genetic inheritance helped 
promote the advent of recombinant DNA technology.113 By 1972, 
breakthrough discoveries—in restriction enzyme 114  and DNA 
double-stranded repair mechanisms—allowed scientists to produce 
the first recombinant DNA molecules by fusing DNA fragments 
from two viruses.115 Within a year, the first genetically modified 
organism created through modern genetic engineering was 
reported in the literature, after a team of researchers introduced 
recombinant DNA into bacterial cells.116 
The science progressed rapidly after those proof-of-concept 
studies were established. In 1974, the world’s first transgenic117 																																																								
 111 Id. 
 112 The Laws of Inheritance originated from Mendel’s observations of how 
traits were passed down from parents to progeny. His studies helped him to 
introduce the Law of Segregation and the Law of Independent Assortment, 
which together form the bulk of his Laws of Inheritance. Ilona Miko, Gregor 
Mendel and the Principles of Inheritance, 1 NATURE EDUC. 134 (2008). 
 113 Enríquez, supra note 1, at 621–22. 
 114 Restriction enzymes, also known as restriction endonucleases, are proteins 
capable of cutting DNA at or near specific nucleotide sequences. See Richard J. 
Roberts & Kenneth Murray, Restriction Endonucleases, 4 CRITICAL REVS. 
BIOCHEMISTRY 123 (1976). 
 115 David A. Jackson, Robert H. Symons, & Paul Berg, Biochemical Method 
for Inserting New Genetic Information into DNA of Simian Virus 40: Circular 
SV40 DNA Molecules Containing Lambda Phage Genes and the Galactose 
Operon of Escherichia Coli, 69 PROC. NAT’L ACAD. SCI. U.S. 2904 (1972). 
 116 Stanley N. Cohen et al., Construction of Biologically Functional Bacterial 
Plasmids in Vitro, 70 PROC. NAT’L ACAD. SCI. U.S. 3240 (1973). 
 117 The term “‘transgenic”’ refers to the artificial introduction of genetic 
material from one organism into the genome of another unrelated organism. See, 
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animal was reported.118 The first genetically engineered plants were 
developed by inserting antibiotic resistance genes into tobacco 
plant cells in 1983.119 A genetically modified bacterium capable of 
breaking down crude oil for bioremediation purposes became the 
first patented GMO.120 The Supreme Court’s decision endorsing 
intellectual property rights for living microorganisms spawned a 
multi-billion dollar biotechnology industry.121 
Soon thereafter, global commercialization of the first GM 
crops got under way. In 1992, a virus-resistant tobacco plant 
produced by Chinese researchers became the world’s first 
commercial GM crop.122 In the United States, a California-based 
firm brought the first GM food—the FLAVR SAVR tomato—to 
market in 1994.123 The first insect and herbicide resistant crops 
were approved in the mid-1990s,124 and marked a turning point in 
agriculture. By 1996, a total of thirty-five approvals had been 
granted for the commercialization of a variety of transgenic crops 
																																																																																																																												
Transgene, SCITABLE, http://www.nature.com/scitable/definition/transgene-223 
(last visited Dec. 1, 2016). 
 118 Rudolf Jaenisch & Beatrice Mintz, Simian Virus 40 DNA Sequences in 
DNA of Healthy Adult Mice Derived from Preimplantation Blastocysts Injected 
with Viral DNA, 71 PROC. NAT’L ACAD. U.S. 1250 (1974). 
 119 Luis Herrera-Estrella et al., Expression of Chimaeric Genes Transferred 
into Plant Cells Using a Ti-Plasmid-Derived Vector, 303 NATURE 209 (1983); 
Michael W. Bevan & Richard B. Flavell, A Chimaeric Antibiotic Resistance 
Gene as a Selectable Marker for Plant Cell Transformation, 304 NATURE 184 
(1983); R. T. Fraley et al., Expression of Bacterial Genes in Plant Cells, 80 
PROC. NAT’L ACAD. SCI. U.S. 4803 (1983). 
 120 U.S. Patent No. 4,259,444 (filed June 7, 1972). 
 121 See Diamond v. Chakrabarty, 447 U.S. 303, 318 (1980) (holding that 
certain genetically modified microorganisms meet the patent eligibility 
requirements set forth in 35 U.S.C. § 101). 
 122  VALEIRE J. KARPLUS & XING WANG DENG, AGRICULTURAL 
BIOTECHNOLOGY IN CHINA: ORIGINS AND PROSPECTS 62 (2008). 
 123 G. Bruening & J. M. Lyons, The Case of the FLAVR SAVR Tomato, 54 
CAL. AGRIC. 6 (2000). 
 124  Charles M. Benbrook, Impacts of Genetically Engineered Crops on 
Pesticide Use in the U.S.—The First Sixteen Years, 24 ENVTL. SCIS. EUR. art. 
24, at 4 (2012). 
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worldwide.125 Genetic engineering also began to be used in the 
production of biofortified crops.126 
The new age of recombinant DNA technology and molecular 
genetics has ushered in a revolution in crop agricultural science the 
world has never before seen. In 2014, a reported 18 million 
farmers in twenty-eight countries across the world devoted 181.5 
million hectares (448 million acres) of arable land for cultivation 
of GM crops. 127  This marked a 107-fold increase in global 
hectarage devoted for GM crops—from the 1.7 million hectares 
reported in 1996—since commercialization of GM crops began.128 
As of 2014, the global market value of GM crops was estimated at 
15.7 billion U.S. dollars129 and continues in an upward trend. 
II. MAKING A GMO 
As pointed out in Part I, genetic modification of crops can be 
achieved through artificial (non-natural) selection of desirable 
agronomic traits. As a result, domestication-induced genetic 
modification technically also leads to the creation of GMOs, even 
though propagation of these crops does not involve genetic 
engineering.130 This is an important and common misperception 
regarding GMOs, namely that (1) intentional breeding followed by 
selection is a natural process—it is not; absent human intervention, 
such breeding and selection would be extremely unlikely to 
occur—and (2) genetic engineering is the only method available to 																																																								
 125 Clive James & Anatole F. Krattiger, Global Review of the Field Testing 
and Commercialization of Transgenic Plants: 1986 to 1995: The First Decade 
of Crop Biotechnology 23 (1996). 
 126 E.g., Ye et al., supra note 5, at 303 (engineering rice enriched in levels of a 
Vitamin A precursor). 
 127 Clive James, Global Status of Commercialized Biotech/GM Crops: 2014, 
at 1 (2014). 
 128 Id. at 2. 
 129 Id. at 12. 
130 Note that, although domestication-induced genetic modification is not a 
“natural” process by any means, there are some opponents of GMOs who 
selectively consider only organisms derived through recombinant DNA 
technologies to be genetically modified. 
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produce GMOs—it is not; other methods exist to introduce new 
alleles and increase genetic diversity. 
This section discusses several methods that have been, and 
continue to be, used in GMO production. Two main categories are 
identified: non-recombinant DNA methods, which do not involve 
genetic engineering, and genetic engineering methods. A third 
category involving genome editing technologies will be discussed 
in Part V. 
A. Non-Recombinant DNA Methods 
Improving crops by modifying plant genetic make-up has been 
a long-standing goal throughout the history of human 
agriculture. 131  The most basic way to introduce genetic 
modifications involves traditional plant breeding, which is 
inherently a human-directed, discriminatory process. In traditional 
breeding, a heterogeneous population of plants undergoes 
inspection to determine the presence of individuals that exhibit a 
trait deemed desirable. Once those particular individuals have been 
identified, their seeds are collected and sown for continuous 
propagation. Over a period of many years, the iterative 
dissemination of genes belonging to the parental line—coupled 
with inter-crossing the most valuable individuals from different 
populations of the same species—leads to a shift in the gene pool, 
thereby ensuring fixation of the desirable trait. 
Another traditional way to increase biodiversity involves cross-
breeding of plants that are sexually compatible. This method has 
proven useful for plant breeders wishing to produce a hybrid that 
exhibits desirable traits from each parent. Cross-breeding sexually 
compatible plants can successfully generate desirable hybrids, but 
getting there requires substantial time and resource commitment. 
This is mainly because of the physical and biological limitations of 
natural genetic recombination.132 Ensuring the recombination of 																																																								
 131 See supra Part I.B. 
 132 Genetic recombination refers to the exchange of DNA between multiple 
chromosomes or different regions of the same chromosome. Suzanne Clancy, 
Genetic Recombination, 1 NATURE EDUC. 40 (2008). It is sometimes commonly 
described as the process of gene shuffling that increases genetic variation. 
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only one particular gene from the parental lines during a cross, 
while leaving all other genes undisturbed, is simply not possible 
through natural means. One hybrid may inherit an intended trait—
e.g., bigger fruit—from one of the parents, but it also may inherit 
other traits, some of which could make the plant undesirable to 
breeders—e.g., a hybrid that produces bigger fruit but is 
susceptible to pests. Although back-crossing to the parental line 
followed by multiple rounds of artificial selection can breed out 
potential undesirable traits and maintain advantageous 
characteristics, the process is time-consuming and inefficient. 
Simply put, cross-breeding requires screening hundreds, or even 
thousands,133 of hybrid progeny to identify offspring having the 
desired traits. 
It bears noting that these processes are human-centric, that is, 
the shift in the genetic population of the plants is driven 
exclusively by human desire. What is most beneficial in a plant 
from a human perspective, may not necessarily promote the plant’s 
fitness from an evolutionary perspective. Bigger fruit size and 
sweet flavor are likely to be important agronomic traits for 
humans, but having those traits might render the plant more 
susceptible to prey, pests, or even reduce its ability to propagate 
the species. 
Scientific advances in the last century now offer plant breeders 
a wide array of alternatives to these laborious and time-consuming 
approaches for increasing genetic diversity beyond natural means. 
The following non-recombinant DNA methods have been routinely 
performed in human agriculture for decades to expand the 
biodiversity of crops. 
1. Interspecific and Intergeneric Hybridization 
This type of hybridization technique involves wide crosses 
between different plant species (interspecific) or genera 
(intergeneric). The goal is to develop novel hybrid cultivars that 
feature traits—improved biotic and abiotic stress tolerance, etc.—																																																								
 133 J. R. Witcombe & D. S. Virk, Number of Crosses and Population Size for 
Participatory and Classical Plant Breeding, 122 EUPHYTICA 451, 460 (2001). 
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that do not occur within a single species. 134  Both types of 
hybridization have been established with multiple cultivars and 
wild relatives in flowering plants, 135  trees, 136  tomato plants, 137 
cereals,138 and other grasses.139 However, cross incompatibility in 
interspecific and intergeneric hybridizations has prevented 
widespread development of these hybrids. Comparable sterility, 
susceptibility to shattering,140 low seed set, and poor germination 
rates141 pose great limitations for this technique. Even when the 
distant species are sufficiently compatible to reproduce, abnormal 
endosperm development and other aberrations often lead to 
abortion of hybrid embryos.142 
Importantly, it should be noted that these types of hybridization 
lead to reshuffling of parental genes,143 which may result in myriad 
changes to chromatin structure of unknown and unpredictable 
function. 
2. Embryo Rescue 
Embryo rescue is an in vitro technique developed in the 1920s 
to address the problem of interspecific and intergeneric 
																																																								
 134 See, e.g., Jaap M. Van Tuyl & Ki-Byung Lim, Interspecific Hybridisation 
and Polyploidisation as Tools in Ornamental Plant Breeding, 612 ACTA 
HORTICULTURAE 13 (2003). 
 135 See, e.g., Knobloch, supra note 31.  
 136  See, e.g., Susan M. Hawkins et al., Interspecific and Intergeneric 
Hybridization in Dissotis and Tibouchina, 51 HORTSCIENCE 325 (2016). 
 137  See, e.g., G. Kalloo, Interspecific and Intergeneric Hybridization in 
Tomato, in GENETIC IMPROVEMENT OF TOMATO, 14 MONOGRAPHS ON 
THEORETICAL AND APPLIED GENETICS 73 (1991). 
 138 See, e.g., Arne Müntzing, Triple Hybrids Between Rye and Two Wheat 
Species, 20 HEREDITAS 137 (1935). 
 139 See, e.g., D. C. Smith, Intergeneric Hybridization of Cereals and Other 
Grasses, 64 J. AGRIC. RES. 33 (1942). 
 140 See id. at 33. 
 141 See Hawkins et al., supra note 136. 
 142  Yukio Kaneko and Sang Woo Bang, Interspecific and Intergeneric 
Hybridization and Chromosomal Engineering of Brassicaceae Crops, 64 
BREEDING SCI. 14, 16 (2014). 
 143 Knobloch, supra note 31, at 97. 
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hybridization embryonic abortion.144 An immature or weak embryo 
is excised from its natural growing environment before it stops 
growing, and moved directly into culture media.145 The wide-cross 
embryo continues to develop in vitro, and then it is inserted into 
the removed endosperm of a compatible species.146 Eventually the 
nursed embryo develops into a plant. This method has proven 
successful at overcoming hybrid embryo inviability and halting 
abortion of starving embryos. Several embryo rescue techniques 
have been devised to mediate completion of gene transfer between 
unrelated species of plants including embryo, ovary, ovule, and 
placenta cultures.147 
3. Chromosome Engineering 
Chromosome engineering148 refers to the use of artificial “mini 
chromosomes” for gene transfer via recombination.149 This method 
comprises a chromosome-based vector system150 that allows the 
transformation of large fragments of DNA encoding one or more 
genes alongside regulatory elements.151 It seeks to overcome some 
of the limitations associated with other gene transfer methods that 																																																								
 144 F. Laibach, Ectogenesis in Plants: Methods and Genetic Possibilities of 
Propagating Embryos Otherwise Dying in the Seed, 20 J. HEREDITY 201 (1929). 
 145  Sandra M. Reed, Embryo Rescue, in PLANT DEVELOPMENT AND 
BIOTECHNOLOGY 237 (2005). 
 146 Id. 
 147 See Kaneko & Woo Bang, supra note 142, at 16 (citations omitted). 
 148 For a detailed exposition of a wide range of aspects related to chromosome 
engineering research in plants, see generally, CHROMOSOME ENGINEERING IN 
PLANTS: GENETICS, BREEDING, EVOLUTION, VOLS. I & II (P. K. Gupta & T. 
Tsuchiya eds., 1991). 
 149 See Weichang Yu et al., Plant Artificial Chromosome Technology and its 
Potential Application in Genetic Engineering, 14 PLANT BIOTECHNOLOGY J. 
1175 (2016). 
150 It should be noted that, although plant minichromosomes have been used 
for gene transfer with non-recombinant DNA methods, chromosome 
engineering in plants is now also used with recombinant DNA technology to 
manipulate plant genomes. See, e.g., id. at 1177 (citations omitted) (stating that 
minichromosomes have been used for genetic engineering in maize, rice, barley, 
and other crops). 
 151 Andreas Houben & Ingo Schubert, Engineering Plant Minichromosomes: 
A Resurrection of B Chromosomes?, 19 PLANT CELL 2323 (2007). 
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allow insertion of one or a few genes. Site-specific recombination 
between a minichromosome and a normal chromosome was 
recently established in plant cells. 152  Overall, chromosome 
engineering aims to mediate safe, controlled, and persistent 
expression of the genes intended for transfer, and to avoid 
chromosomal rearrangements often linked with insertion events.153 
However, this method is limited by the low efficiency rates of 
plant homologous recombination. 
4. Induced Mutagenesis 
Induced mutagenesis refers to the practice of exposing plants 
or seeds to a physical or chemical mutagen—a mutation-inducing 
agent—intending to trigger random changes in the plant’s genetic 
composition.154 The technique, as applicable to plants, was first 
reported in the scientific literature in 1928, when it was shown that 
irradiation with X-rays was capable of inducing mutations in maize 
plants.155 To date, several physical—e.g., X-rays, gamma rays, UV 
light—and chemical—e.g., ethyl methanesulfonate (EMS), diethyl 
sulfate (dES), ethyleneimine (EI), etc.—mutagens have been 
characterized as capable of inducing mutations in plants. 156 
Progeny from induced mutants must be subsequently screened for 
the presence of potential desirable traits.157 
Notably, mutagenesis of plant cells using this technique results 
in random mutation events throughout the plant cell’s genome. 
This means that even if a mutagen-induced GMO plant exhibits a 
desirable trait, there is a strong likelihood that mutations other than 																																																								
 152  See, e.g., W. Yu et al., Construction and Behavior of Engineered 
Minichromosomes in Maize, 104 PROC. NAT’L ACAD. SCI. U.S. 8924 (2007). 
 153 Houben & Schubert, supra note 151. 
 154  M. C. Kharkwal, A Brief History of Plant Mutagenesis, in PLANT 
MUTATION BREEDING AND BIOTECHNOLOGY 22 (Q. Y. Shu et al., eds., 2011). 
 155 L. J. Stadler, Genetic Effects of X-Rays in Maize, 14 PROC. NAT’L ACAD. 
SCI. U.S. 69 (1928). 
 156 Souleymane Bado et al., Plant Mutation Breeding: Current Progress and 
Future Assessment, 39 PLANT BREEDING REVS. 23, 37 (2015). 
 157 See, e.g., L. J. Stadler and G. F. Sprague, Genetic Effects of Ultra-Violet 
Radiation in Maize. I. Unfiltered Radiation, 22 PROC. NAT’L ACAD. SCI. U.S. 
572 (1936). 
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those responsible for said trait are present. Such mutations could, 
in theory, lead to unknown and unpredictable effects. Without 
sequencing the entire mutant plant’s genome, it would be 
impossible to know the exact location and frequency of mutation 
events. 
Despite the potential risks associated with random 
mutagenesis, this type of breeding method is wildly successful as a 
tool for increasing genetic diversity in plants. A partnership 
between the United Nations’ Food and Agricultural Organization 
and the International Atomic Energy Agency has implemented, for 
nearly half a century, plant breeding and genetics programs that led 
to the official release of over 3,200 mutant varieties from 214 
different plant species in more than sixty countries.158 
5. Somaclonal Variation 
Somaclonal variation refers to the genetic differences observed 
among progeny of plants regenerated from somatic cells159 cultured 
in vitro.160 Until the early 1980s, it was generally accepted that 
plants regenerated from tissue culture should be genetically 
identical to the somatic cell source from which they were 
derived.161 However, trait differences were commonly observed in 
these types of regenerated plants.162 
The discrepancy was eventually explained by proposing that 
somaclonal variation was not merely a tissue culture technique, but 
also a new source of genetic variability.163 A number of processes 																																																								
 158 JOINT FAO/IAEA PROGRAMME, Plant Breeding and Genetics, http://www-
naweb.iaea.org/nafa/Pbg/, (last visited Dec. 1, 2016). 
 159 Somatic cells are all of the body’s cells except the reproductive cells. 
BIOLOGY ONLINE, Somatic Cells, http://www.biology-
online.org/dictionary/Somatic_cells, (last visited Dec. 1, 2016). 
 160 Robert A. Morrison et al., Somaclonal Variation: Its Genetic Basis and 
Prospects for Crop Improvement, in OPPORTUNITIES FOR PHYTOCHEMISTRY IN 
PLANT BIOTECHNOLOGY, 22 RECENT ADVANCES IN PHYTOCHEMISTRY 1 (1988). 
 161 P. J. Larkin & W. R. Scowcroft, Somaclonal Variation – A Novel Source of 
Variability from Cell Cultures for Plant Improvement, 60 THEORETICAL & 
APPLIED GENETICS 197, 198 (1981). 
 162 Id. 
 163 Id. at 197. 
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have been associated with the molecular basis for this phenomenon 
including changes in chromosome number, point mutations, 
chromosomal rearrangements, epigenetics, 164  and others. 165 
Although somaclonal variation is considered a nuisance from a 
micropropagation perspective, it nevertheless has become a 
convenient alternative for breeders seeking to introduce genetic 
variability without the need for expensive equipment.166 
B. Genetic Engineering Methods 
1. Agrobacterium tumefaciens-Based Plant Transformation 
Gene transfer via Rhizobium radiobacter, formally known as 
Agrobacterium tumefaciens,167 is the most common method used in 
																																																								
164 Epigenetics refers to the field of scientific research that studies the role of 
histone post-translational modifications, DNA modifications, and non-coding 
RNA molecules in the regulation of gene expression and chromatin structure 
that occur without altering DNA sequences. Paul Enríquez, CRISPR-Mediated 
Epigenome Editing, 89 YALE J. BIOLOGY & MED. 471, 471 (2016). 
 165 See Hare Krishna et al., Somaclonal Variations and Their Applications in 
Horticultural Crops Improvement, 6 3 BIOTECH 54 (2016). 
 166 Id. 
 167  Rhizobium radiobacter or Agrobacterium radiobacter have, in recent 
years, been proposed as more appropriate names to replace Agrobacterium 
tumefaciens, which was used throughout most of the 20th century. See, e.g., H. 
Sawada et al., Proposal for Rejection of Agrobacterium tumefaciens and Revised 
Descriptions for the Genus Agrobacterium and for Agrobacterium radiobacter 
and Agrobacterium rhizogenes, 43 INT’L J. SYSTEMATIC BACTERIOLOGY 694 
(1993); J. M. Young et al., A Revision of Rhizobium Frank 1889, with an 
Emended Description of the Genus, and the Inclusion of all Species of 
Agrobacterium Conn 1942 and Allorhizobium undicola de Lajudie et al. 1998 as 
New Combinations: Rhizobium radiobacter, R. rhizogenes, R. rubi, R. undicola 
and R. vitis, 51 INT’L J. SYSTEMATIC & EVOLUTIONARY MICROBIOLOGY 89 
(2001); J. M. Young et al., Proposal that Agrobacterium radiobacter Has 
Priority over Agrobacterium tumefaciens. Request for an Opinion, 56 INT’L J. 
SYSTEMATIC & EVOLUTIONARY MICROBIOLOGY 491 (2006). Although the new 
name has been proposed, I use both names interchangeably in this Article, 
mainly because of the systemically widespread use of the term Agrobacterium 
tumefaciens in the scientific literature. 
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plant transformation for genetic engineering. 168  This naturally 
occurring, Gram-negative, rod-shaped bacterium was discovered 
over one hundred years ago,169 when it was first identified as the 
causal agent for particular types of plant tumors or galls.170 
Nearly seven decades would pass before researchers realized 
that a large plasmid171 carried within the bacterium was responsible 
for the tumors observed in crown gall disease.172 An explosion of 
interest related to the molecular basis of tumor induction by A. 
tumefaciens ensued in the late 1970s and early 1980s. 173 The 
combined research efforts led to a surprising breakthrough in 1983, 
when various research teams almost simultaneously reported the 
ability to genetically engineer plants by co-opting the A. 
tumefaciens tumor-inducing system.174 
The mechanism by which A. tumefaciens modifies a plant’s 
genetic make-up is now well characterized. When plant tissue 
sustains injury—e.g., a wound—the plant releases a series of 
compounds175 that trigger recruitment of A. tumefaciens to the 																																																								
 168 See, e.g., Sang-Min Chung et al., Agrobacterium is Not Alone: Gene 
Transfer to Plants by Viruses and Other Bacteria, 11 TRENDS PLANT SCI. 1 
(2006). 
 169 The original name proposed for this organism was Bacterium tumefaciens. 
Erwin F. Smith & C. O. Townsend, A Plant-Tumor of Bacterial Origin, 25 
SCIENCE 671, 672 (1907). 
 170 Id. at 672. 
 171 A plasmid is “a small, circular, double-stranded DNA molecule that is 
distinct from a cell’s chromosomal DNA.” See, Plasmid / plasmids, SCITABLE, 
http://www.nature.com/scitable/definition/plasmid-plasmids-28 (last visited 
Dec. 1, 2016). 
 172 I. Zaenen et al., Supercoiled Circular DNA in Crown Gall Inducing 
Agrobacterium Strains, 86 J. MOLECULAR BIOLOGY 109 (1974). 
 173 E.g., Mary-Dell Chilton et al., Stable Incorporation of Plasmid DNA into 
Higher Plant Cells: The Molecular Basis of Crown Gall Tumorigenesis, 11 
CELL 263 (1977); P. Zambryski et al., Tumor DNA Structure in Plant Cells 
Transformed by A. tumefaciens, 209 SCIENCE 1385 (1980). 
 174 See studies cited in supra note 119 and accompanying text. 
 175 One such compound is the phenolic molecule acetosyringone, which 
induces expression of virulence genes in A. tumefaciens. See Charles H. Shaw, 
virA and virG Are the Ti-Plasmid Functions Required for Chemotaxis of 
Agrobacterium tumefaciens Towards Acetosyringone, 2 MOLECULAR 
MICROBIOLOGY 413 (1988) (investigating acetosyringone chemotaxis). 
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injury site via chemotaxis.176 In turn, chemical interaction between 
the bacterium and plant cell induces expression of virulence genes 
within A. tumefaciens’ tumor-inducing (“Ti”) plasmid.177 The Ti 
plasmid encodes the genetic information for a fragment of DNA 
known as transfer DNA (“T-DNA”), which is the segment that 
ultimately integrates into the genome of the plant host cell and 
induces proliferation of crown gall disease.178 T-DNA is flanked by 
short “border” sequences at opposite ends of the fragment179 that 
serve as cleavage sites, which are in turn recognized by proteins 
expressed from the virulence genes. Once the T-DNA is excised 
from the Ti-plasmid, other virulence proteins mediate transfer—
and random integration—of the T-DNA into the nuclear genome of 
the host plant cell.180 
Initially, A. tumefaciens-mediated transformation was thought 
to be limited to dicot181 plant species only. However, it is now well 
established that transformation can be achieved in a wide range of 
plant hosts including monocots 182 —rice, 183  banana, 184  wheat, 185 																																																								
 176 Chemotaxis refers to the process by which the organism moves in the 
direction corresponding to a gradient of concentration of a specific substance or 
set of substances. See Charles H. Shaw, Swimming Against The Tide: 
Chemotaxis in Agrobacterium, 13 BIOESSAYS 25 (1991) (discussing chemotaxis 
related to A. tumefaciens). 
 177 Id. 
 178 Chilton et al., supra note 173. 
 179 Narendra S. Yadav et al., Short Direct Repeats Flank the T-DNA on a 
Nopaline Ti Plasmid, 79 PROC. NAT’L ACAD. SCI. U.S. 6322 (1982). 
 180 For a more detailed exposition of the molecular mechanisms by which A. 
tumefaciens mediates plant transformation, see Stanton B. Gelvin, 
Agrobacterium-Mediated Plant Transformation: The Biology Behind the “Gene-
Jockeying” Tool, 67 MICROBIOLOGY & MOLECULAR BIOLOGY REVS. 16 (2003). 
 181 The term dicot refers to plants that have a pair of leaves, or cotyledons, in 
the embryo of the seed. Dicotyledon, ENCYCLOPEDIA BRITANNICA, 
https://www.britannica.com/plant/dicotyledon (last visited Dec. 1, 2016). 
 182 Monocots can be distinguished from dicots by the presence of only one 
seed leaf, or cotyledon, in the embryo of the seed. Monocotyledon, 
ENCYCLOPEDIA BRITANNICA, https://www.britannica.com/plant/monocotyledon 
(last visited Dec. 1, 2016). 
 183 Y. Hiei et al., Efficient Transformation of Rice (Oryza sativa L.) Mediated 
by Agrobacterium and Sequence Analysis of the Boundaries of the T-DNA, 6 
PLANT J. 271 (1994). 
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etc.—and gymnosperms,186 as well as other unrelated organisms 
such as fungi187 and even human cells.188 Moreover, although A. 
tumefaciens has become the most popular method of plant 
transformation for genetic engineering, other Rhizobium species 
have now been shown capable of shuttling DNA of interest into 
plant hosts.189 Alternative methods of plant transformation based 
on other Rhizobium species could become important open source 
biological tools that allow researchers to circumvent intellectual 
property restrictions imposed by current Agrobacterium-related 
patents.190 
The key insight that paved the way for transgenic plants was 
the realization that the tumor-inducing T-DNA fragment flanked 
by border sequences could be entirely replaced with any DNA 
piece of interest; one that would in theory produce a desirable trait. 
By co-opting this bacterial tumor-inducing system in plants, 
scientists figured out a way to mediate the transfer of any DNA 
fragment—regardless of whether the DNA belonged to the same 
plant species or not—from bacterial plasmid into a plant host using 
bacteria as a shuttle. 
There are a few major unresolved issues related to A. 
tumefaciens transformation. One concern is that scientists cannot 
control the site of T-DNA integration and, therefore, a transgene 																																																																																																																												
 184  Gregory D. May et al., Generation of Transgenic Banana (Musa 
acuminata) Plants via Agrobacterium-Mediated Transformation, 13 NATURE 
BIOTECHNOLOGY 486 (1995). 
 185  M Cheng et al., Genetic Transformation of Wheat Mediated by 
Agrobacterium tumefaciens, 115 PLANT PHYSIOLOGY 971 (1997). 
 186 Anne-Marie Stomp, Extended Host Range of Agrobacterium tumefaciens 
in the Genus Pinus, 92 PLANT PHYSIOLOGY 1226 (1990). 
 187 P. Bundock et al., Trans-Kingdom T-DNA Transfer from Agrobacterium 
tumefaciens to Saccharomyces cerevisiae, 14 EMBO J. 3206 (1995). 
 188 T. Kunik et al., Genetic Transformation of HeLa Cells by Agrobacterium, 
98 PROC. NAT’L ACAD. SCI. U.S. 1871 (2001). 
189 See, e.g., Urmi Patel & Sarika Sinha, Rhizobia Species: A Boon for “Plant 
Genetic Engineering”, 51 INDIAN J. MICROBIOLOGY 521, 521 (2011). 
190 For a review of some Agrobacterium-related patents, see Benoît Lacroix et 
al., Recent Patents on Agrobacterium-Mediated Gene and Protein Transfer, for 
Research and Biotechnology, 2 RECENT PATS. ON DNA & GENE SEQUENCES 69 
(2008). 
MAY 2017] CRISPR GMOs 469 
may theoretically be inserted into a site that could interfere with 
the function of other plant genes. Additionally, duplications, 
translocations,191 and transfer of genetic material other than T-
DNA—such as bacterial chromosomal and Ti plasmid fragments—
have been shown to occur,192 which has prompted concerns for 
greater scrutiny of transgenic plants. These, in a nutshell, are the 
two major limitations of transgenic plants created via genetic 
engineering. 
2. Particle Bombardment Transformation 
Another common technique to generate GM crops is the 
particle bombardment method, also known as biolistics, 
microprojectile bombardment, or gene gun.193 This technique was 
developed to circumvent gene transfer limitations that existed at 
the early stages of A. tumefaciens transformation research. The 
method comprises an acceleration device that can deliver micron-
sized tungsten or gold particles coated with desired DNA 
molecules for plant cell transformation.194 The technique literally 
involves firing metal-complexed DNA microprojectiles into a cell. 
The particles penetrate thousands of cell walls and membranes 
simultaneously without inducing cell lethality.195 Once delivered 
inside the cell, the DNA comes off the metal particles and may 
subsequently be integrated into the host genome.196 
																																																								
 191  See, e.g., Frans E. Tax & Daniel M. Vernon, T-DNA-Associated 
Duplication/Translocations in Arabidopsis. Implications for Mutant Analysis 
and Functional Genomics, 126 PLANT PHYSIOLOGY 1527 (2001). 
 192 See, e.g., B. Ulker et al., T-DNA-Mediated Transfer of Agrobacterium 
tumefaciens Chromosomal DNA into Plants, 26 NATURE BIOTECHNOLOGY 1015 
(2008) (documenting transfer of unexpectedly large fragments of A. tumefaciens 
genic chromosomal DNA during plant transformation). 
 193 John C. Sanford et al., Delivery of Substances into Cells and Tissues Using 
a Particle Bombardment Process, 5 PARTICULATE SCI. & TECH. 27 (1987). 
 194 Julie R. Kikkert et al., Stable Transformation of Plant Cells by Particle 
Bombardment/Biolistics, in TRANSGENIC PLANTS: METHODS AND PROTOCOLS, 
286 METHODS MOLECULAR BIOLOGY 61 (2004). 
 195 Sanford et al., supra note 193, at 27. 
 196 Kikkert et al., supra note 194, at 62. 
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Particle bombardment transformation has been used to 
transform many economically important crops197 that were initially 
recalcitrant to A. tumefaciens-mediated gene transfer. However, 
now that A. tumefaciens transformation has been firmly established 
in a long list of plant species, particle bombardment may be used 
with less frequency. This is particularly because particle 
bombardment-mediated plant transformation requires specialized 
equipment and often leads to insertion of many copies of a 
transgene at multiple sites of the host genome, 198  which can 
potentially lead to altered patterns of gene expression or even gene 
silencing.199 
3. Polyethylene Glycol- and Electroporation-Based Protoplast 
Transformation 
Direct gene transfer using polyethylene glycol (PEG) or 
electroporation for protoplast 200  transformation have also been 
established as viable techniques for plant genetic engineering. The 
mechanism for PEG-mediated DNA uptake is not very well 
understood, but the technique is very simple and relatively 
inexpensive to implement. 201  Electroporation involves polarity 
changes on the cell membrane that trigger pore formation upon 
																																																								
 197 See, e.g., Isabel Dupuis & Gary M. Pace, Gene Transfer to Maize Male 
Reproductive Structure by Particle Bombardment of Tassel Primordial, 12 
PLANT CELL REP. 607 (1993) (using particle bombardment to transform maize). 
 198 See, e.g., H. Shou et al., Assessment of Transgenic Maize Events Produced 
by Particle Bombardment or Agrobacterium-Mediated Transformation, 13 
MOLECULAR BREEDING 201 (2004); W. P. Pawlowski et al., Transgenic DNA 
Integrated into the Oat Genome Is Frequently Interspersed by Host DNA, 95 
PROC. NAT’L ACAD. SCI. U.S. 12106 (1998). 
 199 See, e.g., Ana Leonor Rivera et al., Physical Methods for Genetic Plant 
Transformation, 9 PHYSICS LIFE REVS. 308 (2012). 
 200 A plant protoplast refers to a plant cell from which the cell wall has been 
removed. 
 201 See Zhaohui Liu & Timothy L. Friesen, Polyethylene Glycol (PEG)-
Mediated Transformation in Filamentous Fungal Pathogens, in PLANT FUNGAL 
PATHOGENS: METHODS AND PROTOCOLS, 835 METHODS IN MOLECULAR 
BIOLOGY 366 (Melvin D. Bolton & Bart P.H.J. Thomma eds., 2012) (describing 
protocol for PEG-mediated genetic transformation). 
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exposure to an electrical field.202 Both methods induce changes in 
the cell membrane’s permeability, thereby allowing the entry of the 
foreign DNA of interest. Although relatively simple to perform, 
they are not very popular due to reported marginally low 
transformation efficiency rates 203  and the need for protocol 
optimization to increase transformation efficiency. 
4. Microinjection 
Microinjection-based plant transformation is a direct physical 
approach that relies on glass micro-capillary injection pipettes to 
directly deliver DNA of interest into the plant cell.204 The technique 
requires specialized equipment and is labor-intensive and relatively 
inefficient compared to other methods.205 
5. Other Methods 
Aside from the techniques detailed above, other less common 
methods have been used to mediate plant cell transformation of 
recombinant DNA molecules including, but not limited to, 
liposome encapsulation,206 laser microbeams, vacuum infiltration, 
																																																								
 202 See, e.g., George W. Bates, Fusion of Plant Protoplasts by Electric Fields, 
72 PLANT PHYSIOLOGY 1110 (1983); Ariel Arencibia et al., Production of 
Transgenic Sugarcane (Saccharum officinarum L.) Plants by Intact Cell 
Electroporation, 14 PLANT CELL REP. 305 (1995). 
 203 See, e.g., Carl Rathus & Robert G. Birch, Stable Transformation of Callus 
from Electroporated Sugarcane Protoplasts, 82 PLANT SCI. 81 (1992); A.P. 
Sorokin et al., Production of Fertile Wheat Plants via Tissue Electroporation, 
156 PLANT SCI. 227 (2000); Hiromufi Uchimiya et al., Expression of a Foreign 
Gene in Callus Derived from DNA-Treated Protoplasts of Rice (Oryza sativa 
L.), 204 MOLECULAR & GENERAL GENETICS 204 (1986). 
 204 A. de la Peña et al., Transgenic Rye Plants Obtained by Injecting DNA into 
Young Floral Tillers, 325 NATURE 274 (1987). 
 205 Gunther Neuhaus and German Spangenberg, Plant Transformation by 
Microinjection Techniques, 79 PHYSIOLOGIA PLANTARUM 213 (1990). 
 206 Alain Deshayes et al., Liposome-Mediated Transformation of Tobacco 
Mesophyll Protoplasts by an Escherichia coli Plasmid, 4 EMBO J. 2731 (1985). 
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ultrasound, electrophoresis, and agrolistic transformation.207 More 
recently, an additional category of tools for targeted genome 
editing have been developed that could fundamentally change the 
way we think about GMOs. These will be discussed in more detail 
in Part V. 
III. HEALTH AND ENVIRONMENTAL GMO SAFETY CONCERNS 
In the last two decades, frequent and arduous contention vis-à-
vis the development and commercialization of GMOs for human 
consumption has pitted numerous groups among the general 
public, industry, governmental organizations, and the scientific and 
legal communities against one another. Ill-tempered disputes have 
fomented rapid deterioration of the quality of discourse and public 
attitudes pertinent to the use of biotechnology in this realm. 
Accordingly, it is no surprise that GMOs have become one of the 
most controversial topics in modern times. 
When it comes to bioengineered foods, the controversy can be 
divided into two main categories. The first concerns the view that 
GM food poses grave risk to human health. The second links GM 
crops to detrimental environmental effects.208 
In this section, the Article explores those concerns and 
discusses their merits primarily from a scientific standpoint. The 
motivation for doing so stems from the view that law and policy 
makers must proactively strive to grasp core scientific elements 
associated with that which they must regulate. In previous work, I 
have advocated for adoption of a Jurisprudence of Scientific 
Empiricism as a structural framework to address questions of 
science in law and combat the deleterious effects of scientific 
																																																								
 207 For a detailed review of some of these less common plant transformation 
techniques, see Ana Leonor Rivera et al., Physical Methods for Genetic Plant 
Transformation, 9 PHYSICS LIFE REVS. 308 (2012). 
 208 Other concerns exist, but human health and the environment dominate the 
public’s familiarity with GM food. See, e.g., Gary Null, 44 Reasons to Ban or 
Label GMOs, PROGRESSIVE RADIO NETWORK (Nov. 6, 2015), http://prn.fm/44-
reasons-to-ban-or-label-gmos/. 
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illiteracy.209 The objective here is to provide a succinct resource 
concerning the current scientific status of GM crops for the legal 
community. 
A. Human and Animal Health 
To date, the totality of institutional, governmental, and 
international organizations, as well as the scientific literature 
analyzing the safety of GM foods, has concluded that consuming 
GM-derived foodstuff poses no more a threat to human health than 
foodstuff derived from conventional breeding methods.210 
1. Institutional Authorities and International Organizations 
The National Academies of Science, Engineering, and 
Medicine recently tasked its Committee on Genetically Engineered 
Crops: Past Experience and Future Prospects to assess purported 
negative effects and benefits of GM crops and publish its findings 
in a detailed report.211 
The Committee answered the NASEM’s call and, over a period 
of eight months, heard over eighty presentations from speakers all 
over the world, read more than 700 comments and documents 
submitted from diverse members of the public and organizations, 
and carefully examined peer- and non-peer-reviewed literature 
relevant to the risks and benefits of GM crops in the U.S. and 
abroad.212 The Committee found that, on the basis of comparisons 
between GM and non-GM food in compositional analysis, animal 
toxicity tests, long-term research data on the health of livestock fed 
GM food diets, and human epidemiological data, there is no 
																																																								
 209 See Enríquez, supra note 1, at 611–14. 
 210 See infra Sections III.A.1–2 and accompanying footnotes. 
 211 COMMITTEE ON GENETICALLY ENGINEERED CROPS: PAST EXPERIENCE AND 
FUTURE PROSPECTS; BOARD ON AGRICULTURE AND NATURAL RESOURCES; 
DIVISION ON EARTH AND LIFE STUDIES; NATIONAL ACADEMIES OF SCIENCES, 
ENGINEERING, AND MEDICINE, GENETICALLY ENGINEERED CROPS: EXPERIENCES 
AND PROSPECTS 7 (2016) [hereinafter NASEM REPORT]. 
 212 Id. at 39–42. 
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evidence to suggest that consuming GM food is any riskier than 
consuming non-GM food.213 
The NASEM’s assessment mirrors findings of other 
independent authoritative agencies, international organizations, 
and scientific panels. The American Association for the 
Advancement of Science stated that it is “quite clear” that 
scientific evidence corroborates the safety of GM crops developed 
through biotechnology. 214  The European Commission too has 
published an extensive report presenting findings from hundreds of 
research groups funded by European research grants totaling over 
300 million euros.215 The Commission declared that “[t]he main 
conclusion to be drawn from the efforts of more than 130 research 
projects, covering a period of more than 25 years of research, and 
involving more than 500 independent research groups, is that 
biotechnology, and in particular GMOs, are not per se more risky” 
than non-GM crops.216 Notably, the Commission’s endorsement of 
GM crop safety came despite the fact that a number of European 
countries currently ban production of GM crops in their 
territories.217 																																																								
 213 Id. at 225. 
 214 AM. ASS’N FOR THE ADVANCEMENT OF SCI., STATEMENT BY THE AAAS 
BOARD OF DIRECTORS ON LABELING OF GENETICALLY MODIFIED FOODS (Oct. 
20, 2012), http://www.aaas.org/sites/default/files/AAAS_GM_statement.pdf. 
 215 EUROPEAN COMM’N, A DECADE OF EU-FUNDED GMO RESEARCH (2001-
2010) 15 (2010), http://ec.europa.eu/research/biosociety/pdf/a_decade_of_eu-
funded_gmo_research.pdf. 
 216 Id. at 16. 
 217  See, e.g., U.S.D.A., FAS REPORT, RUSSIAN BANS CULTIVATION AND 
BREEDING OF GE CROPS AND ANIMALS (2016), 
https://gain.fas.usda.gov/Recent%20GAIN%20Publications/Russia%20Bans%2
0Cultivation%20and%20Breeding%20of%20GE%20Crops%20and%20Animal
_Moscow_Russian%20Federation_7-12-2016.pdf (providing an account of the 
enactment of Russia’s Federal Law 358-FZ, which was signed into law by 
Vladimir Putin on July 3, 2016, and prohibits cultivation and breeding of GMOs 
on the Russian Federation territory for all purposes, except scientific research); 
GM Crop Ban, supra note 45 (announcing Scotland’s recent ban of GMOs in 
order to “protect and further enhance [its] clean, green status.”); France Joins 
Green Wave of GM Crop Bans in Europe, SUSTAINABLE PULSE (Sept. 17, 2015, 
6:40 PM), http://sustainablepulse.com/2015/09/17/france-joins-green-wave-of-
gm-crop-bans-in-europe/#.WL1bRXe-Jn4 (reporting on France’s recent decision 
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The American Medical Association (“AMA”) conducted a 
broad appraisal of peer-reviewed, published scientific literature 
and found that although bioengineered foods have been consumed 
for nearly two decades, no overt consequences on human health 
have been substantiated in the peer-reviewed literature. 218  The 
AMA further urged government, industry, consumer advocacy 
groups, and the scientific community to educate the general public 
and increase access to unbiased information on GM food.219 At the 
same time, the AMA indicated that, with respect to GM foods, “a 
small potential for adverse events exists, due mainly to horizontal 
gene transfer, allergenicity, and toxicity.”220 
In similar fashion, the United Nations’ Food and Agriculture 
Organization (“FAO”) has proclaimed that foods derived from 
transgenic crops “have been judged safe to eat and the methods 
used to test their safety have been deemed appropriate.”221 Despite 
human consumption of GM food by millions of people, “no 
verifiable untoward toxic or nutritionally deleterious effects . . . 
have been discovered anywhere in the world.”222 The Union of the 
German Academies of Science and Humanities also published a 																																																																																																																												
to ban GMOs); Germany and Poland Join Green Wave of EU GM Crop Bans, 
SUSTAINABLE PULSE (Sept. 30, 2015, 10:27 PM), 
http://sustainablepulse.com/2015/09/30/germany-and-poland-join-green-wave-
of-eu-gm-crop-bans/#.WL1b_Xe-Jn4 (covering news on GMO bans in 
Germany, Poland, Slovenia, and Serbia). But see, e.g., Jonathan Stearns, 
European Parliament Opposes National Bans on GMO-Food Imports, 
BLOOMBERG (Oct. 28, 2015, 8:46 AM) 
https://www.bloomberg.com/news/articles/2015-10-28/european-parliament-
opposes-national-bans-on-gmo-food-imports (reporting on the European Union 
Parliament’s disagreement with EU member states vis-à-vis the enactment of 
national bans concerning GMO products). 
 218 A M A, Report 2 of the Council on Science and Public Health (A-12): 
Labeling of Bioengineered Foods (2012), 
https://web.archive.org/web/20120907023039/http://www.ama-
assn.org/resources/doc/csaph/a12-csaph2-bioengineeredfoods.pdf. 
 219 Id. at 9. 
 220 Id. at 1. 
 221 FOOD AND AGRIC. ORG. OF THE UNITED NATIONS, THE STATE OF FOOD 
AND AGRICULTURE: AGRICULTURAL BIOTECHNOLOGY MEETING THE NEEDS OF 
THE POOR? 58 (2004), ftp://ftp.fao.org/docrep/fao/006/y5160e/y5160e.pdf. 
 222 Id. 
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report stating that scientific evidence suggests it is “most unlikely 
that the consumption of the well-characterised [sic] transgenic 
DNA from approved GMO food harbours [sic] any recognisable 
[sic] health risk.”223 The Royal Society of the United Kingdom, the 
International Council for Science, various National Academies of 
Science in Brazil, Australia, China, France, India, and the United 
Kingdom, the World Health Organization, and other institutions 
have all concurred in that judgment.224 
2. Scientific Literature 
The vast majority of the relevant published scientific literature 
on the topic of GMO safety spanning the last two decades has 
reached the consensus that GM crops and human health hazards 
are not linked or correlated.225 Published animal feeding studies 
have provided evidence that GM crops are as safe and nutritional 
as conventional breeding crops. 226  Long-term and multi-
generational studies on the effects of diets containing GM maize, 
potato, soybean, rice, or triticale on animal health have found no 
health hazards,227 and concluded that GM crops are nutritionally 																																																								
 223 UNION OF THE GERMAN ACADS. OF SCI. AND HUMANITIES, ARE THERE 
HEALTH HAZARDS FOR THE CONSUMER FROM EATING GENETICALLY MODIFIED 
FOOD? (2006), http://www.interacademies.net/File.aspx?id=6749. 
 224 See id.; AM. ASS’N FOR THE ADVANCEMENT OF SCI., supra note 214. 
 225 See, e.g., Alessandro Nicolia et al., An Overview of the Last 10 Years of 
Genetically Engineered Crop Safety Research, 34 CRITICAL REVS. 
BIOTECHNOLOGY 1 (2013); Rod A. Herman & William D. Price, Unintended 
Compositional Changes in Genetically Modified (GM) Crops: 20 Years of 
Research, 61 J. AGRIC. & FOOD CHEMISTRY 11695 (2013); José L. Domingo, 
Safety Assessment of GM plants: An Updated Review of the Scientific Literature, 
95 FOOD & CHEMICAL TOXICOLOGY 12 (2016). 
 226 See, e.g., P. Liu et al., A 90-day Subchronic Feeding Study of Genetically 
Modified Maize Expressing Cry1Ac-M Protein in Sprague–Dawley Rats, 50 
FOOD & CHEMICAL TOXICOLOGY 3215 (2012); X. He et al., A 90-day 
Toxicology Study of Transgenic Lysine-Rich Maize Grain (Y642) in Sprague-
Dawley Rats, 47 FOOD & CHEMICAL TOXICOLOGY 425 (2009). 
 227 Although some small differences have been documented between animals 
fed GM and non-GM foods, studies have indicated that the differences fall 
within the normal variation parameters and, thus, had no biological or 
toxicological significance. See, e.g., Chelsea Snell et al., Assessment of the 
Health Impact of GM Plant Diets in Long-Term and Multigenerational Animal 
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equivalent to non-GM crops.228 Life-long studies have found no 
long-term structural alterations of the lining of the small or large 
intestines in animals fed GM food, and reported that ageing affects 
animals in similar ways—regardless of whether they are fed GM 
food or not.229 
GM crops have been reported to exert no significant influence 
on health, performance, quality of meat or eggs, milk production, 
or DNA-transfer of animals—e.g., livestock230 and poultry231—
grown for human consumption. A study performed on publicly 
available field data sets over a period of almost thirty years 
(thirteen years before, and fifteen years after the introduction of 
GM crops), representing more than 100 billion animals, “did not 
reveal unfavorable or perturbed trends in livestock health and 
productivity.” 232  Although nucleic acids—such as DNA—and 
proteins are common macromolecular components of all diets, no 
study has revealed detectable or reliably quantifiable233 traces of 
GM foreign DNA in dairy products and meat, or any differences in 
the nutritional profile of products derived from GM crop-fed 
animals.234 																																																																																																																												
Feeding Trials: A Literature Review, 50 FOOD & CHEMICAL TOXICOLOGY 1134 
(2012). 
 228 See id. 
 229 See, e.g., S. Battistelli et al., Histochemical and Morpho-Metrical Study of 
Mouse Intestine Epithelium After a Long Term Diet Containing Genetically 
Modified Soybean, 54 EUROPEAN J. HISTOCHEMISTRY e36 (2010). 
 230  See, e.g., Patrick Guertler et al., Long-Term Feeding of Genetically 
Modified Corn (MON810)—Fate of cry1Ab DNA and Recombinant Protein 
During the Metabolism of the Dairy Cow, 131 LIVESTOCK SCI. 250 (2010); K. 
Steinke et al., Effects of Long-Term Feeding of Genetically Modified Corn 
(event MON810) on the Performance of Lactating Dairy Cows, 94 ANIMAL 
PHYSIOLOGY & ANIMAL NUTRITION e185 (2010). 
 231 See, e.g., Gerhard Flachowsky et al., Long Term Feeding of Bt-Corn—A 
Ten-Generation Study With Quails, 59 ARCHIVES ANIMAL NUTRITION 449 
(2005). 
 232  A. L. Van Eenennaam & A.E. Young, Prevalence and Impacts of 
Genetically Engineered Feedstuffs on Livestock Populations, 92 J. ANIMAL SCI. 
4255 (2014). 
 233 At least using today’s standard methods of detection. 
 234 Van Eenennaam & Young, supra note 232. To the contrary, the data 
available show that U.S. livestock health and feed-conversion efficiency rates 
478 N.C. J.L. & TECH. [VOL. 18: 432 
With respect to cancer, the scientific literature predominantly 
agrees that GM food consumption does not induce, or substantially 
contributes to the incidence of, cancer.235 For example, a study that 
examined breast and cervical cancer incidence and mortality rates 
in 187 countries between 1980 and 2010236 found similar patterns 
in the prevalence of these cancers in North America, where GM 
foods are commercialized, and Europe, where GM foods are 
typically not consumed. These observations are important because 
they dispel the notion that GMOs are directly associated with 
cancer.  
If consumption of GM foods were directly linked to higher 
occurrence of cancer, a putative increase in cancer rates between 
the two populations (a control—Europe, and an experimental—
North America) would be expected. Yet, the data do not support 
this hypothesis. Likewise, data available from the National Cancer 
Institute for trends in cancer incidence among men and women in 
the U.S. compared to data from the United Kingdom’s Cancer 
Research UK organization shows no obvious difference in the 
patterns of several types of cancers that could be attributed to the 
increase in consumption of GM foods.237 This lack of correlation 
was also noted by the NASEM’s 2016 report on GM crops.238 
																																																																																																																												
actually improved over time despite widespread adoption of GM crops in U.S. 
agriculture and livestock diets. Id. at 4259, 4262. However, the increase in 
productivity and animal health could not be directly attributed to the use of GM 
crops for dietary intake because improved rates continued in an upward trend 
observed before and after introduction of GM crops. 
 235 See, e.g., Pamela J. Mink et al., Epidemiologic Studies of Glyphosate and 
Cancer: A Review, 63 REG. TOXICOLOGY & PHARMACOLOGY 440 (2012). It 
should be noted that, although the studies analyzed in this publication came 
from a variety of independent, government, and industry-funded research 
groups, the researchers who published this review received financial support 
from Monsanto, Inc. The authors themselves disclosed funding for this research. 
Id. at 451. But cf. infra Section III.A.3. 
 236 Mohammad H. Forouzanfar et al., Breast and Cervical Cancer in 187 
Countries Between 1980 and 2010: A Systematic Analysis, 378 LANCET 1461 
(2011). 
 237 NASEM REPORT, supra note 211, at 208–11 (citations omitted). 
 238 Id. 
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Data on the onset of type II diabetes rates over the past four 
decades,239 as well as obesity rates between 1984 and 2013,240 also 
seem to reject the hypothesis that GM food consumption is 
contributing to the obesity and diabetes epidemics in the U.S. 
Incidence for both diseases appears to have steadily increased 
before GM crops were introduced and continued to increase at a 
steady pace throughout the 1990s and 2000s. Yet, type II diabetes 
and obesity rates appear to have reached a plateau in the last 
decade.241  
The NASEM’s 2016 report on GM crops also considered 
public comments for a number of other chronic conditions, 
including chronic kidney disease, Celiac disease, food allergies, 
autism spectrum disorders, and more. The report determined, after 
examining the relevant scientific literature and government 
statistics on the prevalence of these conditions, that no palpable 
link exists between them and consumption of GM crops.242 
On the topic of exposure to plant chemicals—e.g., pesticides—
produced by GM crops and the potential adverse effects to human 
health, the scientific literature reveals that both natural and 
synthetic compounds found in all plants could be harmful to 
humans depending on the amount of exposure. For instance, an 
investigation of naturally occurring pesticides in a laundry list of 
common human foods—fruits, legumes, vegetables, herbs, and 
even coffee, chocolate, and honey—found that all contained 
natural pesticides that induced carcinogenicity in rodents. 243 
Although a big focus of GM food products lies in testing for 
toxicity of newly introduced proteins or compounds in rodents, it 
appears that the administration of chemicals at the maximum 
tolerated dose (“MTD”) in standard animal cancer tests may not 																																																								
 239 Tobin M. Abraham et al., Trends in Diabetes Incidence: The Framingham 
Heart Study, 38 DIABETES CARE 482 (2015). 
 240 Ruopeng An, Educational Disparity in Obesity Among U.S. Adults, 1984–
2013, 25 ANNALS EPIDEMIOLOGY 637 (2015).  
 241 See supra notes 239–40 and accompanying text. 
 242 NASEM REPORT, supra note 211, at 213–14, 217–21 (citations omitted). 
 243 Lois Swirsky Gold et al., Pesticide Residues in Food and Cancer Risk: A 
Critical Analysis, in HANDBOOK OF PESTICIDE TOXICOLOGY 801 (R. Krieger ed., 
2d ed. 2001). 
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the most robust method to assess toxicity.244 More than 99.9% of 
the chemicals ingested by humans are naturally occurring, and of 
the small proportion of natural pesticides tested for 
carcinogenicity, more than half have been found to be rodent 
carcinogens.245 
During conventional cross-breeding, gene recombination gives 
rise to a great number of novel gene arrangements and interactions, 
which have not been associated with hazardous effects on human 
health and nutrition, despite the lack of review by regulatory 
agencies.246 Of the hundreds of thousands of GM plant varieties 
that have been created through non-genetic engineering methods, 
the emergence of any novel toxin or allergen has never been 
documented either.247 Thus, because changes in GM crops derived 
through genetic engineering are more precise than those created 
via non-genetic engineering methods, the number of potential 
novel gene recombination events and interactions is incredibly 
miniscule.248 
Some studies have also investigated potential effects of 
exposure to glyphosate, the main broad-spectrum herbicide (Figure 
3)249 used to treat many GM—as well as non-GM250—crops, and 
found no evidence of a pattern of positive associations linking a 
																																																								
 244 Bruce N. Ames & Lois Swirsky Gold, Chemical Carcinogenesis: Too 
Many Rodent Carcinogens, 87 PROC. NAT’L ACAD. SCI. U.S. 7772 (1990). 
 245 Gold et al., supra note 243, at 801. 
 246  Henry-York Steiner et al., Evaluating the Potential for Adverse 
Interactions Within Genetically Engineered Breeding Stacks, 161 PLANT 
PHYSIOLOGY 1587, 1589 (2013). 
 247 Id. at 1588. However, the emergence of predictable toxins has been 
documented at least three times in potato, lima bean, and canola, all of which 
involved toxins that were already known to be endogenous to the crop and were 
detected through screenings mandated by regulatory agencies. Id. 
 248 Id. 
249 See infra note 454. 
250 Glyphosate has also been used as a ripening agent or pseudo-desiccant on 
crops. See, e.g., Clarification of Pre-harvest Uses of Glyphosate, The 
Advantages, Best Practices, and Residue Monitoring, GLYPHOSATE, 
http://www.glyphosate.eu/system/files/sidebox-files/clarification_of_pre-
harvest_uses_of_glyphsate_en_0.pdf. 
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number of non-cancer outcomes with glyphosate exposure. 251 
Lastly, a public database of peer-reviewed research on the relative 
risks of GM crops run by an independent, tax-exempt, non-profit 
organization focusing on plant genetics and genetic engineering in 
agriculture has been created.252 The database, called GENERA, 
features over 400 publications on GMO research including feeding 
studies, toxicology, efficacy, and other topics and lists funding 
information for each study where it is available. 
As is evident from this Section, there is widespread concord in 
the scientific community regarding the safety of GM crops. 
However, although this section is comprehensive and 
representative of the scientific consensus, I would be remiss to 
claim it is complete, particularly given the thousands of studies 
performed over the last two decades related to this topic. 
Furthermore, no discussion of the safety of GM crops would be 
complete without highlighting the few dissenting—and loud—
voices in select scientific niches that have departed from the 
general scientific consensus to argue that GM crops pose grave 
hazards to human health. 
3. Dissenting Voices—Opposition to the Scientific Consensus 
Notwithstanding the scientific consensus that has crystallized 
on the topic of safety of GM crops, there are few dissenting voices 
that have spawned one of the most impassionate controversies in 
modern times. 
Of those voices, perhaps the most prominent is that of Gilles-
Eric Séralini, a French scientist and anti-GMO activist, who has 
																																																								
 251 See, e.g., Pamela J. Mink et al., Epidemiologic Studies of Glyphosate and 
Non-cancer Health Outcomes: A Review, 61 REG. TOXICOLOGY & 
PHARMACOLOGY 172 (2011). 
 252  GENETIC ENGINEERING RISK ATLAS [GENERA], 
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published a series of reports in the last decade253 warning about the 
health dangers of GMOs. Séralini and his colleagues’ studies have 
warned that GM foods can be directly associated with reproductive 
aberrations, 254  liver and kidney damage, 255  cardiotoxicity, 256 
embryonic disturbances,257 and more.258 
The most visible—and notorious—report was published in 
2012,259 which documented a series of long-term effects, including 
the induction of tumors in rats fed GM maize treated with 
Roundup, Monsanto’s popular glyphosate-based herbicidal 
formulation.260 Upon publication, the article was highly criticized 
by many in the scientific community, which pointed to, inter alia, 
the study’s inadequate methods, erroneous conclusions 
unsupported by empirical data, lack of proper statistical analyses, 
improper use of animals,261 etc.262 																																																								
 253 For a list of research papers published by Séralini and his colleagues, see 
Gilles-Eric Séralini, Relevant Research, GMOSERALINI, 
http://www.gmoseralini.org/research-papers/. 
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Herbicide Roundup® in Rat and Rabbit Ventricular Myocardium in Vitro, 15 
CARDIOVASCULAR TOXICITY 324 (2015). 
 257 Nora Benachour & Gilles-Eric Séralini, Time- and Dose-Dependent Effects 
of Roundup on Human Embryonic and Placental Cells, 53 ARCHIVES ENVTL. 
CONTAMINATION & TOXICOLOGY 126 (2007). 
 258  See Relevant Research, supra note 253 (providing a compilation of 
research published by Séralini and colleagues purportedly linking GMOs, or the 
use of GMO-related chemicals, to a range of deleterious cellular and 
physiological outcomes in animal in vitro and in vivo studies). 
 259 Gilles-Eric Séralini et al., RETRACTED: Long-Term Toxicity of a Roundup 
Herbicide and a Roundup-Tolerant Genetically Modified Maize, 50 FOOD & 
CHEMICAL TOXICOLOGY 4221 (2012). 
 260 I have discussed this study in prior work. See Enríquez, supra note 1, at 
655–56 n.342. 
 261 One of the most damaging criticisms of this study involved the use of the 
Sprague-Dawley rat strain, which is commonly known to develop spontaneous 
endocrine tumors with ageing regardless of whether rats are fed GM food or not. 
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Initially the Journal stood by the peer review process and its 
decision to publish. But, ultimately, the Journal initiated an 
independent investigation of the study’s conclusions and—upon 
review—decided to retract it due to the inconclusiveness of its 
results.263 Séralini then republished the same paper—without peer 
review and including minor modifications—in another journal.264 
Notably, the NASEM’s 2016 review of the study also concluded 
that the research was “not conclusive and used incorrect statistical 
analysis.”265 
Opponents of GMOs point to Séralini’s republished paper and 
other studies 266 in support of claims that greedy corporations, 																																																																																																																												
See H. Suzuki et al., Spontaneous Endocrine Tumors in Sprague-Dawley Rats, 
95 J. CANCER RES. & CLINICAL ONCOLOGY 187 (1979) (finding a high 
occurrence of spontaneous endocrine tumors in Sprague-Dawley rats, 
particularly those two years of age and older). 
 262 Many of these criticisms were subsequently published by the Journal. See 
Enríquez, supra note 1, at 655–56, n.342. 
 263 Id. 
 264 See Gilles-Eric Séralini et al., Republished Study: Long-Term Toxicity of a 
Roundup Herbicide and a Roundup-Tolerant Genetically Modified Maize, 26 
ENVTL. SCIS. EUR. 14 (2014). 
 265 NASEM REPORT, supra note 211, at 212.  
 266 For instance, the International Agency for Research on Cancer (“IARC”) 
for the World Health Organization published a report in 2015 stating that despite 
“limited evidence of carcinogenicity in humans,” there is “convincing evidence 
that glyphosate” can cause cancer in laboratory animals. INTERNATIONAL 
AGENCY FOR RESEARCH ON CANCER, IARC MONOGRAPHS VOLUME 112: 
EVALUATION OF FIVE ORGANOPHOSPHATE INSECTICIDES AND HERBICIDES, 1, 2 
(Mar. 20, 2015), http://www.iarc.fr/en/media-
centre/iarcnews/pdf/MonographVolume112.pdf.; see also, I. M. Zdziarski et al., 
GM Crops and the Rat Digestive Tract: A Critical Review, 73 ENV’T INT’L 423, 
432 (2014) (arguing that a majority of published long-term GM crop feeding 
studies concerning histopathological investigations of rat digestive tracts lack 
transparent methodologies and results and, thus, provide incomplete information 
regarding the safety and toxicity of GM foodstuff consumed by humans and 
animals). 
 However, the European Food Safety Authority (“EFSA”) and Canada’s 
federal health regulatory agency evaluated glyphosate following the IARC’s 
report and dismissed the IARC’s hypothesis of probable glyphosate 
carcinogenicity. The Canadian health regulatory agency found the WHO had not 
taken into consideration “the level of human exposure, which determines actual 
risk.” See HEALTH CANADA, PROPOSED RE-EVALUATION DECISION PRVD2015-
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lobbyists, and corrupt government officials have conspired against 
public health by allowing commercialization of GM crops.267 They 
also rely on these studies to demand long-term investigations and 
permanent bans on all GMOs. 268  These demands are often 
sensationalized and receive a great deal of media attention.269 
Moreover, anti-GMO scientists and activists routinely point to 
apparent conflicts of interest arising from the publication of safety 
studies that are funded by the very industries that will benefit from 
favorable GMO reports. For instance, one study found that there 
was a strong correlation between author affiliation to industry and 
a favorable outcome reported for peer-reviewed journal articles 
written on the safety of GM foods. 270 This would give some 
credence to anti-GMO activists and scientists, except that they too 
are guilty of the same type of professional conflicts of interests 
they often decry from proponents of GMOs. 																																																																																																																												
01: GLYPHOSATE, 3 (Apr. 13, 2015), 
http://publications.gc.ca/collections/collection_2015/sc-hc/H113-27-2015-1-
eng.pdf. Similarly, the EFSA concluded “glyphosate is unlikely to pose a 
carcinogenicity risk to humans.” See European Food Safety Authority, 
Conclusion On The Peer Review of The Pesticide Risk Assessment Of The Active 
Substance Glyphosate, 13 EUR. FOOD SAFETY AUTHORITY J. 4302 (2015). 
 267 See, e.g., Mel Gurtov, Food Politics: The GMO Conspiracy, PEACEVOICE 
(Dec. 3, 2016), http://www.peacevoice.info/2016/12/03/food-politics-the-gmo-
conspiracy/; Barbara H. Peterson, Monsanto’s Wheat Conspiracy Theory, FARM 
WARS (June 24, 2013), http://farmwars.info/?p=10908; cf. Mark Lynas, Time to 
Call Out the Anti-GMO Conspiracy Theory, ENVTL. NEWS & COMMENT (Apr. 
29, 2013), http://www.marklynas.org/2013/04/time-to-call-out-the-anti-gmo-
conspiracy-theory/ (recounting the reversal of a former anti-GMO activist). 
 268 See, e.g., Null, supra note 208. 
 269 See, e.g., Mike Adams, The Evil of Monsanto and GMOs Explained: Bad 
Technology, Endless Greed and the Destruction of Humanity, NAT. NEWS (Sept. 
23, 2012), 
http://www.naturalnews.com/037289_Monsanto_corporations_ethics.html#ixzz
4VEmt6BPM; Donald L. Barlett & James B. Steele, Monsanto’s Harvest of 
Fear, VANITY FAIR (May 2008), 
http://www.vanityfair.com/news/2008/05/monsanto200805. 
 270 Johan Diels et al., Association of Financial or Professional Conflict of 
Interest to Research Outcomes on Health Risks or Nutritional Assessment 
Studies of Genetically Modified Products, 36 FOOD POL’Y 197 (2011). It should 
also be noted the report found that slightly less than half of GMO-related articles 
in the study were published by authors having industry ties. Id. at 201–02. 
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Séralini, for example, receives funding from CRIIGEN, a 
company he co-founded in 1999 and of which he is President of 
the Scientific Board,271 as well as other organizations that oppose 
GMOs, including Greenpeace and the Sustainable Food Trust.272 
Sevene Pharma, a company that sells homeopathic remedies,273 has 
provided Séralini—a consultant of the company—mixtures of 
“medicinal plant extracts” that purportedly provide some level of 
protection against GM crop-derived “pollutants.”274 According to 
an article correction issued by a Journal that noted a failure to 
disclose all conflicts of interest, Séralini received funding from 
Sevene for the last five years to study the detoxifying capacity of 
plant extracts sold by Sevene Pharma, and received payment for a 
lecture organized by the company.275 Worse, proponents of GMOs 
have accused Séralini of profiting from shady science by timing 
release of his scientific reports to book and documentary film 
releases, all while forbidding the press to discuss his work with 
other scientists via bizarre confidentiality agreements during the 
book and film promotional periods.276 
Séralini’s supporters argue that he has been ostracized by 
members of the scientific community because he represents a 																																																								
 271  Gilles-Eric Séralini, We Can Depollute Ourselves: The Film, 
http://nous.depolluer.free.fr/gilles-eric-seralini-cv.html (last visited Dec. 1, 
2016). 
 272 David Despain, Organic Industry and Other Funders Behind Séralini’s 
Anti-GMO Studies, GENETIC LITERACY PROJECT (June 18, 2015), 
https://www.geneticliteracyproject.org/2015/06/18/organic-industry-and-other-
funders-behind-seralinis-anti-gmo-studies/. See also supra notes 253–59. 
 273 Sevene Pharma, 15 Homeopathic Medicines: A Range of Products To 
Relieve Common Pains, http://www.sevenepharma.com/medicines/ (last visited 
Dec. 1, 2016). 
 274 See Céline Gasnier et al., Dig1 Protects Against Cell Death Provoked By 
Glyphosate-Based Herbicides in Human Liver Cell Lines, 5 J. OCCUPATIONAL 
MED. & TOXICOLOGY 29 (2010); Steeve Gress et al., Dig1 Protects Against 
Locomotor and Biochemical Dysfunctions Provoked by Roundup, 16 BMC 
COMPLEMENTARY & ALTERNATIVE MED. 234 (2016). 
 275 The PLoS ONE Staff, Correction: Laboratory Rodent Diets Contain Toxic 
Levels of Environmental Contaminants: Implications for Regulatory Tests, 10 
PLOS ONE e0135542 (2015). 
 276 E.g., Declan Butler, Hyped GM Maize Study Faces Growing Scrutiny, 490 
NATURE 158 (2012). 
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danger to powerful corporate interests 277  and, as a result, his 
scientific work is often relegated to low-tier journals. But this 
proposition has little merit, especially given that other scientific 
research—featuring unfavorable evidence that could impact 
industry interests278—has been published in prominent journals and 
proven to be controversial. 279  For instance, in 2014, a paper 
published in Nature reported data suggesting that consumption of 
non-caloric artificial sweeteners—such as those commonly found 
in sugar-free foods and beverages—is associated with metabolic 
dysfunction and glucose intolerance. 280  The first report of the 
potentially harmful effects of GM crops on non-target species, 
such as the monarch butterfly, was also published in Nature back 
in 1999.281 
The overwhelming majority of scientists are not keen on 
hiding, or hindering the advancement and dissemination of, 
knowledge. A research team capable of showing a clear and 
convincing link between human health hazards and a commercial 
GM crop—that is reproducible and backed by rigorous empirical 
testing—is likely to have access to the most prominent platforms in 
the scientific world. Instead, Séralini has not helped himself, or the 
reputation of his research, by publishing studies either without peer 
review or in obscure journals. For example, one of his recent 
																																																								
 277 See, e.g., FEDERATION OF GERMAN SCIENTISTS, 2015 Whistleblower Award 
(Sept. 17, 2015), http://neu.vdw-ev.de/wp-
content/uploads/2015/10/Presseinformation-Whistleblower-Preisverleihung-
2015_150917_eng.pdf (awarding the Whistleblower Award to Séralini for 
revealing the health risks associated with GMOs and standing up to “‘interested 
circles’ from the chemical industry as well as the industry-financed British 
Science Media Centre.”). 
 278 See Jotham Suez et al., Artificial Sweeteners Induce Glucose Intolerance 
by Altering the Gut Microbiota, 514 NATURE 181 (2014). 
 279 Kai Kupferschmidt, Artificial Sweeteners May Contribute to Diabetes, 
Controversial Study Finds, SCIENCE (Sept. 17, 2014), 
http://www.sciencemag.org/news/2014/09/artificial-sweeteners-may-contribute-
diabetes-controversial-study-finds. 
 280 Suez et al., supra note 278. 
 281 John E. Losey et al., Transgenic Pollen Harms Monarch Larvae, 399 
NATURE 214 (1999). 
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papers282 was published in a Nigerian journal, whose website home 
page features multiple typos.283 
Many in the scientific community have become frustrated by 
what they perceive to be baseless obstructionism over the past 
twenty years. A 2016 letter signed by 107 Nobel Laureates urged 
Greenpeace to “cease and desist” in its campaign against GM 
crops, and exhorted the United Nations and other governments 
across the world to reject Greenpeace’s unscientific efforts to 
oppose modern methods of plant breeding.284 Notwithstanding the 
scientific consensus on GM crops, the debate carries on. A joint 
statement signed by more than “300 independent researchers”—
most, though not all, of whom are scientists—recently rejected the 
existence of a scientific consensus concerning the safety of GM 
crops.285 
B. The Environment 
With respect to the environmental effects of GM crop 
production, the prevailing scientific outlook is that no substantial 
evidence or causal relationship has been established between the 
adoption of GM crops and harmful agronomic and environmental 
																																																								
 282 Gilles-Eric Séralini, The Experience of One of the First GM Crop Farmers 
in Europe, 6 SCHOLARLY J. AGRIC. SCI. 9 (2016). 
 283  See SCHOLARLY J. AGRIC. SCI., http://www.scholarly-
journals.com/sjas/archive/2016/January/toc.htm, (last visited Jan. 9, 2017) 
(showing the Journal’s logo on the home page as “Scholarly Joural [sic] of 
Agricultural Science,” and providing a link for “Instruction for Authors”). 
 284  SUPPORT PRECISION AGRIC., Laureates Letter Supporting Precision 
Agriculture (GMOs) (Jan. 29, 2016), 
http://supportprecisionagriculture.org/nobel-laureate-gmo-letter_rjr.html. 
 285 Angelika Hilbeck et al., No Scientific Consensus on GMO Safety, 27 
ENVTL. SCIS. EUR. 4 (2015). Contrary to common sentiments within anti-GMO 
groups, the joint statement published did not “assert that GMOs are unsafe or 
safe. Rather, the statement conclude[d] that the scarcity and contradictory nature 
of the scientific evidence published to date prevents conclusive claims of safety, 
or of lack of safety, of GMOs.” Id. It should be noted that the statement was 
published in Environmental Sciences Europe, the same journal in which Séralini 
republished his retracted study without peer review. 
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impact.286 That was the assessment of the NASEM following an 
extensive review of the global scientific evidence available to date. 
At the same time, the NASEM underscored the need for 
sustainable pest management practices, and acknowledged that 
definitive conclusions are hard to reach in a few, but not all, areas 
related to long-term evaluation of environmental changes.287 
1. Crop Yield and Economics 
Of all the traits introduced into GM plants, including resistance 
to herbicides, insects, viruses, antibiotics, and others,288 a clear 
pattern has been established in the past twenty years. Insect-289 and 
herbicide-resistance290 are the two most common traits in GM crops 
																																																								
 286 See e.g., NASEM REPORT, supra note 211, at 154–55; Philip J. Dale et al., 
Potential For The Environmental Impact of Transgenic Crops, 20 NATURE 
BIOTECHNOLOGY 567 (2002) (“From the current state of knowledge, the impact 
of free DNA of transgenic origin is likely to be negligible compared with the 
large amount of total free DNA. We can find no compelling scientific arguments 
to demonstrate that GM crops are innately different from non-GM crops.”). 
 287 NASEM REPORT, supra note 211, at 154–55. 
 288 For a representative, though incomplete, list of GM traits currently studied, 
see INT’L SERVICE FOR THE ACQUISITION OF AGRI-BIOTECH APPLICATIONS, 
http://www.isaaa.org/gmapprovaldatabase/gmtraitslist/default.asp (last visited 
Dec. 1, 2016). 
 289 Genes transferred from the Bacillus thuringiensis (Bt) soil bacterium 
confer insect resistance in GM plants. See Richard L. Hellmich & Kristina 
Allyse Hellmich, Use and Impact of Bt Maize, 3 NATURE EDUC. KNOWLEDGE 4 
(2012). This species of bacteria produces unique proteins that are toxic to some 
insects and has been used as a natural insecticide in organic farming for over 
half a century. Id. 
 290  Glyphosate (N-phosphonomethyl-glycine), the active ingredient in 
Roundup and other herbicide products, confers herbicide resistance in GM 
crops. See Loredano Pollegioni et al., Molecular Basis of Glyphosate 
Resistance: Different Approaches Through Protein Engineering, 278 FEBS J. 
2753 (2011). This chemical compound kills plants by disturbing the shikimate 
pathway in plants, which is pivotal for the synthesis of some essential aromatic 
amino acids. Glyphosate is a competitive inhibitor of the enzyme 5-
enolpyruvylshikimate-3-phosphate synthase (“EPSPS”), which binds more 
tightly to glyphosate than its natural substrate. Id.; see also infra note 454. 
MAY 2017] CRISPR GMOs 489 
worldwide, and account for more than 99% of total GM crop 
area.291 
Numerous scientific studies have investigated issues related to 
improved yields stemming from the adoption of GM crops. For 
instance, a study of forty-nine peer-reviewed publications reporting 
results from a dozen countries revealed that, with few exceptions, 
GM crops led to higher crop yields and benefited small farmers in 
developing countries. 292  Similarly, a statistical analysis of the 
economic and agronomic performance of GM crops worldwide 
concluded that GM crops perform better than their conventional 
counterparts.293 Another study investigating yield contributions of a 
GM crop in ten universities across the United States over a 
thirteen-year period found that the presence of GM traits has been 
associated with an increase in yields.294 However, the NASEM 
found that although some GM crops have contributed to a 
statistically significant reduction in the gap between actual and 
potential yield in some contexts, other factors may also play 
important roles in yield differences.295 
On the basis of reduced pesticide use, increased crop yields, 
and increased farmer profits, primary data from farm surveys or 
field trials demonstrate that GM crops benefit both developing and 
developed nations. 296  Thus, although transgenic crop 
biotechnologies have been initially targeted for developed 
																																																								
 291 Janet E. Carpenter, Peer-Reviewed Surveys Indicate Positive Impact of 
Commercialized GM Crops, 28 NATURE BIOTECHNOLOGY 319 (2010). 
Interestingly, some evidence alludes that ‘stacking’ of GM traits in the same 
hybrid crop does not lead to additive gains of the combined traits. See Elizabeth 
Nolan & Paulo Santos, The Contribution of Genetic Modification to Changes in 
Corn Yield in the United States, 94 AM. J. AGRIC. ECON. 1171 (2012). 
 292 Carpenter, supra note 291, at 319. 
 293 F. J. Areal et al., Economic and Agronomic Impact of Commercialized GM 
Crops: A Meta-Analysis, 151 J. AGRIC. SCI. 7 (2013). 
 294 Nolan & Santos, supra note 291, at 1172. 
 295 See NASEM REPORT, supra note 211, at 115–16. 
 296 Wilhelm Klümper & Matin Qaim, A Meta-Analysis of the Impacts of 
Genetically Modified Crops, 9 PLoS ONE e111629 (2014). 
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countries, it appears that developing countries have benefited more 
from the spill over technology.297 
2. Pest Management 
Cumulative benefits have been documented for the use of 
transgenic Bacillus thuringiensis (Bt) maize to combat the 
propagation of its primary pest, the European corn borer. 298 
Transgenic maize-based pest suppression has been so effective, 
that some populations of the European corn borer have declined to 
historically low levels.299 Surprisingly, research shows that farmers 
growing non-GM maize are actually reaping more economic 
benefits than those planting GM maize.300 This is largely due to the 
fact that GM seed costs are higher—thereby lowering profit 
margins of GM maize farmers—and overall regional populations 
of the pest have declined, which ultimately has benefited both GM 
and non-GM crop farmers. 301  Such data has led to 
recommendations for the maintenance of non-GM crop refuges as 
a strategy for sustainable pest resistance management.302 
3. Pesticide Use, Acquired Resistance, and Controversies 
Assessments of the potential associations between GM crops 
and the reduction of pesticide use vary.303 Overall, the scientific 
literature points to a reduction of chemical pesticides applications, 
but the decrease is larger for insect-resistant than herbicide-																																																								
 297 Julian Witjaksono et al., Yield and Economic Performance of the Use of 
GM Cotton Worldwide Over Time: A Review and Meta-Analysis, 6 CHINA 
AGRIC. ECON. REV. 616 (2014). 
 298 W. D. Hutchison et al., Areawide Suppression of European Corn Borer 
with Bt Maize Reaps Savings to Non-Bt Maize Growers, 330 SCIENCE 222 
(2010). 
 299 Eric W. Bohnenblust et al., Current European Corn Borer, Ostrinia 
nubilalis, Injury Levels in the Northeastern United States and the Value of Bt 
Field Corn, 70 PEST MGMT. SCI. 1711 (2014). 
 300 Id. 
 301 See supra notes 298–300 and accompanying text. 
 302 Hutchison et al., supra note 298. 
 303 See infra notes 304–21. 
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resistant crops.304 On one hand, the evidence clearly shows that the 
use of insecticides has decreased as a result of GM crop 
cultivation. Data from various countries including India,305 South 
Africa,306 Pakistan,307 Australia,308 the United States,309 and other 
parts of the world310 demonstrate that GM crop technology has 
helped to shrink down the use of insecticides. 
On the other hand, data for the reduction of herbicide use is 
mixed. Research shows that herbicide use decreased for the first 
few years after the adoption of GM crops, but then increased 
modestly in later years. 311  This swing could presumably be 
explained by the development of herbicide resistance among some 
weed populations, which may have induced farmers to apply more 
herbicides to combat glyphosate-resistant weeds.312 Overreliance 
on glyphosate and the rise of resistance in some weed species have 
caused concern in recent years, particularly because some 
glyphosate substitutes may be more toxic and persistent 
herbicides.313 The NASEM acknowledged that weed resistance to 
glyphosate is a problem, and recommended the use of “integrated 
																																																								
 304 Klümper and Qaim, supra note 296. 
 305 See, e.g., Shahzad Kouser & Matin Qaim, Impact of Bt Cotton on Pesticide 
Poisoning in Smallholder Agriculture: A Panel Data Analysis, 70 ECOLOGICAL 
ECON. 2105 (2011). 
 306 See, e.g., Bhavani Shankar et al., Production risk, pesticide use and GM 
crop technology in South Africa, 40 APPLIED ECONOMICS 2489 (2008). 
 307 Shahzad Kouser & Matin Qaim, Bt Cotton, Damage Control and Optimal 
Levels of Pesticide Use in Pakistan, 19 ENV’T & DEV. ECON. 704 (2014). 
 308 See, e.g., Lewis Wilson et al., IPM in the Transgenic Era: A Review of the 
Challenges from Emerging Pests in Australian Cotton Systems, 64 CROP & 
PASTURE SCI. 737 (2013). 
 309 Edward D. Perry et al., Genetically Engineered Crops and Pesticide Use in 
U.S. Maize and Soybeans, 2 SCI. ADVANCES e1600850 (2016). 
 310 See Klümper & Qaim, supra note 296, at e111629. 
 311 Jose Fernandez-Cornejo et al., Genetically Engineered Crops in the United 
States, ERR-162 U.S.D.A., Economic Research Service, at 24 (2014), 
http://www.beyondpesticides.org/assets/media/documents/USDA_GE[smallpdf.
com].pdf. 
 312 Id. 
 313 Id. at 24–25. 
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weed-management approaches beyond simply spraying mixtures of 
herbicides.”314 
One controversial study published in 2012 concluded that, 
contrary to claims that GM crops have reduced pesticide use, the 
spread of glyphosate-resistant weeds has set off “substantial 
increases in the number and volume of herbicides applied.”315 
Opponents of GMOs have relied on this and other similar reports 
to argue that GM crops are polluting the planet and, thus, should be 
banned to protect our health and the environment.316 Critics of this 
study claimed it was flawed because the author, inter alia, “did not 
take into account the fact that glyphosate is less toxic than the 
herbicides it has replaced and, thus, the net toxicity of herbicide 
use had decreased even as the total herbicide use increased.”317 
However, subsequent peer-reviewed research has turned away 
from overarching conclusions and, instead, revealed nuanced crop-
specific differences related to herbicide use. Consider a report 
published in 2016, which found that “[w]hen pesticides are 
weighed by the environmental impact quotient,” non-GM and GM 
crop farmers used about the same amount of soybean herbicides, 
but roughly 10% less maize herbicides. 318  The NASEM also 
reviewed the 2012 report319 and concluded that the study’s author 
had failed to perform a statistical analysis.320 The NASEM also 
discouraged researchers from publishing data that makes “simple 
determination of whether total kilograms of herbicide used per 																																																								
 314 NASEM REPORT, supra note 211, at 15. 
 315 Benbrook, supra note 124. 
 316  See, e.g., Andrew Kimbrell, New Report: GMOs Causing Massive 
Pesticide Pollution, HUFFINGTON POST (Mar. 18, 2010, updated May 25, 2011), 
http://www.huffingtonpost.com/andrew-kimbrell/new-report-gmos-causing-
m_b_362888.html; Tom Laskawy, GMOs, Pesticides, and the New Scientific 
Deadlock, GRIST (Oct. 5, 2012), http://grist.org/food/superweeds-story/. 
 317  GENETIC LITERACY PROJECT, Charles Benbrook: Former Washington 
State Adjunct Consultant for Organic Industry (Aug. 10, 2016), 
https://www.geneticliteracyproject.org/glp-facts/charles-benbrook-former-
washington-state-adjunct-consultant-organic-industry/. 
 318 Perry et al., supra note 309, at e1600850. 
 319 The study was published in Environmental Sciences Europe, the same 
journal that republished Séralini’s controversial 2012 retracted paper in 2014. 
 320 NASEM REPORT, supra note 211, at 139. 
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hectare per year has gone up or down,” because such data “is not 
useful for assessing changes in human or environmental risks” and 
could “mislead readers.”321 
4. Non-Target Species and Biodiversity 
In the last two decades, the mass production and 
commercialization of GM crops has raised environmental concerns 
involving biodiversity and the reduction of non-target species 
populations. 
The first study to report a possible risk for non-target 
organisms that feed on plants producing transgenic Bt insecticides 
(Figure 2)322 was published in 1999 and focused on the monarch 
butterfly. 323  Through laboratory assays, the study showed that 
larvae of monarch butterflies reared on milkweed leaves dusted 
with pollen from a GM crop exhibited retarded growth and high 
mortality rates.324 Following that report, a research collaboration 
between several scientists in the U.S. and Canada performed a two-
year study to examine Bt corn pollen toxicity on the monarch 
butterfly.325 The study found that the impact of transgenic pollen 
was negligible primarily because Bt expression in pollen is low, 
and laboratory and field tests failed to establish acute toxic effects 
at concentrations the insects would likely encounter in the field.326 
The study criticized the 1999 report for not having specified the 
dose of pollen used in the study.327 
 
 
 																																																								
 321 Id. 
322 See infra note 328. 
 323 Losey et al., supra note 281, at 214. 
 324 Id. 
 325 Mark K. Spears et al., Impact of Bt Corn Pollen on Monarch Butterfly 
Populations: A Risk Assessment, 98 PROC. NAT’L ACAD. SCI. U.S. 11937, 11937 
(2001). 
 326 Id. 
 327 Id. 
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FIGURE 2 
 
The molecular basis for insecticide resistance in GM crops—A Bt 
insecticidal Cry protein. X-Ray, crystal structure of the full-length 
insecticidal protein Cry1Ac from Bacillus thuringiensis. After ingestion 
by a susceptible insect, this inactive full-length protoxin becomes active 
via proteolytic cleavage inside the insect’s midgut environment. The 
protoxin domain (yellow) is cleaved off and the toxic core (blue and 
red) becomes active. The unleashed toxic core is then free to bind 
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specific midgut receptors, thereby creating ion channels or pores in the 
midgut membrane.328 Systemic infection resulting from the ulcerated 
midgut eventually kills the host insect.329 The figure appears in color in 
the online version of the Article.330 
 
The potential effects on monarch butterfly fitness arising from 
the use of glyphosate and other herbicides to control milkweed, the 
main source of monarch larvae nutrition, has also been studied in 
recent years. Ample disagreement among researchers can be found 
in the literature, with some groups arguing that glyphosate-based 
reduction of milkweeds can be a negative factor in the monarch 
butterfly’s survival,331 and others claiming no such effect exists.332 
The debate carries on.333 
Honey bee pollination is vital in agriculture.334 A concern about 
the effects of Bt crops on honey bees has prompted research into 
this field. Results from a meta-analysis of twenty-five studies 
focused on chronic toxicity of Bt proteins or plant tissues on honey 																																																								
328 The model of this Bt insecticidal protein was built using the atomic 
coordinates deposited in the Protein Data Bank, accession code 4W8J (2014), 
http://www.rcsb.org/pdb/explore/explore.do?structureId=4W8J. 
329 For a more detailed exposition of various Bt pesticidal proteins, see 
generally E. Schnepf et al., Bacillus thuringiensis and Its Pesticidal Crystal 
Proteins, 62 MICROBIOLOGY & MOLECULAR BIOLOGY REVS. 775 (1998). 
330 The online version can be accessed at the Journal’s website, ncjolt.org, by 
clicking on the “Articles” tab, Volume 18, Issue 4. 
 331 See, e.g., John M. Pleasants & Karen S. Oberhauser, Milkweed Loss in 
Agricultural Fields Because of Herbicide Use: Effect on the Monarch Butterfly 
Population, 6 INSECT CONSERVATION & DIVERSITY 135 (2012). 
 332 See, e.g., Leslie Ries et al., The Disconnect Between Summer and Winter 
Monarch Trends for the Eastern Migratory Population: Possible Links to 
Differing Drivers, 108 ANNALS ENTOMOLOGICAL SOC’Y AM. 691, 691 (2015) 
(attributing certain regional declines to factors other than milkweed loss). 
 333 Compare John M. Pleasants et al., Conclusion of No Decline in Summer 
Monarch Population Not Supported, 109 ANNALS ENTOMOLOGICAL SOC’Y AM. 
169 (2016) (pointing to evidence that the key driver of monarch butterfly 
population decline is a massive loss of milkweeds), with Hidetoshi Inamine et 
al., Linking the Continental Migratory Cycle of the Monarch Butterfly to 
Understand its Population Decline, 125 OIKOS 1081(2016) (rejecting the 
milkweed limitation hypothesis). 
 334 Jian J. Duan et al., A Meta-Analysis of Effects of Bt Crops on Honey Bees 
(Hymenoptera: Apidae), 3 PLOS ONE e1415, e1415 (2008). 
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bee larvae and adults showed that GM crops do not negatively 
affect the species’ survival in laboratory settings, but that 
additional field environmental stresses could, in theory, lead to 
indirect effects.335 Another study concluded that a common Bt 
protein—even at concentrations too high to be found in natural 
conditions—was not lethal to the bees.336 However, such high 
concentrations could likely affect the honey bees’ food 
consumption or learning processes, which in turn could impact 
honey bee foraging efficiency.337 
In addition, some studies of the effects of glyphosate on soil, 
water, and air contamination have determined that, compared to 
some of the herbicides that glyphosate replaced, the environmental 
effects are minimal. 338  For example, one meta-analysis of a 
drought-tolerant GM crop found no impact on yield, and shoot or 
root architecture when grown in moderate- to high-yield 
environments. 339  Another meta-analysis examining forty-four 
studies addressing diversity trends associated with eight different 
field crops demonstrated that overall, in the long run, “no 
substantial reduction in the regional diversity of crop varieties 
released by plant breeders has taken place.”340 Comparative risk 
assessments have found that transgenic crops behave similarly to 
their non-transgenic counterparts and are not invasive.341 Other 
various studies also describe that, overall, currently 
commercialized GM crops have reduced the impacts of agriculture 
on biodiversity primarily through enhanced adoption of 																																																								
 335 Id. 
 336  R. Ramirez-Romero et al., Does Cry1Ab Protein Affect Learning 
Performances of the Honey Bee Apis mellifera L. (Hymenoptera, Apidae)?, 70 
ECOTOXICOLOGY & ENVTL. SAFETY 327, 332 (2008). 
 337 Id. at 332. 
 338 Antonio L. Cerdeira et al., The Current Status and Environmental Impacts 
of Glyphosate-Resistant Crops: A Review, 35 J. ENVTL. QUALITY 1633 (2006). 
 339 Chang et al., supra note 14, at 125. 
 340 Mark van de Wouw et al., Genetic Diversity Trends in Twentieth Century 
Crop Cultivars: A Meta Analysis, 120 THEORETICAL & APPLIED GENETICS 1241, 
1241 (2010). 
 341 Alan Raybould et al., Assessing the Ecological Risks from the Persistence 
and Spread of Feral Populations of Insect-Resistant Transgenic Maize, 21 
TRANSGENIC RES. 655 (2012). 
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conservation tillage practices, reduction of insecticide use, 
adoption of more benign herbicides, and improved yields that have 
prevented conversion of additional land for agricultural use.342 
The NASEM’s 2016 report concluded that the bulk of 
scientific evidence shows that the planting of GM crops tends to 
result in higher insect biodiversity than the planting of non-GM 
crops that are treated with synthetic insecticides, and that GM crop 
fields sprayed with glyphosate have similar or more weed 
biodiversity than non-GM crop fields.343 The report concluded that 
the totality of evidence on the environmental impacts of GM crops 
currently grown in agriculture shows no cause-and-effect 
relationships between transgenic crops and environmental harm.344 
IV. THE REGULATORY LANDSCAPE—A COORDINATED 
FRAMEWORK 
The advent, and swift progress, of recombinant DNA 
technologies throughout the 1970s and 1980s signaled the start of a 
new era. Public health and environmental concerns about the 
prospects of new biotechnologies surfaced. 345  Legislative and 
judicial developments in the early to mid-1980s began to exert 
pressure on the executive branch to take action.346 
On one front, Congress held hearings and entertained the 
possibility of enacting legislation to deal specifically with new 
technological developments.347 Around the same time, an activist 																																																								
 342 See, e.g., Janet E. Carpenter, Impacts of GM Crops on Biodiversity, 2 GM 
CROPS & FOOD 1 (2011). 
 343 NASEM REPORT, supra note 211, at 146. 
 344 Id. at 154–55. 
 345 See supra Part III for a discussion of some of the health and environmental 
concerns surrounding GMO biotechnology. 
 346 See infra notes 347–55 and accompanying text. 
 347 Biotechnology Regulation: Hearing Before the Subcomm. on Oversight 
and Investigations of the House Comm. on Energy and Commerce, 98th Cong. 
98–193 (1984); Environmental Implications of Genetic Engineering: Hearing 
Before the Subcomm. on Investigations and Oversight and the Subcomm. on 
Science, Research and Technology of the House Comm. on Science and 
Technology, 98th Cong. 2–3 (1983). 
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environmental organization filed a lawsuit in the D.C. District 
Court against federal officials in charge of supervising scientific 
research performed at the National Institutes of Health (“NIH”).348 
The complaint alleged violations of the National Environmental 
Policy Act of 1969 (“NEPA”)349 and the Administrative Procedure 
Act (“APA”),350 and sought a preliminary injunction to enjoin a 
deliberate release experiment involving genetically modified 
bacteria.351 
The Reagan Administration’s response to congressional and 
judicial pressures was to task a group of the White House Office of 
Science and Technology Policy (“OSTP”) with outlining a federal 
framework for the regulation of biotechnology. OSTP published a 
proposal draft on the last day of 1984. 352  The proposal was 
subsequently finalized in 1986 and gave birth to a new 
“Coordinated Framework for the Regulation of Biotechnology.”353 
This policy document avowed that, for the most part, current laws 
would adequately address regulatory needs related to products 
derived from traditional genetic manipulation techniques.354 Thus, 
OSTP argued successfully that “existing health and safety laws . . . 
could provide more immediate regulatory protection and certainty 
for the industry than . . . new legislation.”355 
The Coordinated Framework assigned broad federal 
jurisdiction over biotechnology products to three federal agencies: 
the United States Department of Agriculture (“USDA”), the Food 
and Drug Administration (“FDA”), and the Environmental 
Protection Agency (“EPA”).356 Significantly, the new regulatory 																																																								
 348 Found. on Econ. Trends v. Heckler (Heckler I), 587 F. Supp. 753, 754 
(D.D.C. 1984), aff’d, 756 F.2d 143 (D.C. Cir. 1985). 
 349 42 U.S.C. §§ 4321–70 (2012). 
 350 5 U.S.C. § 706 (2012). 
 351 Heckler I, 587 F. Supp. at 754. 
 352  See Proposal for a Coordinated Framework for Regulation of 
Biotechnology, 49 Fed. Reg. 50,856 (proposed Dec. 31, 1984). 
 353 Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg. 
23,302 (June 26, 1986). 
 354 Id. 
 355 Id. 
 356 The 1986 final policy draft followed the 1984 proposal’s vision, which 
stated that 
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scheme made it clear that biotechnology products should be 
reviewed by the pertinent agencies in “essentially the same manner 
for safety and efficacy as products obtained by other 
techniques.”357 Accordingly, U.S. policy would primarily follow a 
products-based, rather than a process-based, approach as had been 
the case for products derived without genetic engineering 
techniques. Where needed, OSTP recommended that “[a]n 
independent review of potential risks should be conducted on a 
case-by-case basis . . . .”358 
OSTP further declared the new Coordinated Framework would 
be expected to evolve and could be modified via administrative or 
legislative action. 359  Clarifications to the scope of the 
biotechnological regulatory scheme were delineated in a 1992 
policy statement, which reaffirmed that federal oversight should be 
confined to a science-based risk assessment with emphasis on the 
characteristics, risks, and applications of a biotechnological 
product, rather than the process by which it was created.360 The 
policy was based on OSTP’s view that “[p]roducts developed 
through biotechnology processes do not per se pose risks to human 
health and the environment; risk depends instead on the 
characteristics and use of individual products.”361 Those products 																																																																																																																												
the Food and Drug Administration (FDA) would regulate genetic 
engineering products no differently that those achieved through 
traditional techniques. The Environmental Protection Agency (EPA) 
described existing and proposed new policies for regulating pesticidal 
and nonpesticidal microorganisms. The Department of Agriculture 
(USDA) stated that under its different legislative authorities it could 
broadly regulate genetically engineered plants and animals, and plant 
and animal pathogens. 
Id. 
 357 Id. 
 358 Id. 
 359 Coordinated Framework for the Regulation of Biotechnology, 51 Fed. Reg. 
23,302 (proposed June 26, 1986). 
 360  Exercise of Federal Oversight Within Scope of Statutory Authority: 
Planned Introductions of Biotechnology Products into the Environment, 57 Fed. 
Reg. 6753 (proposed Feb. 27, 1992). 
 361 Id. at 6760. The opinion mirrors the findings of an extensive review 
performed by the National Research Council (“NRC”) on the potential risks of 
introductions of organisms made from new biotechnology processes. The NRC 
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posing little to no risk ought not to be subject to onerous regulation 
during testing and commercialization.362 
A. The United States Department of Agriculture 
The Coordinated Framework co-commissioned the USDA as 
one of the agencies with jurisdiction over GM crops. The USDA 
derives its authority to regulate biotechnology primarily via the 
Plant Protection Act (“PPA”).363 The PPA sanctions the Secretary 
of Agriculture with power to restrict the interstate commerce of 
plants, plant pests, noxious weeds, and other articles that could 
harm U.S. agriculture, so as to avoid their dissemination.364 
Pursuant to that authority, the Animal and Plant Health 
Inspection Service (“APHIS”) promulgated regulations that, in 
effect, created a presumption that categorized GM crops as 
“regulated articles”365 or “plant pests”366 simply because they are 																																																																																																																												
found that “the nature of the process is not a useful criterion for determining 
whether [a] product requires less or more oversight . . . [and] [n]o conceptual 
distinction exists between genetic modification of plants and microorganisms by 
classical methods or by molecular techniques that modify DNA and transfer 
genes.” Id. at 6755. 
 362 Id. at 6760. 
 363 See 7 U.S.C. §§ 7701–86 (2012). Before the PPA was enacted, USDA 
derived authority in this realm from the Federal Plant Pest Act. See infra note 
368. 
 364 § 7712(a) states that in general 
[t]he Secretary may prohibit or restrict the importation, entry, 
exportation, or movement in interstate commerce of any plant, plant 
product, biological control organism, noxious weed, article, or means 
of conveyance, if the Secretary determines that the prohibition or 
restriction is necessary to prevent the introduction into the United 
States or the dissemination of a plant pest or noxious weed within the 
United States.  
Id. 
 365 7 C.F.R. § 340.0(a)(2), n.1 (1997). A regulated article is defined as 
[a]ny organism which has been altered or produced through genetic 
engineering, if the donor organism, recipient organism, or vector or 
vector agent belongs to any genera or taxa designated in § 340.2 and 
meets the definition of plant pest, or is an unclassified organism and/or 
an organism whose classification is unknown, or any product which 
contains such an organism, or any other organism or product altered or 
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derived through genetic engineering techniques. Furthermore, a 
GM crop may also be deemed a “noxious weed,”367 if APHIS 
believes it is capable of causing injury or damage to any 
agricultural interest, such as crops or livestock. Accordingly, under 
current law, GM crops fall within the purview of the PPA until 
APHIS makes a determination to the contrary.368 
A developer may receive authorization to use and 
commercialize a GM crop by (1) a notification procedure, (2) a 
permit for release into the environment, or (3) a petition for 
determination of nonregulated status. 369  The first category is 
difficult for a GM crop to overcome because it prohibits the plant 
to have genetic material from animal or human pathogens, and 
requires the introduced genetic material to be of known function, 
not result in plant disease, and lack substances that can be toxic to 
																																																																																																																												
produced through genetic engineering which the Administrator 
determines is a plant pest or has reason to believe is a plant pest. 
Excluded are recipient microorganisms which are not plant pests and 
which have resulted from the addition of genetic material from a donor 
organism where the material is well characterized and contains only 
non-coding regulatory regions. 
 Id. § 340.1. 
 366 7 C.F.R. § 340.1 defines a plant pest as 
[a]ny living stage (including active and dormant forms) of insects, 
mites, nematodes, slugs, snails, protozoa, or other invertebrate animals, 
bacteria, fungi, other parasitic plants or reproductive parts thereof; 
viruses; or any organisms similar to or allied with any of the foregoing; 
or any infectious agents or substances, which can directly or indirectly 
injure or cause disease or damage in or to any plants or parts thereof, or 
any processed, manufactured, or other products of plants.  
Id. 
 367 7 C.F.R. § 360.100 defines a noxious weed as “[a]ny plant or plant product 
that can directly or indirectly injure or cause damage to crops (including nursery 
stock or plant products), livestock, poultry, or other interests of agriculture, 
irrigation, navigation, the natural resources of the United States, the public 
health, or the environment.” 
 368 Prior to the enactment of the PPA, the USDA derived its authority to 
regulate the movement of “plant pests,” from the Federal Plant Pest Act, which 
was repealed in 2000. See 7 U.S.C. § 150aa-jj (repealed 2000). 
 369 7 C.F.R. §§ 340.3, 340.4, 340.6 (2016). 
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non-target species that may feed on the plant.370 In essence, this 
forecloses any crop that produces Bt insecticides and has herbicide 
resistance—virtually all GM crops371—from being authorized by a 
notification procedure. 
The second category delineates the rules for applying for a 
permit to introduce a regulated article. 372  APHIS takes into 
consideration information ranging from the intended use and 
distribution to the article’s composition and molecular biology of 
the system by which it was produced.373 If APHIS grants the 
permit, rules related to containment and other measures to prevent 
dissemination come into force.374 Such a permit can be rescinded 
for noncompliance of the conditions listed on the document.375 
The third category involves a process of consultation by which 
APHIS determines whether the GM crop should or should not be 
regulated. “Any person may submit . . . a petition to seek a 
determination that an article should not be regulated” because it 
does not present a plant pest risk.376 The petition must include all 
relevant published and unpublished scientific studies, data from 
tests performed, and information deemed to contain trade secrets or 
confidential business information (“CBI”), which must be marked 
“CBI.”377 The promulgations also impose a duty of disclosure by 
requiring that a petitioner include any information known which 
																																																								
 370  See §§ 340.3(b-c) (stating that regulated articles must meet six 
requirements and performance standards to be eligible for introduction under the 
notification procedure). 
 371 Nearly 100% of GM crops sold are genetically engineered with either 
herbicide tolerance or insect resistance, or both. Those traits account for almost 
all of the GM crops grown commercially over the past 20 years. Canadian 
Biotechnology Action Network (CBAN), Where in the World are GM Crops 
and Foods?, 1, 2 (2015), http://gefreekamloops.org/wp-
content/uploads/2015/07/where-in-the-world-gm-crops-foods.pdf. See also 
supra note 328 and infra note 454 and accompanying text.  
 372 7 C.F.R. § 340.4 (2016). 
 373 See §§ 340.4(b)(1–12). 
 374 §§ 340.4(f)(1–11). 
 375 § 340.4 (g). 
 376 § 340.6. 
 377 § 340.6(b). 
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would be unfavorable to the petition, or state that no such 
unfavorable information is known at the time of the petition.378 
B. The Food and Drug Administration 
The Coordinated Framework empowers the FDA to, inter alia, 
protect the public health and ensure the safety of our nation’s food 
supply.379 The agency has jurisdiction over GM crops through the 
Federal Food, Drug, and Cosmetic Act (“FFDCA”)380 and its food 
adulteration (§ 402) and additive (§ 409) provisions.381 
Under the FFDCA, a foodstuff is deemed to have been 
“adulterated” “[i]f it bears or contains any poisonous or deleterious 
substance which may render it injurious to health.”382 The law 
prohibits introduction, or delivery for introduction, of any 
adulterated food in interstate commerce. 383  The adulterated 
provision grants the FDA power to impose sanctions—including 
injunctive relief, fines, imprisonment, and seizures—on 
violators,384 and to remove any food from interstate commerce that 
could pose injury to health by virtue of either (1) its adulterated 
status or (2) the presence of large quantities of an inherent 
constituent of the food that renders it injurious to health.385 
A GM crop is also subject to review if the FDA considers it to 
contain a “food additive,” which has been defined as any substance 
that can potentially become “a component or otherwise affect[] the 
characteristics of any food.”386 The FFDCA mandates that plants 
containing food additives must undergo a safety review prior to 																																																								
 378 7 C.F.R. § 340.6(b) (2016). 
 379  U.S. FOOD & DRUG ADMIN., FDA Mission, 
http://www.fda.gov/AboutFDA/WhatWeDo/ (last updated Oct. 24, 2016). 
380 See 21 U.S.C. § 301 (2012). 
 381 It bears noting that other statutes, such as the Public Health Service Act, 42 
U.S.C. §§ 201–300mm-61 (2012), also grant the FDA jurisdiction over certain 
aspects related to GM crops, including the regulation of drugs and biological 
products derived from GM plants, which are outside the scope of this Article. 
 382 21 U.S.C. § 342(a)(1). 
 383 § 331. 
384 See §§ 331–35. 
385 See § 342. 
386 § 321(s). 
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market release, regardless of how the additive found its way into 
the food.387 A petitioner wishing to bring said food to market must 
establish the existence of reasonable scientific certainty that the 
food additive is not harmful.388 
Importantly, the law acknowledges that establishing complete 
certainty of absolute lack of harm may be impossible given the 
current state of scientific knowledge.389 In any event, safety must 
be established by a series of “scientific procedures”390 aimed at 
studying stability, purity, potential toxicity, potency, and 
performance of the food additive.391 If the food additive is not 
approved following a formal petition, the item is deemed unsafe 
and subject to the adulterated provision. 392  Alternatively, if a 
substance added to food is generally recognized as safe (“GRAS”) 
“among experts qualified by scientific training and experience to 
evaluate its safety,”393 it is exempt from the food additive provision 
and no market pre-approval is warranted. 
The new FDA authority under the Coordinated Framework 
guidelines gave rise to numerous inquiries from industry, 
government agencies, academia, and the public concerning the 
regulatory status of new plant varieties, including those derived 
from recombinant DNA technologies.394 As a result, the FDA 
published a policy statement in 1992 to clarify its interpretation of 
the FFDCA regarding the extent of the agency’s jurisdictional 
reach vis-à-vis GM crops.395 In it, the FDA made three important 
remarks. 
First, the FDA reiterated the position that the process by which 
food is produced or developed should bear no adverse impact on a 
																																																								
 387 21 U.S.C. § 348 (2012). 
 388 21 C.F.R. § 170.3(i) (2016). 
 389 Id. 
 390 Id. 
 391 § 171.1(c) (2016). 
 392 See 21 U.S.C. § 342(a)(2)(c). 
 393 § 321(s). 
 394 See U.S. Food & Drug Administration, Statement of Policy: Foods Derived 
From New Plant Varieties, 57 Fed. Reg. 22,984 (proposed May 29, 1992). 
 395 Id. 
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safety calculus.396 Thus, the key factors for a determination of 
safety ought to be the characteristics of the food product, rather 
than the method used to produce it.397 
Second, the agency declared that material derived from nucleic 
acids are presumed to be GRAS because they can be found in 
every living organism, including all animals and plants used for 
human consumption, and do not raise safety concerns as food 
components.398 Thus, transferred genetic material is not likely to 
call into question the safety of GRAS substances or trigger the 
need for increased regulatory scrutiny. 
Third, the agency introduced a policy of informal, voluntary 
consultation to determine the regulatory status of new GM crop 
varieties. This policy was based on the recognition that expression 
of nucleic acids introduced via genetic engineering could, in 
theory, lead to production of proteins, carbohydrates, metabolites, 
and other materials not substantially equivalent to those found in 
current food.399 The FDA refrained from making the consultation 
process a legal requirement, but it explicitly stated that each food 
producer is responsible for assuring the safety of products 
introduced in interstate commerce.400 
Although the consultation process instituted by the FDA is not 
compulsory, in practice, it has become a de facto pre-market 
approval mandate. To date, FDA has completed 174 consultations 
related to GM plants under its 1992 voluntary consultation 
policy. 401  A possible explanation for this phenomenon is that 
developers wish to minimize their exposure to stringent product 
liability laws.402 Indeed, because each developer is charged with 																																																								
 396 Id. at 22,984–85. 
 397 Id. 
 398 Id. at 22,989–90. 
 399 U.S. Food & Drug Administration, Statement of Policy: Foods Derived 
From New Plant Varieties, 57 Fed. Reg. 22,990. 
 400 Id. 
 401 U.S. FOOD & DRUG ADMIN. Biotechnology Consultations on Food from 
GE Plant Varieties, http://www.accessdata.fda.gov/scripts/fdcc/?set=Biocon 
(last visited Dec. 1, 2016). 
 402  See, e.g., GRANT ISAAC, AGRICULTURAL BIOTECHNOLOGY AND 
TRANSATLANTIC TRADE: REGULATORY BARRIERS TO GM CROPS 186 (2002). 
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ensuring the safety of its food product,403 it is hard to conceive, 
from a risk-management perspective, that developers would be 
willing to invest considerable resources to introduce a product that 
could be later recalled by the FDA. 
C. The Environmental Protection Agency 
The EPA is the federal agency in charge of enforcing 
environmentally-conscious federal statutes concerning human 
health and the environment. The agency’s authority to develop and 
promulgate rules to ensure the safety of GM plants, and pesticides 
thereof, stems primarily from two statutes. Jurisdiction over 
pesticides and plant-incorporated protectants (“PIPs”) 404  comes 
from the Federal Insecticide, Fungicide, and Rodenticide Act 
(“FIFRA”). 405  In contrast, authority over pesticide residues in 
foodstuff flows from § 408 of the FFDCA.406 
Under FIFRA, it is unlawful for any person to sell or distribute 
pesticides without a proper registration from the federal 
government.407 A pesticide within the meaning of the Act refers to 
“any substance, or mixtures thereof, intended for 1) the prevention, 
destruction, or mitigation of any pest; or 2) use as a plant regulator, 
defoliant, or desiccant.”408 
The law aims to prevent “unreasonable adverse effects on the 
environment,”409 which encompass “any unreasonable risk to man 
or the environment.” 410  The analysis for establishing the 
unreasonable adverse effects of this provision is two-fold. First, 																																																								
 403 57 Fed. Reg. 22,984. 
 404 A plant-incorporated protectant is “a pesticidal substance that is intended 
to be produced and used in a living plant, or in the produce thereof, and the 
genetic material necessary for production of such a pesticidal substance. It also 
includes any inert ingredient contained in the plant, or produce thereof.” 40 
C.F.R. § 152.3 (2016). 
 405 Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. §§ 136–
136y (2012).  
 406 Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301–399h (2012).  
 407 7 U.S.C. § 136a(a). 
 408 § 136(u). 
 409 § 136a(a). 
 410 § 136(bb). 
MAY 2017] CRISPR GMOs 507 
EPA’s determination cannot be solely based on scientific data; it 
warrants a cost-benefit analysis that takes into consideration 
relevant economic, social, and environmental factors connected 
with the pesticide’s use. 411  Second, the risks associated with 
residues in foodstuff resulting from pesticide use must be 
consistent with the safety standards outlined in § 408 of the 
FFDCA.412 Consequently, registration of a pesticide substance is 
only warranted if both prongs of the unreasonable adverse effect 
test are satisfied. 
In addition, registration may be granted only after the petitioner 
submits sufficient scientific information to demonstrate adequate 
testing and safety of the pesticide.413 This helps to ensure that 
“when used in accordance with widespread and commonly 
recognized practice[,] [the pesticide] will not generally cause 
unreasonable adverse effects on the environment. 414  Prior to 
commercialization, the EPA exercises authority over field tests via 
Experimental Use Permits (“EUPs”), which sanction the limited 
use of pesticides on a set number of acres of land or surface water 
under controlled conditions. 415  Minimum risk pesticides—
substances that pose little to no risk to human and animal health, 
plants, or the environment—are exempt from the registration 
requirements under FIFRA.416 
Pesticides, or chemical residues thereof, that may find their 
way into foodstuff come under the purview of the EPA’s authority 
under the FFDCA. As discussed earlier, a food is deemed 
“adulterated” under FFDCA when it contains a substance that 
could be potentially injurious to health.417 Thus, the EPA has 
determined pesticides to be the type of substances covered under 
FFDCA’s adulterated food provision. Furthermore, FFDCA grants 
																																																								
 411 Id. 
 412 Id. 
 413 See, e.g., 7 U.S.C. § 136a(c)(5) (2012); 40 U.S.C. §§ 152.50, 152.170, 
158.70, 158.130 (2012). 
 414 7 U.S.C. § 136a(c)(5). 
 415 § 136c. 
 416 40 U.S.C. § 152.25(f) (2012). 
 417 21 U.S.C. § 342(a)(1) (2012). 
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EPA authority to set tolerance levels for a pesticide chemical 
residue in or on food if the agency determines it is safe to do so.418 
A pesticide substance or residue is safe within the meaning of 
21 U.S.C. § 342 if (1) a tolerance pronouncement is in effect and 
the quantity of the residue is within the limits of said tolerance, or 
(2) the EPA has carved out an exemption for the pesticide 
chemical residue. 419  Safety, insofar as tolerance concerns, is 
established when there is “a reasonable certainty that no harm will 
result from aggregate exposure to the pesticide[,]” which includes 
all foreseeable dietary exposures.420 When contemplating whether 
to grant an exemption for a pesticide in food under FIFRA, the 
EPA uses the FFDCA “reasonable certainty” safety standard.421 
Tolerance determinations and exemptions are dynamic. They can 
be modified or revoked on the basis on available information 
related to several safety factors.422 
V. CRISPR GMOS—NEW FOOD OR JUST GMOS 2.0? 
The Coordinated Framework for the regulation of 
biotechnology has now been in force for over three decades. 
During that time, biotechnology and basic scientific knowledge 
about diverse mechanisms to accomplish genetic manipulation in 
cells and whole organisms has progressed immensely. Compared 
to previous generations, scientists and plant breeders of this 
generation have, at their disposal, more powerful and precise tools 
to manipulate nucleotide sequences at will. Few, if any, 
scientists—let alone law and policy makers—could have predicted, 
at the time the Coordinated Framework went into effect, all the 
ways in which humans are now able to alter the genetic 
composition of whole organisms. 
																																																								
 418 § 346a(b)(2)(A). 
 419 §§ 342(a)(2)(A)–(B). 
 420 § 346a(b)(2)(A)(ii). 
 421 Id. 
 422 § 346a(b)(2)(D). 
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The era of recombinant DNA is in the past. A genome editing 
revolution is now underway. 423  This revolution, led by 
macromolecular machines that shear DNA with tremendous 
precision, is challenging long-held conventions of how humans 
view life and the incipient power to control and alter the genetic 
destiny of every living creature. 
In the last few years, new methods of genetic manipulation 
involving programmable nucleases such as Zinc Finger Nucleases 
(“ZFNs”), Transcription Activator-Like Effector Nucleases 
(“TALENs”), and CRISPR systems have emerged and taken root 
in laboratories around the world with remarkable speed.424 Of 
these, CRISPR systems are the most renown due to their ease of 
use, efficiency, and modular nature. 
A. CRISPR-Based, Targeted Genome Editing—A Brief Overview 
CRISPR is an adaptive immunity system used by bacteria and 
archaea that provides resistance to attacks by phages and other 
foreign genetic elements. 425  This immune system uses 
complementary RNAs to recognize and cleave select foreign DNA. 
In other words, when a virus infects a bacterium, the CRISPR 
system—alongside a variety of CRISPR-associated (“Cas”) 
proteins—responds to the invasion by recruiting specific RNAs 
and Cas proteins that will be subsequently targeted to the foreign 
DNA. Once the CRISPR-Cas complex encounters the foreign 
DNA, it triggers a precise double-stranded cut that ultimately 
neutralizes the ability of the pathogen to wreak havoc in the host. 
This seek-and-destroy machinery has been co-opted in recent 
years for targeted genome editing in various organisms ranging 
from plants and animals, to even human cells.426 To induce targeted 
genome editing, scientists engineer a short, synthetic RNA 																																																								
 423 For a detailed exposition of the history of genome editing, as well as some 
of its applications and implications for science and law, see generally Enríquez, 
supra note 1. 
 424 Other tools for genome editing exist. See Enríquez supra note 1, at 622–33. 
 425 Rodolphe Barrangou et al., CRISPR Provides Acquired Resistance Against 
Viruses in Prokaryotes, 315 SCIENCE 1709, 1709 (2007). 
 426 Enríquez, supra note 1, at 632. 
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molecule, called a single-guide RNA (“sgRNA”),427 that is partly 
complementary to the DNA sequence that will be modified. The 
sgRNA forms a complex with a Cas—e.g., Cas9—protein. 
Following complex formation, the sgRNA guides the Cas protein 
to its target DNA site. Upon binding to the desired DNA sequence, 
the Cas protein cleaves the DNA backbone and leaves an open cut. 
Because DNA cuts are highly deleterious, mechanisms to 
repair DNA breakage have evolved within cells.428 Scientists have 
figured out that they can take advantage of various DNA repair 
mechanisms to either delete endogenous DNA sequences or insert 
new DNA into the cleavage sites. This breakthrough system for 
genetic manipulation is revolutionizing science and has significant 
implications for the future of biotechnology and medicine.429 
B. CRISPR-Based Genome Editing and the Coordinated 
Framework 
Genetic manipulation via modern genome editing technologies, 
such as CRISPR systems, is strikingly different—in a few, but 
significant areas—from older genetic engineering methods based 
on recombinant DNA technology. With respect to GM crops, the 
primary difference rests on the fact that older methods of plant 
transformation are limited by the random integration of foreign 
DNA sequences into the target plant species. Simply put, it is 
impossible to control where, and with what frequency, insertion of 
foreign DNA occurs via older genetic engineering techniques. In 
contrast, modern genome editing technologies are precise and need 
not rely on the insertion of foreign DNA sequences at all to carry 
out intended genetic manipulations. 
																																																								
 427 The sgRNA is an engineered fusion of two RNA molecules—a crRNA and 
tracrRNA—naturally found in CRISPR-Cas9 systems. The first report of a 
sgRNA for use in genome editing was reported in 2012. See Martin Jinek et al., 
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial 
Immunity, 337 SCIENCE 816 (2012). 
 428 For a brief overview of DNA repair mechanisms, see Enríquez, supra note 
1, at 620–21. 
 429 Id. at 628–33. 
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The most important implication, for purposes of this 
discussion, is that modern genome editing methods extend 
previously unavailable opportunities to help allay controversies 
surrounding GM crops.430 
Consider the case of Arctic Apples431 and Innate potatoes432 
recently approved by the FDA for human consumption after five- 
and two-year review periods, respectively. The apples, for 
example, are engineered to resist browning associated with cuts 
and bruises via introduction of foreign nucleotide sequences to 
suppress endogenous genes and the addition of a selectable marker 
gene (nptII) for antibiotic resistance.433 This is precisely one of the 
most unacceptable aspects of GM crops for critics: the transfer of 
genetic material from an unrelated species—bacteria, fungi, 
animals, etc.—into the genome of a crop plant, which would not 
otherwise occur in nature.434 
But what if a non-browning apple cultivar could be grown 
without introducing any foreign DNA and selectable markers, and 
instead possessed modifications that were no different from a 
naturally occurring event? What if there was an alternative method 
																																																								
 430 The opportunities referred to in this Section may not be entirely adequate 
or meaningful for some people who oppose GMOs from a purist perspective. 
That is, some anti-GMO people believe that any type of genetic engineering, no 
matter what the approach or end point, is inherently inappropriate because 
nature must be allowed to take its course without human intervention. For those 
who hold that view, modern genome editing technologies are not likely to help 
minimize the controversies surrounding GMOs. 
 431 U.S. FOOD & DRUG ADMIN., Biotechnology Consultation Agency Response 
Letter BNF 000132 (Mar. 20, 2015), 
http://www.fda.gov/Food/FoodScienceResearch/GEPlants/Submissions/ucm436
163.htm. 
 432 U.S. FOOD & DRUG ADMIN., Biotechnology Consultation Agency Response 
Letter BNF 000141 (Mar. 20, 2015), 
http://www.fda.gov/Food/FoodScienceResearch/GEPlants/Submissions/ucm436
169.htm.  
 433 Biotechnology Consultation Agency Response Letter BNF 000132, supra 
note 431. 
 434  CENTER FOR FOOD SAFETY, About Genetically Engineered Foods, 
http://www.centerforfoodsafety.org/issues/311/ge-foods/about-ge-foods# (last 
visited Dec. 1, 2016). 
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to locally suppress the endogenous genes that contribute to 
browning? 
Prior to 2016, inquiries to USDA’s APHIS led the agency to 
issue determinations that a GM crop modified using earlier 
genome editing technologies—such as ZFNs and TALENs—does 
not fall within the purview of its regulatory oversight because it is 
not deemed a regulated article.435 As discussed in Part IV, USDA 
authority over GM crops is warranted if the genetically engineered 
organism or product is, or there is a reason to believe it is, a “plant 
pest.”436 However, the crop’s own DNA is not considered to be 
plant pest material within the purview of the PPA.437 
Less than a year ago, the USDA issued back-to-back responses 
to the first two inquiries regarding the regulatory status of GM 
crops modified using the CRISPR-Cas9 system438 The first inquiry 
came from researchers at the Pennsylvania State University 
regarding anti-browning, genome edited mushrooms designed to 
produce less melanin—brown pigment—and improve the 
mushroom’s appearance and shelf-life.439 The second inquiry came 
from DuPont Pioneer concerning a type of waxy corn edited to 
possess an altered starch composition.440 In letters issued five days 
apart, the USDA declared that, based on the information provided 																																																								
 435 See, e.g., Michael Gregoire, APHIS Review as to Whether Zea mays Plants 
with the IPK1 Gene Deleted Using Zinc Nuclease Technology is Regulated by 
APHIS 2 (May 26, 2010), 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/DOW_ZFN_IPK
1_052610.pdf. 
 436 7 C.F.R. § 340.0(a)(2), n.1 (1997). 
 437 See § 340.1. 
 438  See Yinong Yang, UNITED STATES DEPARTMENT OF AGRICULTURE, 
REQUEST FOR CONFIRMATION THAT TRANSGENE-FREE, CRISPR-EDITED 
MUSHROOM IS NOT A REGULATED ARTICLE (Apr. 4, 2016), 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-321-
01_air_response_signed.pdf; Daria H. Schmidt, UNITED STATES DEPARTMENT 
OF AGRICULTURE, CONFIRMATION OF REGULATORY STATUS OF WAXY CORN 
DEVELOPED BY CRISPR-CAS TECHNOLOGY (Apr. 18, 2016), 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/15-352-
01_air_response_signed.pdf. 
 439 Yang, supra note 438. 
 440 Schmidt, supra note 438. 
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by the researchers, neither crop fell under APHIS jurisdiction 
pursuant to 7 C.F.R. § 340.441 
USDA’s decision to decline jurisdiction to regulate these GM 
crops marks a significant first that will likely open the gates for 
some level of deregulation of CRISPR-based crops. Unlike older 
genetic engineering methods, CRISPR-mediated genome editing 
does not require the introduction of foreign DNA into a crop’s 
genome—unless a researcher so desires—as a prerequisite for 
proper function. Furthermore, the system can target select genes in 
their native genomic loci. These are fundamental distinctions that 
may eventually transform, alleviate, or even further complicate, 
culture wars concerning GMOs. 
One important note is that, although it appears that crops 
generated using modern genome editing technologies are not 
within the USDA’s jurisdiction, they may still face regulation by 
the FDA and EPA. In any event, opponents of GMOs decry the 
current regulatory scheme—including USDA’s decision not to 
regulate CRISPR GM crops—and argue that conglomerates are 
circumventing regulation through technical loopholes in outdated 
regulations.442 
VI. A REGULATORY PATH FOR GENOME EDITED CROPS IN THE 
TWENTY-FIRST CENTURY 
CRISPR-based genome editing technologies and their progeny 
are poised to raise challenging problems that our legal system will 
be forced to address. The current GM crop regulatory scheme 
concocted by the Coordinated Framework is largely driven by the 
realities and limitations of genetic engineering methods that rely 
on recombinant DNA technology.443 In particular, the regulatory 
calculus focuses heavily on the introduction of transgenic DNA, 
from foreign organisms—e.g., viruses or bacteria—considered to 
be plant pests, into GM food by virtue of human intervention. 																																																								
 441 See Yang, supra note 438; Schmidt, supra note 438. 
 442 Andrew Pollack, By ‘Editing’ Plant Genes, Companies Avoid Regulation, 
N.Y. TIMES, Jan. 2, 2015, at B1. 
 443 See supra Part II.B. 
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There is a high degree of dissonance between the ways in 
which GM crops derived through transgenesis, or conventional 
hybridization and plant breeding are regulated. On one hand, GM 
crops developed with non-recombinant DNA techniques—e.g., 
intergeneric hybridization, induced mutagenesis, etc.—for cross-
breeding non-related444 crop species are largely overlooked under 
the Coordinated Framework. This is true even though these types 
of modifications are, in theory, more likely to result in significant 
reshuffling of parental genes,445 which can lead to unexpected 
phenotypic or compositional changes in GM food. 
On the other hand, GM crops developed with recombinant 
DNA technology, using either non-related or related crop species, 
trigger immediate regulatory scrutiny because, despite being more 
precise than non-recombinant methods, the technique used to 
introduce DNA could also, in theory, lead to unexpected 
phenotypic or compositional changes in GM food. 
It is apparent that making a GM crop, using a myriad number 
of techniques outlined in this Article, may in theory lead to 
unforeseeable changes in foodstuff derived from it. It is also clear 
that, despite the congruent likelihood of changes that could arise 
from all GM crop methods, only recombinant DNA-based methods 
have been associated with GMO controversies. The question, thus, 
is one of risk. Namely, are the health and environmental risks 
associated with recombinant DNA-derived GM crops greater than 
those from their non-recombinant counterparts? 
Three decades of scientific research suggests that the answer to 
that question is no, and a scientific consensus has now formed to 
support that proposition.446 From a strict risk-based standpoint, it 
seems logical that some level of deregulation of GM crops would 
be prudent. Indeed, many in the scientific community have 																																																								
 444 It is important to distinguish cross-breeding of non-related and related 
plant species. Although both types are deemed not to fall under the regulatory 
oversight of the Coordinated Framework, crosses between plants of the same 
species are less likely to lead to unexpected phenotypic or compositional 
changes in crops. 
 445 See Knobloch, supra note 31. 
 446 See studies previously cited supra note 225 and accompanying text; see 
generally supra Section III.A.  
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recently argued on behalf of a risk-based approach to replace the 
current process-based approach to biotechnology.447 
The risk-based deregulation line of reasoning comes at the eve 
of forthcoming updates to modernize the Coordinated Framework 
initiated by the Obama Administration in 2015.448 The Executive 
Branch’s directive to modernize the U.S. regulatory system for 
biotechnology aims to improve transparency, efficiency, 
predictability, and public confidence in the federal government’s 
ability to develop sound health and environmental policy.449 The 
initiative explicitly aspires to ensure that biotechnology product 
evaluations adhere to a “risk-based” system that is grounded in the 
“best science available.”450  
The White House initiative coupled with the findings in the 
most recent report by the NASEM on the status of GM crops 
suggests that the future regulatory landscape for GM crops will 
likely be less restrictive than its current incarnation. However, if 
the new approach to biotechnology is risk-based, how will 
CRISPR-mediated genome edited crops be regulated? In the near 
future, it will likely be increasingly cumbersome to distinguish a 
genome-edited crop from a naturally occurring crop. Therefore, 
technological advances in genome editing are likely to challenge 
the very essence of what constitutes a GMO. And, if that is where 
the technology is headed, should CRISPR GM crops be regulated 
at all? To shed some light on these questions, a hypothetical 
involving bananas and a fungus could be particularly illustrative. 
																																																								
 447 See, e.g., Gregory Conko et al., A Risk-Based Approach to the Regulation 
of Genetically Engineered Organisms, 34 NATURE BIOTECHNOLOGY 493 (2016). 
 448 See EXECUTIVE OFFICE OF THE PRESIDENT, Memorandum for Heads of 
Food and Drug Administration, Environmental Protection Agency, and 
Department of Agriculture: Modernizing the Regulatory System for 
Biotechnology Products (July 2, 2015), 
https://www.whitehouse.gov/sites/default/files/microsites/ostp/modernizing_the
_reg_system_for_biotech_products_memo_final.pdf. 
 449 Id. at 4. 
 450 Id. 
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A. Banana vs. Fungus—A Hypothetical 
Suppose a group of researchers is deeply concerned about 
bananas and their susceptibility to a crippling fungus.451 After 
many years of study, the researchers have finally discovered that 
the fungus secretes factors that bind to a small epitope site on a 
receptor of the plant’s cell membrane. Upon binding, a series of 
conformational changes occur in the receptor that make it easy for 
the pathogen to perforate the membrane and cause cell lysis, 
eventually leading to cell death. The researchers have further 
discovered that resistance to this deadly fungus occurs naturally in 
some populations of a distantly related crop. 
Using the latest technologies on high-throughput sequencing, 
bioinformatics, functional genomics, and molecular biology, the 
researchers have discovered that the receptor in banana cells is 
conserved across all plant species. Structural and biochemical 
information has revealed that the epitope site is less than five 
ångströms452 away from the active site of the receptor’s catalytic 
domain, and that mutating or deleting only one residue453 in the 																																																								
 451 In fact, the Cavendish banana—the most popular fruit in the world—is 
currently in danger of extinction in some parts of the world due to its 
susceptibility to the Tropical Race 4 fungus. See DAN KOEPPEL, BANANA: THE 
FATE OF THE FRUIT THAT CHANGED THE WORLD (2008); Dan Charles, Our 
Favorite Banana May Be Doomed; Can New Varieties Replace It? NPR (Jan. 
11, 2016), http://www.npr.org/sections/thesalt/2016/01/11/462375558/our-
favorite-banana-may-be-doomed-can-new-varieties-replace-it. The hypothetical 
presented is not reflective of the actual pathophysiology of the Tropical Race 4 
fungus disease and is merely based on the banana’s susceptibility to the disease 
for illustrative purposes. 
452 An ångström (Å) is a unit of length equal to 10–10 meters. 
 453 Mutations of only a few nucleotides in a gene can potentially lead to 
dramatic phenotypes. For instance, a naturally occurring mutation of only two 
amino acids (T102I and P106S) in the 5-enolpyruvylshikimate-3-phosphate 
synthase (EPSPS) gene confers resistance to glyphosate in Eleusine indica, a 
type of Indian grass. See Q. Yu et al., Evolution of a Double Amino Acid 
Substitution in the 5-enolpyruvylshikimate-3-phosphate Synthase in Eleusine 
indica Conferring High-Level Glyphosate Resistance, 167 PLANT PHYSIOLOGY 
1440 (2015). This phenomenon is not unique to plants. For instance, a single 
point mutation in human cells is responsible for the most common form of 
Cystic Fibrosis, which has been corrected using CRISPR-Cas9 genome editing 
in stem cells in vitro. See Gerald Schwank et al., Functional Repair of CFTR by 
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receptor protein prevents binding of the fungus factor altogether, 
thereby sparing the fate of the crop.  
FIGURE 3 
 
The molecular basis for herbicide resistance in GM crops—A 
glyphosate-resistant EPSPS (5-enolpyruvylshikimate-3-phosphate 
synthase) enzyme. X-Ray, crystal structure of the class I EPSPS from 
Escherichia coli in complex with ligands shikimate-3-phosphate (S3P, 																																																																																																																												
CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients, 13 
CELL STEM CELL 653 (2013). 
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green) and the broad spectrum herbicide glyphosate (represented by 
spheres) caged between the enzyme’s globular N-terminal (blue and 
orange) and C-terminal (red and cyan) domains. 454  The TIPS 
(T97I/P101S—Threonine97-to-Isoleucine and Proline101-to-Serine in E. 
coli—colored in purple) mutations confer glyphosate resistance by 
causing fine structural changes in the active site that inhibit optimal 
glyphosate binding without substantially compromising EPSPS 
catalytic efficiency.455 The figure appears in color in the online version 
of the Article.456 
 
The researchers transfected preassembled complexes of 
purified CRISPR-Cas9 and a sgRNA into banana protoplasts.457 
The CRISPR-Cas9 complexes induced recombinant DNA-free 
genome editing that generated small insertions or deletions that 
either deleted the lone residue essential for binding of the fungus 
factor, caused a point mutation that triggers misfolding and 
premature degradation of the protein, or introduced a stop codon 
that resulted in a truncated version of the receptor. With the 
exception of plants harboring the mutation that causes receptor 
misfolding and premature degradation—all of which exhibited 
arrested development—all other plants developed to maturity and 
																																																								
454 The model of this double mutant EPSPS was built using the atomic 
coordinates deposited in the Protein Data Bank, accession code 3FK1 (2009), 
http://www.rcsb.org/pdb/explore/explore.do?structureId=3FK1. 
455 Structural and biochemical details of the TIPS mutations as well as their 
impact on EPSPS efficiency and glyphosate resistance are discussed in Todd 
Funke et al., Structural Basis of Glyphosate Resistance Resulting from the 
Double Mutation Thr97 ! Ile and Pro101 ! Ser in 5-Enolpyruvylshikimate-3-
phosphate Synthase from Escherichia coli, 284 J. BIOLOGICAL CHEMISTRY 9854 
(2009). 
456 The online version can be accessed at the Journal’s website, ncjolt.org, by 
clicking on the “Articles” tab, Volume 18, Issue 4. 
 457  See KOEPPEL, supra note 451. A similar DNA-free genome editing 
approach was recently reported to introduce targeted mutations in various genes 
in Arabidopsis thaliana, tobacco, lettuce, and rice plants without using any 
recombinant DNA. See Je Wook Woo et al., DNA-Free Genome Editing in 
Plants with Preassembled CRISPR-Cas9 Ribonucleoproteins, 33 NATURE 
BIOTECHNOLOGY 1162 (2015). 
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are indistinguishable from wildtype458 plants. Furthermore, all the 
banana plants developed from the CRISPR-Cas9 genome editing 
experiment are immune to the fungus. Whole genome sequencing 
of the new mutants revealed that the only change in the entire 
banana genome was at the intended site, and that the mutations 
were the same as those found naturally in the distant crop that is 
resistant to the fungus. 
In summary, the researchers used CRISPR-Cas9 to introduce a 
point mutation in the banana receptor, which conferred resistance 
to the fungus. The mutant banana has zero foreign DNA, is 
genetically identical to all other bananas—but for the single 
residue mutation or truncation of the receptor protein—and 
contains mutations that have already been found to occur in nature 
and confer natural resistance to the fungus in another crop species. 
How should this new banana be regulated? 
B. Applying the Coordinated Framework to Reveal Regulatory 
Gaps 
Under a broad interpretation of the current Coordinated 
Framework, the new banana crop could arguably fall under the 
jurisdiction of the USDA, FDA, and EPA because it involves the 
genetic modification of a crop used in agriculture, grown with the 
expectation that it will be sold across interstate lines for human 
consumption, and comprising a substance that, in effect, acts as a 
pesticide against the fungus. 
However, because the crop was produced without addition of 
foreign DNA and introduced only a small insertion or deletion in 
the target gene, the USDA is likely to determine that the crop is not 
a regulated article or plant pest—pursuant to 7 C.F.R. § 340—as it 
has done with other CRISPR GM crops.459 Furthermore, because 
the mutation is naturally occurring in a distant plant, APHIS may 
declare that there is a miniscule risk for harm to U.S. agriculture 																																																								
458 Wildtype refers to the most common phenotype for an organism in a 
natural breeding population. BIOLOGY ONLINE, Wildtype, http://www.biology-
online.org/dictionary/Wildtype (last visited March 7, 2017). 
 459 See Yang, supra note 438; Schmidt, supra note 438. 
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that could justify impediments for transit of the crop through 
interstate commerce. 
An argument could be made that the crop should not be 
considered safe because it contains a mutation that, while found in 
nature in distant species, is novel in bananas. Accordingly, the 
researchers should seek a permit and a safety assessment should be 
performed. But this argument falters460 because the new banana 
mutation is of known function and does not result in plant 
disease.461 
Similarly, it would be unlikely that the FDA would determine 
that the new banana is an adulterated food product within the 
meaning of the FFDCA. 462  The single point mutation, which 
already occurs in nature and was characterized in the distantly 
related crop, is probably not going to trigger compositional 
changes in the food that would qualify it as a food additive that is 
injurious to human health.463 Given the (1) lack of foreign DNA 
sequences, (2) genome-wide similarities between the normal and 
the mutant bananas, (3) presumed lack of off-target effects from 
CRISPR-Cas9 genome editing,464 and (4) well-established status of 
the banana as a nutritious crop, it would be difficult to imagine that 
the FDA would impose roadblocks in the path to 
commercialization. 
The EPA could decide that the point mutation in the receptor is 
a plant-incorporated protectant or pesticide.465 However, because 
the genetic material needed to produce the purported pesticidal 
substance is endogenous to the plant and can be found in nature, 																																																								
 460 Suppose that the researchers subsequently find a region of the world in 
which the banana evolved natural resistance to the fungus resulting from the 
same mutation that was introduced with CRISPR-Cas9. Such a discovery would 
seriously undermine any arguments in favor of restrictions based on safety. 
 461 See 7 C.F.R. § 340.3(b) (2016). 
 462 21 U.S.C. § 342(a)(1) (2012). 
 463 § 321(s). 
 464 Off-target activity of CRISPR-based genome editing is an active field of 
scientific research. Significant improvements in this area have been made in the 
past three years. See, e.g., Seung Woo Cho et al., Analysis of Off-Target Effects 
of CRISPR/Cas-Derived RNA-Guided Endonucleases and Nickases, 24 GENOME 
RESEARCH 132 (2014). 
 465 See 40 C.F.R. § 152.3 (2016); 7 U.S.C. § 136 (2012). 
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the agency could likely find that the crop does not represent an 
“unreasonable adverse effect on the environment.”466 Moreover, 
under this specific scenario, the fungus is exclusively acting as a  
pest and its eradication would presumably pose no threat to the 
ecosystem. If the targeted species was an insect instead of a 
fungus, it may be necessary to assess the potential unreasonable 
adverse effects on the environment.467 
An additional factor that may favor deregulation of the banana 
crop comes from the unique requirement that, under FIFRA, 
EPA’s determination cannot be solely based on scientific data, but 
also on other economic, social, and environmental factors.468 This 
standard might strengthen the argument for deregulation given that 
the mutation is highly specific, characterized, and could potentially 
save an extremely important agricultural crop from the brink of 
extinction. Likewise, the EPA would probably issue an exemption 
to the registration requirements because the banana mutation poses 
a minimal risk to human and animal health, plants, or the 
environment.469 
The analysis would change slightly if the truncation, and not 
the point mutation, was the dominant effect from genome editing. 
It is possible that a non-functional, truncated receptor in a cell 
membrane would interfere with cellular pathways and other 
functional roles. If the truncation leads to accumulation of a 
particular protein that has allergenic potential, it could, in theory, 
represent a potential danger to human health or the environment. 
The problem under this scenario would be predicting such adverse 
effects, which are unlikely to occur.  
C. Regulatory Outlook and Policy Perspectives 
As is evident from the foregoing analysis, it is quite probable 
that certain types of CRISPR GM crops will escape regulation 
under the Coordinated Framework. However, perhaps the most 																																																								
 466 7 U.S.C. § 136a(a). 
467 Id. 
 468 See § 136(bb). 
 469 See 40 C.F.R. § 152.25(f) (2016). 
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interesting question is not how will CRISPR crops be regulated, 
but rather should they be regulated at all? 
If the banana crop is nearly identical to a naturally occurring 
cultivar and the mutation has been found in nature, it is puzzling to 
imagine the government treating the crop differently than one 
developed via traditional plant breeding methods. If anything, this 
banana would presumably be safer because any genetic changes 
made are probably very precise and their exact location is known. 
1. The Worlds of Science and Policy 
For better or worse, issues concerning the contours of 
regulatory oversight and policy making cannot be resolved in a 
scientific vacuum, in which the sole and primary considerations 
necessary to adjudicate controversies orbit the relevant scientific 
facts and evidence. Quite the contrary, the process of developing 
policy is inherently complex and dependent on a multitude of 
factors—e.g., legal, economical, social, political, and others.470 In 
fact, studies suggest that scientific-based evidence is often eclipsed 
by other considerations, and those who develop and promote 
model public health laws—laws or private policies publicly 
recommended by organizations for adoption by government bodies 
or private entities—frequently provide scant information about the 
methods and evidence used in developing such laws.471  This policy 
“reality” can be difficult to grasp for many scientists and advocates 
of strict science-based law and policy making who are routinely 
dismayed when law and policies eschew scientific evidence. 																																																								
470 See, e.g., MASON A. CARPENTER & SANJYOT P. DUNUNG, CHALLENGES 
AND OPPORTUNITIES IN INTERNATIONAL BUSINESS V. 1.0 67, 73 (2012), 
http://2012books.lardbucket.org/pdfs/challenges-and-opportunities-in-
international-business.pdf (linking some of these factors to global trade); Andy 
Norton & Diane Elson, What’s Behind the Budget? Politics, Rights and 
Accountability in the Budget Process 5 (2002), 
https://www.odi.org/sites/odi.org.uk/files/odi-assets/publications-opinion-
files/2422.pdf (connecting similar factors to budgetary policy). 
471 See, e.g., DeKeely Hartsfield et al., A Review of Model Public Health Laws, 
97 AM. J. PUB. HEALTH S56, S59 (2007) (revealing findings from a study of 107 
model public health laws published between 1907 and 2004 in which only 7 
(6.5%) of the 107 sponsors provided scientific information to support the laws). 
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Consider, for example, a scenario in which the CRISPR banana 
illustrated earlier is commercially viable but threatens a select few 
local economies because producers are suddenly unshackled from 
considerable expenditure of resources associated with the non-GM 
version of the crop. Technological advances may save the banana 
from extinction, but impose high social costs such as job losses for 
hundreds or thousands of workers that irrigate fields with 
pesticides and fungicides, perform labor on the land, and remove 
individual plants when signs of infection appear.472 
Social, economic, and political costs may not rank at the top of 
scientists’ concerns, but considering those costs is likely a pivotal 
task for elected public officials and other policy makers who must 
answer to their constituents.  
Although scientists and policy makers can sometimes share 
common interests and goals, they largely operate on a myriad of 																																																								
472 This scenario is not far from the actual tensions between heeding scientific 
recommendations and weighing other non-scientific factors. For instance, 
President Donald Trump recently signed an Executive Order to “review existing 
regulations that potentially burden the development or use of domestically 
produced energy resources and appropriately suspend, revise, or rescind those 
that unduly burden the development of domestic energy resources beyond the 
degree necessary to protect the public interest or otherwise comply with the law.” 
Exec. Order No. 13,782, 82 Fed. Reg. 16,093 (Mar. 27, 2017). 
The Executive Order is seen by many as an effort to roll back climate change 
policies implemented during the Obama Administration. See, e.g., Doral 
Davenport & Alissa J. Rubin, Trump Signs Executive Order Unwinding Obama 
Climate Policies (Mar. 28, 2017), 
https://www.nytimes.com/2017/03/28/climate/trump-executive-order-climate-
change.html?_r=0. Critics of the recent move to curb such policies argue that the 
Trump Administration is favoring the coal industry and other energy interest 
groups over scientists’ warnings concerning a “future of severe droughts, floods, 
rising sea levels and food shortages” as a result of climate change. Id. 
Trump’s comments during the Executive Order’s signing ceremony illustrate 
the significance that non-scientific factors play in developing national policy. At 
the conclusion of his speech, he addressed a group of coal miners present at the 
ceremony and remarked: “Come on, fellas. Basically, you know what this is? 
You know what it says, right? You’re going back to work.” Donald Trump, U.S. 
President, Remarks at Signing of Executive Order to Create Energy 
Independence (Mar. 28, 2017), https://www.whitehouse.gov/the-press-
office/2017/03/28/remarks-president-trump-signing-executive-order-create-
energy. 
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distinct functional systems of accountability, career development, 
research methodology, and problem-solving. Scientists—and 
scholars in general—are typically interested in pushing the 
boundaries of knowledge and drawn to questions of theoretical or 
empirical value to them.473 They are accountable under a system of 
peer-review and advance their careers by publishing work that will 
impress others in their field.474 There often is no reward system for 
scientists to engage in policy development. 475  Involvement in 
controversial policy debates may actually be detrimental to 
scientists’ careers by making them subject to personal attacks476—
which, unlike politicians, scientists are not sufficiently inured to—
or impacting their ability to secure funding for their work via 
research grants.477 Accordingly, it is no surprise that scientists 
seldom engage in policy development. 
Policy makers, on the other hand, have little to no interest in 
the types of theoretical or empirical inquiries that fuel scientists’ 
endeavors.478 They value research, but usually only if it serves as a 
tool to tackle problems their constituents face.479 Policy makers are 
held accountable at the voting ballot, either directly or indirectly 
depending on whether they are elected officials or appointed by 
them. This system of accountability guarantees that individuals in 
charge of policy development will give great weigh to public 
opinion, particularly when an issue receives considerable attention 
in the media.480 Indeed, research suggests that when confronted 
with a tough policy issue, policy makers seldom turn to published 																																																								
473 David N. Plank & Debbi Harris, Minding the Gap Between Research and 
Policymaking, in THE SAGE HANDBOOK FOR RESEARCH IN EDUCATION: 
ENGAGING IDEAS AND ENRICHING 38 (Clifton F. Conrad & Ronald C. Serlin eds., 
2006).  
474 Id. 
475 Ross C. Brownson et al., Researchers and Policymakers: Travelers in 
Parallel Universes, 30 AM. J. PREVENTIVE MED. 164, 167 (2006). 
476 Id. 
477 See, e.g., Keelie Lyn Elektra Murdock & David Koepsell, Principals, 
Agents, and the Intersection Between Scientists and Policy-Makers: Reflections 
on the H5N1 Controversy, 2 FRONTIERS PUB. HEALTH art. 109, at 3 (2014). 
478 Plank & Harris, supra note 473, 38. 
479 Id. 
480 Id. 
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literature.481 Instead, they often turn to their constituents, a group 
that may include lobbyists and other interests groups.482 The end 
result of this process is that policy makers can adopt policies that 
exhibit little regard, or run contrary to, scholarly and scientific-
based research.483 
2. Promoting Research- and Scientific-Based Policy Development 
There are several obstacles to developing scientific-based 
public policy in the realm of GMOs. Perhaps the most intractable 
impediment is overcoming the breed of hyper sensationalism—i.e., 
deceptive simplicity484—that can sometimes flourish within public 
opinion, which flows directly from the public’s lack of education 
about the science concerning GMOs in general, and GM foods in 
particular. A potentially effective strategy to ameliorate this 
problem is to develop policies that aim to tackle a range of 
seemingly peripheral, but fundamentally central, areas surrounding 
regulation of GMOs and technological advances in general. 
 2.1 Facilitate Transparency in the Regulatory Process 
The bulk of opposition to GMOs in the public discourse stems 
primarily from perceptions that corporate conglomerates with 
ulterior motives control the output of scientific research available 
on the health and safety risks of GMOs.485 As pointed out in Part 
III, evidence suggests that a vast majority of the peer-reviewed 
studies on the safety of GMOs do not actually corroborate 
conspiracy theories about insidious links between the research 
published by scientists all over the world and corporate efforts to 
undermine public health and the environment. However, it is also 																																																								
481 See, e.g., Richard Sorian & Terry Baugh, Power of Information: Closing 
The Gap Between Research and Policy, 21 HEALTH AFF. 264, 269 (2002). 
482 Id. 
483 Plank & Harris, supra note 473, at 39. 
484 “Deceptive simplicity” is as an umbrella term used to refer to common 
substantive impediments to constructive debate that consist of impractical and 
often sensationalist claims about issues raised by scientific and technological 
advances. See Enríquez, supra note 1, at 614–16. 
485 See supra Section III.A.3. 
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true that many peer-reviewed studies—both in favor and in 
opposition of GMOs—are published by authors with some industry 
ties.486 
Given the highly charged controversies surrounding GMOs in 
recent years, it would be beneficial for industry and government 
agencies to work together to formulate and implement policies that 
make more scientific health and testing data public. Publication of 
these data would involve a careful and delicate balance between 
(1) protecting intellectual property rights—e.g., trade secrets—and 
confidential business information (“CBI”) of producers of GM 
crops, and (2) ensuring adequate disclosure of health and safety 
data to the public.487 
In general, the law permits companies to avail themselves of 
the right to claim some or all of data submitted to regulatory 
agencies as CBI.488 However, the 1990 case concerning the use of 
recombinant bovine growth hormone (rbGH) in dairy cattle489 set a 
unique, and presumably limited, precedent for a federal regulatory 
agency’s decision to publish scientific information used in the 
safety evaluation of a product prior to its approval. In that case, the 
FDA decided to publish a summary of the relevant health and 
safety data to address public concerns about potential hazards from 
the use of rbGH that had been reported in the media.490 Although 
the FDA’s decision to make the data public did not put to rest all 
controversies surrounding rbGH,491 it brought an increased level of 
transparency to the regulatory process. Industry players and policy 
makers should consider the rbGH case as a potential precursory 																																																								
486 See supra note 270. 
487  Rena Steinzor and Matthew Shudtz, Sequestered Science: Secrets 
Threatening Public Health, CTR. FOR PROGRESSIVE REFORM 1 (Apr. 2007), 
http://www.progressivereform.org/articles/Secrecy_703.pdf. 
488 Id. at 5.  
489 See generally Judith C. Juskevich & C. Greg Guyer, Bovine Growth 
Hormone: Human Food Safety Evaluation, 249 SCIENCE 875 (1990). 
490 Id. 
491 See Richard Raymond et al., Recombinant Bovine Somatotropin (rbST): A 
Safety Assessment, NAT’L ANIMAL INTEREST ALL. 14–15 (Mar. 22, 2010), 
http://www.naiaonline.org/uploads/WhitePapers/RecombinantSomatotropinASa
fetyAssessment2010.pdf. 
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model that can be tweaked to educate and allay public concerns 
surrounding select biotechnologies.492 
2.2 Disclose Conflicts of Interest 
The concern engendered by the appearance of deep-seated 
conflicts of interests as perceived by many who oppose GMOs is 
not entirely unreasonable. After all, history has shown that in some 
instances powerful corporate entities—as well as the individuals 
who lead them—can act unethically and put financial interests 
ahead of their social responsibilities to the public. A notorious 
example is the case of the tobacco industry—circa the early 
1950s—and the smear campaign it launched in response to the 
peer-reviewed scientific evidence and consensus that had 
crystallized around the deleterious health hazards of smoking.493 																																																								
492 On the topic of transparency, The NASEM Report recommended that GM 
crop producers publicly disclose as much health and safety data submitted to 
regulatory agencies during the approval process as possible, and that regulatory 
exemptions from disclosure should be as narrow as possible. See NASEM 
REPORT, supra note 211, at 506. However, the NASEM did not elaborate or 
provide guidance regarding what constitutes a narrow exemption, which would 
ultimately be an issue of law. Furthermore, the amount of information a 
corporation deems to fall under an “as much as possible” category for purposes 
of voluntary disclosure is likely to be substantially different from the amount of 
information that a regulatory agency, or even the public in general, will deem 
appropriate to disclose. A recommendation without some degree of specificity is, 
therefore, likely to vanish in rhetorical quicksand. Accordingly, this Article goes 
a step further and recognizes that industry and government agencies could use 
the rbGH case as a starting point to delineate the contours of the relationship 
between data disclosure and regulatory exemptions that take into account the 
interests of GM crop developers and the public. 
493 See Allan M. Brandt, Inventing Conflicts of Interest: A History of Tobacco 
Industry Tactics, 102 AM. J. PUB. HEALTH 63 (2012). Curiously, the case of the 
tobacco industry involved a powerful lobby deploying an arsenal of strategies 
designed to undermine the legitimacy of scientific research, engineer 
controversies about purported conflicts of interest, and generate public 
skepticism of science by calling for more research and offering funding as a 
public relations plot. Id. In contrast, GMO-related controversies in the last 
decade or so are propelled mainly by activist organizations that defy powerful 
corporations that seek to commercialize the production of GM crops. 
Although not exactly analogous, there are commonalities between the two 
cases. The legitimacy of scientific evidence is at the core of both controversies. 
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The infamous Volkswagen affair also comes to mind.494 The auto 
maker recently agreed to plead guilty to federal conspiracy charges 
to defraud the United States government and pay a record $ 4.6 
billion fine for selling vehicles with software designed to cheat 
pollution laws.495 Given some high profile corporate scandals in the 
last decades, it is no surprise that some segments of the public may 
distrust powerful interests and corporations. 
To mitigate some of the controversies associated with either 
the existence or appearance of conflicts of interest in scientific 
research, policy makers and scientific publishers should promote 
full disclosure of all potential conflicts in scientific publications. 
Because the appearance of a conflict of interest can damage a 
journal’s reputation, publishers ought to require disclosure of all 
competing interests—financial, political, institutional, personal, 
etc.496 
Journals may enforce this policy by issuing special corrections 
for inadvertent omissions, and imposing fines or banning repeat 
offenders from publishing work in the journal and its affiliates. 
Government agencies should implement strict guidelines outlining 
compulsory disclosure of any possible conflicts of interest for 
specified periods of time—e.g., sources of funding that may raise 
conflicts for the three, five, or seven years preceding the published 
research. The guidelines should further explicitly communicate 
consequences for failing to disclose conflicts, which could include 																																																																																																																												
However, unlike the case of the tobacco industry—in which the corporations 
tried to undermine the science that had accumulated on the health risks of 
tobacco—biotechnology corporations now seek shelter in the peer-reviewed 
scientific evidence, while activist entities dismiss the peer-reviewed scientific 
consensus and promote public skepticism by calling for more research to be 
performed on the health impacts of GMO consumption. See supra Section 
III.A.3. 
494 Nathan Bomey, VW Pleads Guilty to Conspiracy, Obstruction of Justice; 6 
Execs Charged, USA TODAY (Jan. 11, 2017, 6:26 PM), 
https://www.usatoday.com/story/money/cars/2017/01/11/volkswagen-epa-doj-
department-of-justice-settlement/96439678/. 
495 Id. 
496 Conflict of Interest in Peer-Reviewed Medical Journals, WORLD ASS’N OF 
MEDICAL EDITORS (Jul. 25, 2009), http://www.wame.org/about/conflict-of-
interest-in-peer-reviewed-medical. 
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a mix of penalties, requirements to enroll and attend ethics 
seminars, or even temporary banning repeat offenders from 
applying for government grants. 
Adhering to clear and robust conflict of interest policies can 
help scientists defend the integrity of their work. For instance, 
shortly after the NASEM Report was released, a study criticized 
some members of the committee for not disclosing apparent 
financial and institutional conflicts of interest.497 The study claimed 
that the NASEM failed to follow disclosure requirements set forth 
in the Federal Advisory Committee Act.498 The NASEM quickly 
responded to the allegations by pointing out that it has “a stringent, 
well-defined, and transparent conflict-of-interest policy, with 
which all members of [the] study committee complied[,]” and that 
“its report underwent the Academies’ usual rigorous, external, and 
anonymous peer-review process before it was approved for 
publication.”499 The NASEM further characterized the authors of 
the study and its conclusions as “unfair and disingenuous” for 
applying “their own perception of conflict of interest . . . in place 
of [] tested and trusted conflict-of-interest policies.”500 
2.3 Develop Policies to Promote Dedicated Grants 
Another potential strategy that could impact the advancement 
of scientific-based policy development in the realm of GMOs is to 
promote policies that erect a buffer zone between industry and 																																																								
497 Sheldon Krimsky & Tim Schwab, Conflicts of Interest Among Committee 
Members in the National Academies’ Genetically Engineered Crop Study, 12 
PLOS ONE e0172317 (2017). 
498 Id. 
499  Statement by the National Academies of Sciences, Engineering, and 
Medicine Regarding PLOS ONE Article on Our Study of Genetically Engineered 
Crops, NAT’L ACADS. SCIS., ENG’G, & MED. (Mar. 1, 2017), 
http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=31201
7b&utm_source=NASEM+News+and+Publications&utm_campaign=049bfc0b
62-NAP_mail_new_2017-03-
06&utm_medium=email&utm_term=0_96101de015-049bfc0b62-
101937173&goal=0_96101de015-049bfc0b62-
101937173&mc_cid=049bfc0b62&mc_eid=d85449f0d2. 
500 Id. 
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scientific research. Independent researchers at public universities 
and non-profit institutions must sometimes rely on private industry 
players for sources of funding due to scarcity of government funds 
or programs. This, in turn, leads to perceived or apparent conflicts 
of interest between the researchers and their funders.501 
To address this problem, policy makers should consider the use 
of dedicated grants to encourage independent study of the short- 
and long-term effects of GM food consumption. For instance, the 
State of Washington recently appropriated funds for a Dedicated 
Marijuana Account to study the short- and long-term health effects 
of marijuana use as part of Initiative 502 (“I-502”). 502  I-502 
provides research funds for proposals awarded under a peer-review 
process on the basis of scientific merit.503 
The National Institute of Food and Agriculture and the USDA 
also jointly administer the Biotechnology Risk Assessment 
Research Grants (BRAG) program.504 The BRAG program was 
created to “support the generation of new information that will 
assist Federal regulatory agencies in making science-based 
decisions about the environmental effects of introducing organisms 
genetically engineered [] by recombinant nucleic acid 
techniques.”505 However, funding for BRAG is currently limited to 
roughly $ 4 million in fiscal year 2017, which means the program 
is limited in reach.506 Similar programs of dedicated grants could be 
instituted by other federal and state agencies to support increased 
independent research on the potential long-term effects of GMOs 
consumption. 																																																								
501 See supra Section VI.C.2.2.2 and accompanying text. 
502 Guidelines for ADAI Small Grants with I-502 Marijuana, ALCOHOL & 
DRUG ABUSE INST., 
http://adai.uw.edu/grants/Small%20Grants%20Guidelines%20Marijuana%20FI
NAL.pdf (last visited Apr. 14, 2017).  
503 Id. 
504  Biotechnology Risk Assessment Research Grants Program, U.S.D.A., 
https://nifa.usda.gov/sites/default/files/rfa/FY2017%20Biotechnology%20Risk
%20Assessment%20Research%20Grants%20Program%20%28BRAG%29%20
RFA.pdf. 
505 Id. at 4. 
506 Id. at 12. 
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Admittedly, developing such policies can be difficult in an 
ever-increasing political environment of budgetary cuts to 
scientific research. 507  However, from a science-based policy 
perspective, it may be worthwhile in the long-run for policy 
makers to consider all avenues to develop policies to support 
independent scientific research. For instance, to pay for its 
dedicated grants program, the State of Washington designated the 
Liquor and Cannabis Board as the regulatory entity in charge of 
collecting “marijuana excise taxes, license fees, penalties, 
forfeitures, and all other moneys including income, or revenue 
received [from] marijuana-related activities.”508 
2.4. Incorporate Modern Technologies, When Feasible, and 
Promote Technology Development 
A fundamental question regarding crops developed via 
traditional breeding methods and transgenic crops containing 
recombinant DNA material is the degree to which changes in the 
crop’s genome may ultimately render the plant hazardous to 
humans.509 As detailed in Part II, GMOs are produced using non-
recombinant, as well as recombinant, DNA methods.510 However, 
the current regulatory scheme under the Coordinated Framework 
only requires health and safety testing of crops produced through 
recombinant DNA technology, despite the fact that both categories 
of making GMOs can lead to unintended changes in the plant’s 
genome.  
Although a large body of peer-reviewed literature concerning 
the health and environmental safety of GMOs has accumulated in 
the past two decades,511 it is important to recognize that human 
knowledge is not absolute and we may continue to learn more 																																																								
507 See, e.g., NIH, DOE Office of Science Face Deep Cuts in Trump’s First 
Budget, SCIENCE (Mar. 16, 2017), 
http://www.sciencemag.org/news/2017/03/nih-doe-office-science-face-deep-
cuts-trumps-first-budget. 
508 H.B. 2136, 2015 Leg. 2d Spec. Sess. (Wash. 2015). 
509 See supra Part II. 
510 Id. 
511 See supra Part III. 
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about the science behind GM crops as technological improvements 
in methods of detection and statistical analysis in the realm of 
“omics”512 disciplines occur. 
Already, a wealth of information has been compiled about the 
equivalence of GM crops compared to their near isogenic513 non-
GM counterparts.514 Many of the omics assessments performed to 
date reveal that GM crops do not raise safety concerns relative to 
non-GM crops, even when some compositional differences, which 
are within the range of expected natural variation due to 
environmental growth conditions, are detected. 515  Despite the 
advantages and potential uses of emerging omics technologies as 
powerful research tools, mandatory requirements of omics safety 
assessments of GM crops are not appropriate at this point in time 
given the early stage of some omics tools, which can be susceptible 
to bias, experimental design flaws, and statistical errors.516 																																																								
512 Omics is a term that refers to the study of “the collective characterization 
and quantification of pools of biological molecules that translate into the 
structure, function, and dynamics of an organism or organisms.” Omics, 
WIKIPEDIA, https://en.wikipedia.org/wiki/Omics. This discipline concerns the 
large-scale interactions, relationships, and networks within biological systems. 
Thus, for example, genomics is the large-scale study of the genomes of 
organisms, proteomics is the large-scale study of proteins produced by 
organisms, and metabolomics is the large-scale study of metabolites produced 
from cellular processes. Id. 
513 A near isogenic line refers to a strain of an organism—e.g., a plant—that 
has a near identical genetic composition, but for a few specific differences at 
certain genomic loci. Guangdi Yuang et al., Development of Near-Isogenic 
Lines in a Parthenogenetically Reproduced Thrips Species, Frankliniella 
occidentalis, 8 FRONTIERS PHYSIOLOGY art. 130, at 1 (2017) (citations omitted). 
514 See, e.g., Agnès E. Ricroch et al., Evaluation of Genetically Engineered 
Crops Using Transcriptomic, Proteomic, and Metabolomic Profiling Techniques, 
155 PLANT PHYSIOLOGY 1752, 1753–57 (2011). But cf. Robin Mesnage et al., 
An Integrated Multi-Omics Analysis of the NK603 Roundup-Tolerant GM Maize 
Reveals Metabolism Disturbances Caused by the Transformation Process, 6 
SCIENTIFIC REPS. art. no. 37855, at 1 (2016) (using a multi-omics approach to 
compare a widely commercialized GM crop and its non-GM isogenic line, and 
concluding that the two lines are not “substantially equivalent” in terms of 
nutritional and compositional content). 
515 Ricroch et al., supra note 514, at 1755, 1757–59.  
516 See generally Jackson O. Lay Jr. et al., Problems with the “Omics”, 25 
TRENDS ANALYTICAL CHEMISTRY 1046 (2006); Ricroch et al., supra note 514, 
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However, as technological advances in omics disciplines 
accrue and gaps in methodology and statistical analysis begin to 
close, policy makers ought to develop policies that encourage 
researchers and GM crop developers to incorporate modern 
technologies—including high-throughput whole-genome 
sequencing (“WGS”), mass spectrometry, chromatin 
immunoprecipitation followed by sequencing (“ChIP-Seq”), 
Bisulfite sequencing, RNA sequencing, and others—in their 
research, so long as these tools do not pose undue financial 
burdens.517 Fortunately, the use of modern technologies is unlikely 
to be a burden on all major GM crop producers. 
Consider the downward trend in genome sequencing costs over 
the past decade and a half. Estimates of the total cost to sequence 
the first human genome at the dawn of the twenty first century 
range from half a billion to one billion dollars.518 By 2006, the cost 
had dropped to roughly between twenty and twenty-five million 
dollars.519 Today, that figure has dropped to approximately 1,000 to 
1,500 dollars.520 
Given the increasing accessibility of these technologies, it may 
be prudent, in the near future, to require GM crop producers to 
submit omics data to corroborate their products’ “substantial 
equivalence” 521  to crops developed via traditional breeding 																																																																																																																												
at 1757–58. See also NASEM REPORT, supra note 211, at 395 (stating that, in 
order to realize the full potential of omics technologies, “a more comprehensive 
knowledge base of plant biology at the systems level (DNA, RNA, protein, and 
metabolites) should be constructed for the range of variation inherent in both 
conventionally bred and genetically engineered crop species.”) 
517 Note that some in the scientific community have criticized the idea of 
introducing policy proposals that require the use of high-throughput “omics” 
technologies in GM crop regulation because the state of the technology is not 
fully developed, and there is not enough information as of yet to correlate omics 
patterns to specific traits. See L. Val Giddings & Henry Miller, US National 
Academies Report Misses the Mark, 34 NATURE BIOTECHNOLOGY 1226, 1227 
(2017). 
518 The Cost of Sequencing a Human Genome, NAT’L HUMAN GENOME RES. 
INST. (Jul. 6, 2016), https://www.genome.gov/sequencingcosts/. 
519 Id. 
520 Id. 
521 “Substantial equivalence” refers to the concept that “an assessment of a 
novel food, in particular one that is genetically modified, should demonstrate 
534 N.C. J.L. & TECH. [VOL. 18: 432 
methods when seeking approval before regulatory agencies. Policy 
makers should weight the benefits and costs of imposing such a 
requirement, which would inevitably add a regulatory burden on 
developers in the short-term,522 but may help to allay the type of 
fervid controversies concerning GM products in recent times. It 
may also be in the interest of GM crop producers to make that 
information publicly available to demonstrate to the general public 
that GM crops are indeed virtually indistinguishable from 
traditional crops.     
Lastly, it is important to point out that promoting policies for 
omics technology development could present new opportunities to 
reassess what constitutes “substantial equivalence,” and whether 
the concept in its current incarnation is an adequate standard for 
GM crop production safety assessments.523 																																																																																																																												
that the food is as safe as its traditional counterpart.” Substantial Equivalence, 
OECD, https://stats.oecd.org/glossary/detail.asp?ID=2604. It was first 
introduced in 1993 by the Organization for Economic Co-operation and 
Development. Id. The concept has since been adopted as a global standard for 
GM food safety assessment by many national and international agencies, 
including the United States FDA. Substantial Equivalence in Food Safety 
Assessment, COUNCIL FOR BIOTECHNOLOGY INFORMATION (2001), 
http://thebeuselaer.weebly.com/uploads/6/3/8/4/6384873/substantial_equivalenc
e.pdf. 
522 Policy makers must also weigh the potential effects of those regulatory 
burdens on small businesses and farmers, which may not be able to compete 
with corporate conglomerates in an undue regulatory environment. 
523 In the past, the concept of substantial equivalence has been characterized as 
unscientific, arbitrary, and intentionally vague by some critics. Compare Erik 
Millstone et al., Beyond ‘Substantial Equivalence,’ 401 NATURE 525, 525–26 
(1999) (arguing that “substantial equivalence has never been properly defined” 
and “is a pseudo-scientific concept because it is a commercial and political 
judgment masquerading as if it were scientific.”) and Mae-Wan Ho & Ricarda A. 
Steinbrecher, Fatal Flaws in Food Safety Assessment: Critique of the Joint 
FAO/WHO Biotechnology and Food Safety Report, THIRD WORLD NETWORK, 1, 
23 (2002), http://www.twn.my/title2/biosafety/pdf/bio01.pdf (characterizing the 
principle as “unscientific,” “arbitrary,” and “intentionally vague and ill-defined 
so as to be as flexible, malleable and open to interpretation as possible.”), with 
Harry A. Kuiper et al., Substantial Equivalence—An Appropriate Paradigm for 
the Safety Assessment of Genetically Modified Foods?, 181–82 TOXICOLOGY 
427, 430 (2002) (opining that “[t]he concept of substantial equivalence is an 
adequate tool in order to identify safety issues related to genetically modified 
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Case in point, a recent omics study of GM maize and its 
isogenic non-GM counterpart reported that the nutritional and 
compositional contents of the two crops were not substantially 
equivalent and, thus, argued that the commonly used standard 
should not be used as proof of safety.524 Of course, finding a 
compositional difference in a food or crop is not prima facie 
evidence of a safety risk.525 However, although the study indicated 
that a clear mechanistic link between food compositional 
differences and deleterious health effects of long-term 
consumption of the GM crop have not been established,526 anti-
GMO outlets rushed to sensationalize the report by claiming it 
reveals “serious safety implications” related to the toxic and 
carcinogenic effects of GMOs. 527  The study was promptly 
criticized by many in the scientific community for, inter alia, 
having inadequate statistical modeling, including flawed 
experimental designs, and confusing statistically significant with 
biologically significant differences.528 
Without clear guidance on precisely what constitutes 
substantial equivalence 529  among crop varieties, and necessary 																																																																																																																												
products that have a traditional counterpart. It is not a safety assessment 
procedure per se.”). 
524 See Mesnage et al., supra note 514, at 6. The study was co-authored by 
Gilles-Eric Séralini, who has published a string of anti-GMO reports in recent 
years. See Relevant Research, supra note 253 (providing a compilation of 
research published by Séralini and colleagues purportedly linking GMOs, or the 
use of GMO-related chemicals, to a range of deleterious cellular and 
physiological outcomes in animal in vitro and in vivo studies). 
525 See NASEM REPORT, supra note 211, at 511.	
526 Mesnage et al., supra note 514, at 10. 
527 See, e.g., Why You Should Really Think Twice About Eating GMO Corn, 
ALTERNET, http://www.alternet.org/food/new-study-raises-questions-about-
safety-eating-gmo-corn. 
528 See, e.g., Expert Reaction to Multiomics Analysis of NK603 GM Maize, 
SCIENCE MEDIA CENTRE, http://www.sciencemediacentre.org/expert-reaction-to-
multiomics-analysis-of-nk603-gm-maize/; Séralini Paper: Molecular Analysis 
Shows GMO Corn Differs from Non-GMO—Is Difference Meaningful?, 
GENETIC LITERARY PROJECT,  
https://geneticliteracyproject.org/2016/12/21/seralini-paper-molecular-analysis-
shows-gmo-corn-differs-non-gmo-difference-meaningful/. 
529 Although the FDA has broad discretion to make determinations about the 
safety and effectiveness of products under its regulatory oversight, courts have 
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improvements in omics technologies discussed earlier in this 
Section, increased controversy over the complex meaning of 
substantial equivalence could ultimately fuel litigation. 
Accordingly, technological progress in omics tools could lead to 
significant developments for the implementation of the substantial 
equivalence standard. 
CONCLUSION 
CRISPR GMOs are poised to fundamentally change how 
humans perceive the future of food production. Unlike previous 
technological advances in crop transgenesis, which have been rife 
with issues concerning random insertion of foreign DNA material 
from the start, CRISPR-based genome editing has proven to be 
highly efficient and precise at modifying the genetic composition 
of plants intended for human consumption. Remarkably, new 
CRISPR crops can be produced without the need for foreign DNA 
material. This scientific fact raises interesting issues about the 
ability of the Coordinated Framework for the Regulation of 
Biotechnology to provide adequate regulatory oversight of the 
potential health and environmental safety effects—if any— 
concerning this new breed of GMOs. 
In the coming years, CRISPR technologies will offer a 
meaningful opportunity to engage the public, developers of 
biotechnology products, and law and policy makers in discussions 
about how genetic engineering in general, and genome editing in 
particular, can be used to the benefit or detriment of society. As 
discussed throughout this Article, issues concerning regulatory 
oversight and policy making cannot be resolved in a scientific 																																																																																																																												
not always been “entirely comfortable with the FDA’s interpretation of 
‘substantial equivalence.’” General Medical Co. v. FDA, 770 F.2d 214, 217 n.1 
(D.C. Cir. 1985). In General Medical, a case involving a petition of 
reclassification of an antiperspirant device, the D.C. Circuit Court of Appeals 
acknowledged that “[t]he determinations of safety and effectiveness are clearly 
crucial considerations in the classification of devices,” but expressed concerns 
that FDA arguments may “require [the Court] to make a hop and a skip of faith 
from the safety-and-effectiveness provisions to the classification provisions to 
the substantial-equivalence provisions.” Id.	 
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vacuum, in which the sole and primary considerations necessary to 
adjudicate controversies orbit the relevant scientific facts and 
evidence. Sociopolitical, economical, and legal concerns are 
pivotal in shaping policy. And it is in the interest of scientists and 
GM crop developers to recognize how these factors can play 
crucial roles in promoting scientific-based public policy.530 
“Science is not democratic.”531 The truth about established 
scientific facts is neither susceptible to, nor dependent on, public 
referenda. However, a majority of the scientific research around 
the world takes place in countries where democracy guarantees the 
right to vote, even for people who are not well educated in 
scientific matters. As a result, scientific progress—regardless of 
whether it is meritorious and seeks to address human problems—
depends heavily on societal support and can be stifled by undue 
public concerns. 532  Opposition to scientific advances based on 
public misperceptions about scientific facts can suppress or even 
halt progress altogether. Legal challenges can cripple entire 
industries and make it difficult to bring technologies to market. 
Thus, failure to meaningfully engage the public through education 
while dismissing opposing viewpoints533 can be very costly for the 
development of scientific-based policies.  
Significant legal issues surrounding CRISPR-based 
technologies are looming in the horizon. For instance, complex 
																																																								
530 See supra Section VI.C.	
531 Giddings & Miller, supra note 517, at 1227.  
532 See, e.g., Found. on Econ. Trends v. Heckler, 756 F.2d 143, 146 (D.C. Cir. 
1985) (enjoining the University of California from conducting a “deliberate 
release experiment” to delay field testing of genetically altered bacteria on select 
crops after environmental groups filed suit against federal officials for alleged 
NEPA violations). 533	For instance, an article recently criticized the NASEM for not overtly 
backing genetically engineered crops, while devoting time to examine the value 
of scientific studies that depart from the consensus regarding the health and 
environmental safety of GM crops. See Giddings & Miller, supra note 517, at 
1226 (arguing that the NASEM “[R]eport’s efforts to give credence to 
alternative  viewpoints—rather like the media’s obsession with giving two sides 
of an argument equal play, irrespective of which view is supported by the 
evidence—is puzzling [and] . . . damaging.”).	
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global problems 534  related to the national and international 
governance of CRISPR GMOs are likely to exert effects on current 
intellectual property, international trade, and foreign investment 
regimes. Regulatory agencies will decide whether statutory 
authority grants them jurisdiction to develop and promulgate rules 
for genome-edited crops, and whether the crops fall under the 
purview of new GMO labeling laws. 535  Issues of statutory 
interpretation—e.g. substantial equivalence—may be the subject of 
litigation as new methods of detection and statistical analysis 
mature and become routine in the safety assessment of new crop 
varieties. There is much the legal community can contribute to this 
emerging field. 
On the basis of the scientific evidence available to date, this 
Article recommends that genome-edited crops should not be 
subject to the same laws governing traditional GM crops derived 
via recombinant DNA techniques. 536  Accordingly, the Article 																																																								
534 Enríquez, supra note 44, at 1269, 1336.  
535 The USDA has declared that at least two CRISPR crops do not fall under 
APHIS jurisdiction pursuant to 7 C.F.R. § 340. See Yang, supra note 438; 
Schmidt, supra note 438. However, the FDA and EPA have yet to make similar 
determinations about the regulatory status of CRISPR crops. Whether CRISPR 
GMOs are treated as GM or non-GM products will delineate the scope and reach 
of new GMO labeling laws. 
536 To be clear, this Article advocates for the deregulation of genome-edited 
crops based on the analysis for the hypothetical model discussed in Sections 
VI.A–B, which focused primarily on the case of DNA-free, CRISPR-based 
genome editing. In the hypothetical, CRISPR-Cas9-sgRNA was delivered into 
plant protoplasts as a ribonucleoprotein complex—i.e., the Cas9 protein and the 
sgRNA were preassembled in vitro before transfection—which guarantees that 
the CRISPR-Cas9-sgRNA complex will be degraded shortly after triggering the 
target DNA cuts within cells. 
There are other methods—e.g., A. tumefaciens-mediated transformation, non-
integrating plasmids, etc.—that can be used to deliver the CRISPR-Cas9 
endonuclease and sgRNA and involve the introduction of plasmids encoding the 
Cas9 and sgRNA components. These methods could presumably increase the 
likelihood of inserting Cas9 and sgRNA recombinant DNA into the genomes of 
target cells. Because of the presence of recombinant DNA, these methods would 
likely fall within the current regulatory oversight of GM crops. See supra Part 
IV. An argument can be made that CRISPR-based genome editing, even if 
performed using recombinant DNA technology, should not be subject to the 
same types of regulations that govern traditional GM crops because the changes 
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advocates for the adoption of a rational framework for the 
regulation of genome-edited crops. It also underscores the 
importance of an interdisciplinary approach to address emerging 
issues raised by gene editing technologies. Above all, the Article 
seeks to jumpstart a conversation about global food security and 
sustainable agricultural practices and, more broadly, about how 
science and technology can influence the world. 	
																																																																																																																												
made to the organism’s genome are far more precise than what can be achieved 
using older recombinant DNA technologies. However, the analysis becomes 
more complex relative to the use of DNA-free genome editing articulated in 
Section VI.A. 
Furthermore, the hypothetical in Section VI.A specifically relied on the 
Nonhomologous End Joining (“NHEJ”) pathway for DNA double-stranded 
break (“DSB”) repair. “NHEJ is an error-prone DSB repair mechanism that can 
efficiently introduce small, random nucleotide mutations . . . .” Enríquez, supra 
note 1, at 620. Another DSB repair mechanism called Homology-Directed 
Repair (“HDR”) is significantly more precise than NHEJ, “ . . . but requires the 
presence of an undamaged, homologous, donor template for repair.” Id.  
Although HDR-mediated DSB repair is less efficient than NHEJ-mediated DSB 
repair, the potential need for a donor DNA template—either synthetic or created 
via recombinant DNA techniques—raises the likelihood that it may be subject to 
the type of traditional GM crop regulations that the DNA-free method is able to 
circumvent more easily.  
